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 Abstract 
 
Background: Stop smoking services (SSSs), combined with pharmacotherapy, are more 
effective for quitting smoking than other aids used alone, including e-cigarettes. SSS 
uptake has nonetheless declined for six years. Amidst pressure on council budgets, this 
declining footfall has led to many areas reducing or discontinuing services. When 
making cuts, councils often cite widespread vaping and suggest this indicates smokers 
nowadays need SSSs less. This PhD aimed to investigate whether vaping amongst 
smokers can influence SSS use and, if so, how this occurs.  
 
Methods: A systematic review synthesised evidence on sociodemographic differences 
in e-cigarette use from 58 studies identified across seven databases. Repeat cross-
sectional survey data was collected from 2,139 current smokers through questions 
added into the ‘Smoking Toolkit’ survey. Multivariable logistic regression assessed 
associations between SSS uptake and: a) e-cigarette use; b) knowledge/belief 
statements about e-cigarettes or SSSs. Finally, 46 semi-structured interviews were 
undertaken with smokers and SSS professionals at three sites. Principles of framework 
analysis were applied to examine factors influencing smokers’ decisions to use e-
cigarettes or SSSs, including potential impacts of differences in perspectives between 
smokers and SSS professionals. 
 
Findings: Systematic review results suggested higher e-cigarette use among younger 
adults, males and people of white ethnicity. Survey data showed smokers who vaped 
were more likely than others to report both past and planned SSS uptake. Further 
analyses showed beliefs about e-cigarettes’ effectiveness and familiarity with vaping 
were associated with decisions to use SSSs. Semi-structured interviews indicated a 
range of views on potential risks from vaping. These appeared to be key factors 
influencing – for smokers – their e-cigarette use, and – for services – the support 
provided in relation to e-cigarettes. 
 
Conclusion: Smokers using e-cigarettes remain keen to use SSSs. Given social gradients 
in smoking rates, removing opportunities to access such services may have retrograde 
health impacts for society’s most vulnerable people. 
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 Chapter 1:   Background 
 
1.1   Introduction   
 
E-cigarettes remain one of the most topical and vigorously debated issues in public 
health today. Since their arrival into European and US markets over a decade ago, 
uptake has increased dramatically, both internationally and within the UK; here, for 
instance, 5.4-6.2% of all adults are estimated to be currently using them, as of 2018.(1) 
Research into the potential risks and benefits of vaping has also expanded enormously 
over this time, with 1,097 publications recorded in 2018 alone.(2) The research that has 
been undertaken to date into their effectiveness as tobacco quit aids is, however, limited 
and inconclusive.(3,4) Moreover, academic interest potentially appears to be shifting 
elsewhere, with bibliometric analysis suggesting an increasing research focus on issues 
around youth uptake and a declining interest in areas concerning ‘cessation’.(2)  
 
In contrast to e-cigarettes, a well-established evidence base exists for stop smoking 
services (SSSs) which - combined with pharmacotherapy - have been shown to be more 
effective than other measures alone.(5) In England, SSSs are commissioned by local 
authorities and most commonly provide face-to-face support from qualified 
practitioners, as well as stop smoking medications. During several sessions over the 
course of weeks or months, a smoker is encouraged to set a quit date, before being 
advised on how to prepare for it and then given support following the ‘jumping off 
point’ to manage cravings, to use pharmacotherapy correctly and - if desired - to wean 
off any nicotine replacement products. Around 90% of services also offer telephone 
support and around 50% offer group sessions. The latest research from Action on 
Smoking and Health (ASH) and Cancer Research UK (CRUK) shows the impact that 
budget pressures are having on local authorities, however.(6) Only 56% of councils still 
maintain a ‘universal’ SSS (i.e. one accessible to any smokers in their area) staffed by 
stop smoking specialists or wellbeing/lifestyle counsellors, as other models have 
increasingly emerged in recent years. Approximately 22% of local authorities have 
moved from specialist services to ‘integrated lifestyle’ services (providing smoking 
support alongside advice on diet, alcohol and physical activity), for instance, while in 
9% of areas the only assistance provided to smokers is from pharmacists and GPs.(6)  
14
  
Despite the strong evidence of their effectiveness,(5) uptake of SSSs has nonetheless 
now been dwindling for six consecutive years (2012/13-2017/18), dropping between 
11% and 23% annually over this period.(7) In the context of ongoing, sustained 
pressure on council public health budgets, it is this declining footfall that has led to SSSs 
in many areas being scaled back considerably and some even being completely 
discontinued.(6) When making these cuts, councils have frequently cited the 
widespread popularity of e-cigarettes and suggested that this indicates smokers have 
less need for SSSs nowadays.(8–11) Meanwhile, there has been increasing recognition 
nationally about the importance of investigating whether e-cigarette use could be 
impacting smokers’ uptake of more effective cessation options such as behavioural 
support.(1,7,12,13) The single English study to date that considered this as one of 
several outcomes reported inconclusive findings, so this remains an ongoing 
concern.(14) As Filippidis et al. have argued, “the question of whether the availability of 
e-cigarettes will displace other methods, and the impact of such a displacement, should 
be closely evaluated”.(13)  
 
This research gap has in fact become even more important to address in light of 
emerging evidence suggesting the potential effectiveness of e-cigarettes when used 
specifically within the context of SSSs. Routine data suggests, for instance, that SSS 
clients who use e-cigarettes in combination with behavioural support have comparable 
quit rates to those using licensed pharmacotherapy,(4) and this picture was recently 
supported by the first major RCT on this specific issue.(15) Yet far more SSS clients 
currently use licensed medicines compared to e-cigarettes.(4,16) The 2018 Public 
Health England (PHE) report on e-cigarettes therefore included a conclusion that “if ECs 
[e-cigarettes] are contributing to higher success rates, Stop Smoking Services in England 
may be missing an opportunity to maximise cessation outcomes for smokers who use 
their service”.(4) Researchers such as Salloum et al. have similarly flagged up that “more 
investigation is needed, including qualitative studies, of perceptions about evidence-
based pharmacological and behavioural cessation therapies, as well as investigation 
into patient-provider interactions related to e-cigarette use”.(17) This thesis set out to 
address these research gaps. 
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 1.2   Aims and objectives  
 
The aim of this thesis is to investigate whether, amongst English smokers (the 
‘population’), the use of e-cigarettes (the ‘exposure’) could be influencing their use of 
SSSs (the ‘outcome’) and, if so, how this is occurring. 
 
Three objectives underpin this aim: 
 
 Objective A: To understand, within English smokers (the ‘population’), how use 
of e-cigarettes (the ‘exposure’) varies across sociodemographic groups, and to 
consider this in relation to existing data on how use of SSSs (the ‘comparator’) 
varies across the same population; 
 Objective B: To investigate whether, amongst English smokers (the ‘population’), 
use of e-cigarettes (the ‘exposure’) is associated with use of SSSs (the ‘outcome’), 
including in comparison to NRT use (the ‘comparator’); 
 Objective C: To investigate, amongst English smokers (the ‘population’) what 
factors (the ‘exposures’) influence decisions to use either e-cigarettes or SSSs 
(the ‘outcomes’), including the potential impact each can have on the other. 
 
 
1.3   Overview of thesis methods 
 
1.3.1   Systematic review 
 
First, I undertook a systematic review to synthesise the available evidence on 
sociodemographic differences related to e-cigarettes. This involved systematically 
searching seven major electronic research databases, without any restrictions on 
publication year or geography, as well as undertaking a trawl of 12 grey literature 
databases and key websites (an example of my search strategy is available at Appendix 
A). Primary outcomes were e-cigarette awareness, trial (‘ever use’) and current use. 
Cross-sectional and longitudinal studies were included if they contained subgroup 
analysis of any of the PROGRESS Plus sociodemographic groups (place of residence, 
16
 race/ethnicity, occupation, gender, religion, education level, socioeconomic status and 
social capital, with ‘Plus’ signifying additional categories such as age, disability and 
sexual orientation). Data from the 58 eligible studies were extracted and checked, 
before an established tool originally created by the Joanna Briggs Institute (JBI) was 
adapted to assess quality and risk of bias. Results were drafted into a narrative review, 
where detailed outcome data were contained within an ‘effect direction plot’ (available 
at Appendix B), a technique for visually displaying reported impacts developed by 
Thomson and Thomas.(18) Across all the outcomes, I found that e-cigarettes appeared 
to have achieved greater reach among older adolescents and younger adults, males and 
people of white ethnicity. Awareness and ‘ever use’ were also greater in subpopulations 
with relatively higher educational attainment. 
 
1.3.2   Quantitative workstream 
 
I then collected new repeat cross-sectional survey data from 2,139 current smokers 
through the addition of 6 new questions into the Smoking Toolkit Study (STS), a long-
running, nationally representative survey in England.(19) The analyses of these new 
data primarily assessed associations between e-cigarette use and past or planned 
uptake of SSSs through the use of multivariable logistic regression to adjust for potential 
confounding variables. Analyses also examined sociodemographic differences in these 
associations through the inclusion of interaction terms. In summary, dual users of 
tobacco and e-cigarettes were more likely than other current smokers to report having 
accessed SSSs in the past and intending to take up these services in the future. Smokers 
who ‘dual used’ nicotine replacement therapy (NRT) and tobacco reported similar 
findings. 
 
The STS questions furthermore collected information about knowledge and beliefs – 
including those relating to e-cigarettes – that could be influencing the use of SSSs. In a 
separate piece of analysis using data from the same 2,139 respondents, multivariable 
logistic regression was again used to assess associations between these knowledge and 
belief variables and past or planned SSS uptake. Similarly, interaction analyses again 
examined potential sociodemographic differences in the associations, as well as 
differences between ‘dual users’ of e-cigarettes and tobacco versus other smokers. I 
17
 found that, among current smokers, beliefs about e-cigarette effectiveness and 
familiarity with vaping (both knowing how to vape oneself and knowing others who 
vaped) were associated with decisions to access SSS support. These decisions were also 
associated with familiarity with SSSs themselves, as well as with perceptions of SSSs 
(including convenience, likely time commitments and anticipated welcome) and valence 
of any previous SSS uptake. Interaction analyses suggested that, for some of these 
variables, differences existed between smokers of different gender, social grade and 
vaping status. 
 
1.3.3   Qualitative workstream 
 
For my qualitative workstream, I conducted 46 semi-structured interviews with current 
and recent ex-smokers (n=29), as well as SSS professionals (n=17), at three research 
sites in England, each comprising an SSS and its surrounding local ‘catchment’ area. For 
smokers, these interviews explored factors influencing their decisions around using 
behavioural support or e-cigarettes (as Pearson et al. have stated, qualitative research is 
arguably the most appropriate for these kinds of “in-depth explorations of reasons for 
[e-cigarette] use”).(20) For SSS professionals, interviews explored characteristics of 
their service’s policy on e-cigarettes and how this was translated into practice, as well 
as individuals’ own views on e-cigarettes. They thus provided insights into how both 
SSS policies on e-cigarettes and individual practitioners’ own beliefs about them could 
be influencing the attendance of some of their potential clients. All interviews were 
based on topic guides that were adapted as necessary depending on an individual’s 
specific background (e.g. some questions about SSS or vaping experiences were less 
appropriate for non-SSS users or non-vapers). Interviews also left space for discussion 
of any areas that were of particular interest for individual interviewees. Supplementary 
materials relating to the recruitment and consent arrangements for the qualitative 
workstream, as well as examples of topic guides used, are included at Appendices C to G. 
 
Analyses were based on the principles of framework analysis,(21) with findings framed 
using the ‘COM-B’ model of behaviour change.(22) In a heavily populated field, COM-B 
has the strong advantage over previous models and theories of being based on a wide-
ranging, transparent and systematic synthesis of preceding research. Like all models, it 
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 is not perfect – in particular, it has been criticised by Ogden who perceives it as 
removing valuable theory variability.(23) In addition, had I been researching smoking 
relapse, other frameworks such as the ‘Stages of Change’ or ‘Transtheoretical’ model 
would arguably have incorporated that concept more naturally. Yet, as a theoretical 
framework, it has proved a coherent and robust foundation for a broad range of 
research across the field of smoking cessation and beyond. It has been applied 
productively, for instance, to studies examining the uptake of vaping and behavioural 
support respectively, as well as research into smoking-related behaviours more 
generally.(22,24–26) COM-B’s pragmatism has also led to it being used to underpin the 
SSS commissioning guidance provided by PHE to local authorities.(27) Framing my 
findings using it should therefore have the added advantage of facilitating the 
dissemination and impact of my final recommendations.  
 
Overall, I found that both smoker and SSS participants reported a range of individual 
views on the potential risks of long-term vaping; these appeared to be key factors 
influencing – for smokers – their use of e-cigarettes, and – for services – the scope of 
advice and support they provided in relation to e-cigarettes. Conversely, the two groups 
differed in their perceptions of how much opportunity services were providing for 
educating smokers about e-cigarettes and for helping with ongoing nicotine addiction 
after quitting smoking. Further important influences reported by smokers on their use 
of e-cigarettes often overlapped with influences on their use of SSSs. 
 
1.3.4   Mixed methods 
 
This thesis uses a ‘mixed methods’ approach to address its overall aim. Widely used 
within the social sciences, mixed methods research involves collecting and analysing 
both qualitative and quantitative data.(28) There are a number of reasons for this 
choice. Most fundamentally, it derives from the overall epistemological grounding of my 
research since, throughout this work, I have been guided by the philosophy of ‘subtle 
realism’ described by Mays and Pope: 
 
“Other authors agree that all research involves subjective perception and that 
different methods produce different perspectives, but, unlike the anti-realists, they 
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 argue that there is an underlying reality which can be studied. The philosophy of 
qualitative and quantitative researchers should be one of ‘subtle realism’ – an 
attempt to represent that reality rather than to attain ‘the truth’”.(29)  
 
In my case, I have been interested in both the perspectives of smokers who are 
answering fixed questions in the context of a face-to-face but computer-assisted survey 
and the perspectives of smokers and SSS professionals when they are able to elaborate 
at length in response to more fluid questions during a semi-structured interview. In 
both the quantitative and qualitative work, the responses provided will have been 
influenced to varying degrees by the specific environment of the interview as well as by 
the unique interaction with the interviewer (myself in the case of the qualitative 
interviews). This influence will have resulted, for instance, from the rapport or dynamic 
created with an individual interviewee, as well as the inherent characteristics (ethnicity, 
gender, age etc.) of myself as the qualitative data collector or the Ipsos-MORI employees 
as the quantitative ones. So while I believe there is ‘an underlying reality’ to why people 
make decisions in this area, this will be a reality which varies from one individual to 
another (and perhaps even from one day to another) and which no single research 
method has exclusive access to. Mixing methods therefore surely gets us closer to 
understanding the complexity of this ‘underlying reality’ than collecting either 
quantitative or qualitative data alone. Related to this, the acknowledgment of my own 
‘subjective perception’ is another reason for my use of framework analysis, given its 
recognition that there are often ‘a priori’ deductive concepts which a researcher is 
interested in and that not all themes therefore need to emerge inductively from the 
data. 
 
Studies into the value of mixed methods approaches suggest that - where they are 
feasible - they can strengthen the validity of research’s conclusions and potentially 
provide fuller, richer insights into phenomena than data collected by a single 
method.(30–32) A key element of this is the integration of different data types which, it 
has been argued, provides more assurance in the robustness of results by bringing 
together the advantages of each individual method while minimising limitations.(33) 
Others suggest that the approach is more inclusive as it incorporates diverse 
perspectives or that it facilitates the generation of recommendations for further 
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 studies.(34,35) Conversely, concerns have occasionally been raised that individual 
researchers often have insufficient expertise to examine issues using both approaches, 
or that mixed methods designs are sometimes employed in situations where collecting 
either quantitative or qualitative data in isolation would actually be more appropriate 
for costs and timeframes.(36) In light of these criticisms, I undertook a broad range of 
training over the course of my research programme into key aspects of both qualitative 
and quantitative methods. As for the appropriateness of combining qualitative and 
quantitative methods for my particular research questions, there are already 
precedents demonstrating that this approach can reveal unanticipated factors shaping 
the use of smoking cessation services.(37,38) Furthermore, Tashakkori and Teddlie 
argue that “if there is a strong possibility that one might get incomplete and 
unsatisfactory answers, shorter and less expensive paths that provide such answers are 
not desirable”.(36) In my case, I was fortunate to have sufficient time and funding to do 
justice to both quantitative and qualitative workstreams. I also felt that both sets of 
proposed data were necessary in order to address my specific objectives fully. 
 
One further key question to address up front is what I really mean by ‘mixed’. It has 
been argued that insufficient thought is sometimes given to how different methods 
being mixed will complement each other and be combined, which can risk qualitative 
elements being subordinated to quantitative ones.(36) In my own case, I have 
undertaken 'convergent' mixed methods research, a recognised design whereby 
separate quantitative and qualitative findings are examined alongside each other in 
order to validate findings.(33,39) Drawing on a widely used typology,(40) my mixed 
methods approach informed my overall research programme through the concepts of 
'development', 'complementarity' and 'expansion’: 
 
 My systematic review collated existing quantitative studies relating to e-cigarette 
use and helped to identify population groups of interest for later tests of 
sociodemographic interactions within my quantitative data (‘development’); 
 The questions decided upon for the quantitative workstream, and emerging 
insights from my STS data analysis, also informed the broader discussion areas 
included in the topic guides for the semi-structured interviews (‘development’); 
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  These interviews in turn allowed the STS question areas to be investigated at 
greater length and depth (‘complementarity’), drawing out real-life experiences 
of smokers and extending the range of inquiry to include emergent themes as 
well as the incorporation of SSS professional views (‘expansion’).  
 
Given the ‘research paper’ format of this PhD, the qualitative and quantitative 
workstreams’ findings are initially presented separately, as this has facilitated the 
submission of my results to various journals, before key findings from both datasets are 
brought together for full consideration within the thesis. The following section provides 
further details on my overall thesis structure. 
 
1.4   Thesis structure 
 
A short outline of the thesis’s structure is presented here for ease of reference. Table 1 
also shows the chapters and page ranges that address my different objectives. 
 
Table 1: Links between objectives and chapters 
Objective 
Objective 
summary 
Addressed 
in chapters 
A: To understand, within English smokers 
(the ‘population’), how use of e-cigarettes (the 
‘exposure’) varies across sociodemographic 
groups, and to consider this in relation to 
existing data on how use of SSSs (the 
‘comparator’) varies across the same 
population  
How is e-cigarette 
use (the ‘exposure’) 
patterned across 
society compared 
to SSS use (the 
‘comparator’)? 
3,7 
B: To investigate whether, amongst English 
smokers (the ‘population’), use of e-cigarettes 
(the ‘exposure’) is associated with use of SSSs 
(the ‘outcome’), including in comparison to 
NRT use (the ‘comparator’) 
Is e-cigarette use 
(the ‘exposure’) 
associated with SSS 
use (the ‘outcome’)?  
4,7 
C: To investigate, amongst English smokers 
(the ‘population’) what factors (the 
‘exposures’) influence decisions to use either 
e-cigarettes or SSSs (the ‘outcomes’), 
including the potential impact each can have 
on the other 
What factors (the 
‘exposures’) 
influence e-
cigarette or SSS use 
(the ‘outcomes’)? 
5,6,7 
 
Part I provides context to the thesis as a whole. Chapter 1 concludes with a brief 
summary of the ethics clearances obtained for this programme of work, while Chapter 2 
presents a narrative literature review enabling the findings that follow to be placed 
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 within the broader research landscape. Chapter 3 provides additional important 
research context in the form of the first of four research papers: the systematic review 
into sociodemographic differences in e-cigarette use published in Tobacco Control.(41) 
Part II contains the findings from the quantitative and qualitative workstreams within 
three further research papers. Firstly, Chapters 4 and 5 present the two papers using 
STS data. Chapter 4 assesses the association between e-cigarette use and SSS uptake 
while Chapter 5 assesses the associations between various knowledge and belief 
variables and SSS uptake. These chapters include the versions of the papers that were, 
at the time this thesis was examined, being finalised for submission to the journals 
Thorax (Chapter 4) and Drug and Alcohol Dependence (Chapter 5) respectively. They 
have since been updated to incorporate minor corrections recommended by my Viva 
examiners. Chapter 6 is my qualitative results paper containing the findings from my 46 
semi-structured interviews which, at the time this thesis was examined, was in the 
process of being sent for peer review by the first journal approached, Addiction. 
Similarly, it has subsequently been updated to incorporate minor corrections 
recommended by my Viva examiners. Finally, in Part III, the findings from the various 
research papers are explored in more depth, structured by the thesis’s three objectives. 
Chapter 7 therefore contains a full discussion integrating my quantitative and 
qualitative results, as well as presenting implications and final concluding remarks. 
 
As per London School of Hygiene & Tropical Medicine’s (LSHTM’s) ‘research paper style 
thesis’ format, the various results chapters are included in the form of manuscripts for 
journals. In the case of the systematic review (Chapter 3), this is the published version 
so is presented as formatted and printed within Tobacco Control. For readability 
purposes, the other three manuscripts have been formatted to align with the rest of the 
thesis, with the relevant reference list provided at the close of each chapter. Wherever 
possible, repetition between sections has been minimised, although there is inevitably 
some similarity in parts of the methods sections for Chapters 4 and 5 given they 
employed data from the same participants. For the purposes of preserving anonymity, 
care has been taken in Chapters 6 and 7 to ensure no identifying details are included for 
individuals or research areas (given, for instance, that each SSS has only one manager). 
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 1.5   Role of candidate 
 
This PhD research was funded by a National Institute of Health Research (NIHR) Clinical 
Doctoral Research Fellowship. I therefore went ‘out of programme’ (OOP) from my 
training as a public health specialty registrar for the three year period and instead held 
a fixed-term contract with LSHTM. As well as the research skills developed during this 
time, I was therefore also able at various points to gain some further teaching 
experience by supporting a number of the university’s MSc modules.  
 
Each of my results papers involved co-authors but, in each case, I had overall lead 
responsibility for conceptualisation, data collection, analysis, drafting and revision, with 
guidance and input from my supervisors as required. Both my own responsibilities and 
those of co-authors are detailed fully in the methods sections of Chapters 3 to 6, as well 
as in the ‘contributors’ paragraphs within Chapters 3 and 4. The ‘research paper cover 
sheets’ at the start of each results chapter also summarise my contribution in each case. 
 
1.6   Ethical clearances 
 
The programme of research contained within this thesis received all necessary ethical 
approvals through submissions to the LSHTM Research Ethics Committee (REC, 
reference 11672) and the Social Care REC (reference 11672, IRAS ID 223311). Although 
my study did not involve social care settings or organisations, the Research Ethics 
Service’s position is that Social Care REC review is the most appropriate option for 
studies like mine that use qualitative methods, such as semi-structured interviews, 
without involving any change in treatment or clinical practice.(42) Local NHS R&D 
requirements were furthermore fully met at each of the three research sites in advance 
of any interviews commencing, while overall HRA approval was also sought and 
obtained (reference 17/LO/0414, IRAS ID 223311). Full copies of approval letters are 
contained in Appendix H. 
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 Chapter 2:   Literature review 
 
2.1   The burden of tobacco 
 
Tobacco remains one of the greatest public health challenges faced globally.(1) The 
demonstration by twentieth-century researchers of the array of risks faced by tobacco 
users may have prompted the steady declines in prevalence currently being observed in 
many higher-income countries,(2) but over 1.1 billion people, or 20.2% of the world’s 
adult population, still smoke, as of 2018.(3) The associated health and economic 
burdens are therefore vast: globally, tobacco is still responsible for one in ten of all 
deaths (an estimated six million annually) and is the second highest risk factor for 
morbidity and premature mortality.(1,2) Its contribution to world-wide disease 
burdens is in fact increasing, with this varied morbidity in turn placing severe pressure 
on health services.(2,3) Estimates suggest 5.7% of global health expenditure is directed 
towards smoking-attributable diseases, and the total economic cost from smoking has 
been calculated to amount to almost 2% of the world’s entire gross domestic product 
(GDP).(4) It also hits the world’s poorest the hardest, as research indicates tobacco is 
driving increases in health inequalities in nations with the most enduring rates of 
smoking.(5,6) At a global level, disadvantaged smokers aged between 35 and 69 have 
been shown to have far higher mortality rates than others.(7)  
 
These stark patterns are very much evident within the UK, where smoking remains the 
biggest cause of preventable morbidity and mortality,(8) as well as a leading driver of 
health inequalities.(9) Here, 15.1% of the adult population smoke (2017 data), equating 
to some 7.4 million people,(10) resulting in over 474,000 hospital admissions annually 
from smoking and 200 deaths each day from preventable smoking-related diseases.(9) 
Although overall prevalence of smoking in adults is declining slowly, latest data 
suggests that this is not the case for some vulnerable groups, such as pregnant women, 
and that the gap in smoking rates between higher and lower socioeconomic groups 
remains unchanged.(11) Around 50% of UK smokers who cannot, or do not wish to quit 
will die prematurely as a result of their tobacco use, each losing on average a decade of 
their life.(12) Costs borne by the NHS are in the region of £2.6billion annually, with 
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 smoking estimated to reduce the UK’s GDP overall by approximately £11billion each 
year.(9) The Government’s current main aim for tackling this, as outlined in the Tobacco 
Control Plan published by the Department of Health and Social Care (DHSC) in 2017, is 
to reduce the prevalence of smoking in adults in England to 12% or less by 2022.(9)  
 
Efforts such as these to reduce prevalence in higher-income countries like the UK have 
the advantage that most of the general population now has an awareness of tobacco’s 
overall negative impacts on health, including its role in causing lung cancer and heart 
disease.(13) Furthermore, smokers are generally not willing addicts. Two thirds of them 
report a desire to quit,(14) while over 80% of smokers report high levels of discontent 
from their regret about having taken up tobacco and their disappointment at failing to 
quit.(15) Most smokers, after all, take up the habit in adolescence (when they have less 
understanding about the tenacity of nicotine addiction), before going on to regret it 
later as adults.(16,17) In the US, for instance, 90% of smokers start by the age of 18, 
95% by age 21 and around 99% by age 25.(18)  
 
The reasons why so many smokers wish to quit but cannot are diverse and complex. 
Fundamentally, nicotine is of course a powerfully addictive stimulant. Yet, beyond this, 
there are a vast array of psychological, pharmacological and social factors that influence 
smoking behaviour.(19) Smoking initiation has been shown, for instance, to be 
predicted by: impulsivity, socioeconomic status (SES), mental health challenges, 
genetics and having friends or parents who smoke.(19,20) Moving from initiation to 
regular smoking can meanwhile be predicted by: alcohol use, levels of parental support, 
smoking attitudes, academic interest, and - again - socioeconomic status and having 
friends who smoke.(19,20) Decisions about whether or not to quit are influenced by 
how much pleasure someone derives from smoking as well as how much they enjoy the 
sense of identity of being a smoker.(21) Perceived benefits from smoking in terms of 
relieving stress, managing weight, improving concentration and facilitating socialising 
have also been shown to predict someone’s likelihood of making a quit attempt.(21) Yet 
amongst those smokers who do take action to try to quit, most still choose relatively 
ineffective methods for attempting this. Going ‘cold turkey’ without any 
pharmacological quit aids, for instance, is the most common technique used by smokers 
in such attempts, despite being one of the least effective options available.(22) 
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 Conversely, the most effective option - attending a local stop smoking service (SSS) to 
receive support from a trained practitioner, alongside pharmacotherapy - is being 
chosen by a declining minority.(23)  
 
2.2   The rise of e-cigarettes and associated research 
 
Despite there still being limited data on their effectiveness,(24–26) electronic cigarettes 
(also known as e-cigarettes)  have also been used by increasing numbers of smokers 
over the last decade in their efforts to quit tobacco use; after ‘cold turkey’, they are now 
easily the second most popular quit method in England.(22) E-cigarettes are battery-
powered devices which heat a liquid solution, usually containing nicotine, into an 
aerosol or 'vapour', hence the term 'vaping' to denote the act of using them. Since their 
introduction into European and North American markets in around 2006/07, e-
cigarettes have emerged as a highly disruptive technological development.(27) The 
array of devices, most commonly termed e-cigarettes or ‘vapes’, have proven attractive 
to many smokers given that they mimic the behavioural aspects of smoking and deliver 
nicotine while avoiding the vast majority of toxins produced by the combustion of 
tobacco (the predominant risk factor for smoking-related disease). As a result, the 
global market for e-cigarettes has grown to the point where it is now expected to reach 
US$26billion by 2023,(28) although significant variation exists internationally in the 
availability of these devices given the diverse regulatory approaches adopted by 
different countries.(29) In Great Britain, following a rapid rise in uptake prior to 2015, 
subsequent prevalence has remained relatively stable, with various surveys reporting 
approximately 5.4%-6.2% of adults to be using e-cigarettes, as of 2018.(30) As is the 
case with nicotine replacement therapy (NRT), the majority of these users are current 
smokers.(30,31) Among smokers as a whole, prevalence of current use in 2018 stood at 
around 14.9%-18.5%, with only 37.2% of smokers reporting never having used an e-
cigarette at any point.(30) Of the smokers using them, the most common reason stated 
is to help with giving up conventional/combustible cigarettes;(25,32) indeed, such ‘dual 
using’ smokers have been shown to have greater motivation to quit tobacco than other 
smokers (AOR 1.95, 95% CI = 1.10 to 3.46).(33)  
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 This rapid uptake of e-cigarettes seen in Great Britain and elsewhere has led to a 
corresponding surge in research aiming to more fully understand both their potential 
risks and benefits,(34) but some divisions remain within the public health community 
on the topic.(35,36) Health concerns are frequently raised, for instance, about the 
individual constituents of e-cigarette liquid and the potential long-term harms from 
inhaling these,(37) with many studies assessing the impacts of e-cigarette vapour down 
to a cellular level.(38) Part of the challenge is the speed with which the industry and its 
technology has developed over recent years. As ‘second generation’ and ‘third 
generation’ modifiable devices have increasingly proved preferable to vapers over the 
‘first generation’ of early ‘cigalike’ e-cigarettes,(39–41) research has perhaps struggled 
to keep pace with the market.  
 
Amidst this fluid context, and in light of the tobacco industry’s increasing absorption of 
smaller manufacturers, some prominent figures have argued for caution from policy-
makers and regulators or even outright bans on the use of e-cigarettes.(36,42) Indeed, 
internationally, diverse approaches have been taken amongst the 98 countries that have 
national e-cigarette regulations in place, with 29 forbidding e-cigarette sales 
entirely.(30) A recent study argued that regulations primarily reflected whether e-
cigarettes are classed by individual nations as tobacco, consumer or medicine 
products.(29) The authors found that adverts for e-cigarettes were prohibited in 51% of 
the countries that have regulations, while 38% had banned vaping in ‘public places’. 
Safety standards were mandated in 38% of countries with regulations, while ‘market 
authorisation’ was needed to sell these devices in 25% of them.(29) Within the UK, the 
‘UK Tobacco and Related Products Regulations 2016’ implemented the European Union 
Tobacco Products Directive (TPD), which contained regulations on e-cigarettes and 
refills, including - notably - restrictions on marketing, stronger safety standards, clearer 
labelling requirements and a 20mg/ml cap on nicotine concentrations.(29,43) Canada 
has adopted a relatively similar approach to the UK through its Tobacco and Vaping 
Products Act, which encompasses e-cigarette production, selling, product warnings and 
marketing. It aims to limit youth access and prevent uptake whilst enabling a harm 
reduction approach for adult smokers that allows them to continue to purchase e-
cigarettes.(30) Conversely, in Australia, electronic cigarettes containing nicotine are 
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 banned from being sold until one is licensed as an effective smoking cessation tool by 
their National Health and Medical Research Council.(30)  
 
Broader, societal risks from e-cigarettes that have been increasingly debated and 
researched include the threat that non-smokers will take them up before moving onto 
tobacco (often termed the ‘gateway hypothesis’) and the associated argument that 
widespread acceptance of vaping could ‘renormalise’ smoking-related behaviour, thus 
undoing decades of hard-won progress in tobacco control.(34,35) The risk of non-
smoking youngsters initiating regular e-cigarette use is an area which has caused 
considerable alarm in the US in particular, often centred around the specific ‘Juul’ brand. 
With rates of past-year vaping amongst 12th graders (final year high school students) 
rising in one survey from 27.8% to 37.3% between 2017 and 2018,(44) the US Surgeon 
General termed their teen vaping situation an “epidemic”.(45) Linked to this, the Food 
and Drug Administration (FDA) has tried to clamp down on any targeted marketing of 
e-cigarettes towards children by manufacturers such as Juul, threatening to ban non-
compliant companies from the marketplace.(18) A key difference between the UK and 
the US in this area is the 20mg/ml nicotine cap that the aforementioned ‘UK Tobacco 
and Related Products Regulations 2016’ introduced into the UK, based on the EU’s TPD. 
As yet, such constraints on nicotine concentrations in Juul and similar devices have not 
been implemented across the US.(30) 
 
These differences in regulations may be a key factor in explaining why England has not 
to date experienced a spike in adolescent vaping like the US, with e-cigarette use 
amongst teenagers here remaining at very modest levels and predominantly being 
reported in those who are also smoking.(30) Although ‘ever use’ of e-cigarettes among 
youngsters has slowly risen, the most recent (2018) data from regular surveys by 
Action on Smoking and Health (ASH) show that only 1.7% of 11-18 year olds are regular 
vapers and only 0.2% of this age group are never-smokers but regular vapers.(30) This 
picture appears to be echoed across Great Britain, with a recent repeat cross-sectional 
study finding “little evidence that renormalisation of youth smoking was occurring 
during a period of rapid growth and limited regulation of e-cigarettes from 2011 to 
2015”.(46) That study did however observe a “marginally significant slowing in the rate 
of decline for regular smoking” among young teens between 2010 and 2015 when e-
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 cigarettes were surging in popularity across the UK market. Prospective cohort research 
adds stronger notes of caution. A study of 3,800 Scottish 11-18 year olds in 2015/16 
showed, for instance, that ‘never smoking’ participants who had tried e-cigarettes were 
more likely to then also try tobacco (AOR 2.42, 95% CI = 1.63 to 3.60).(47) Similarly, 
follow-up of almost 3,000 young teens in England in 2014/15 found that e-cigarette use 
at baseline was strongly associated with initiating smoking within the following twelve 
months (AOR 4.06, 95% CI = 2.94 to 5.60).(48) The recent introduction of Juul devices 
into the UK market, including the supermarket sector, potentially gives further cause for 
concern, particularly in light of cross-sectional evidence that teens’ exposure to e-
cigarette shop displays is associated with their intention to use e-cigarettes (as strongly, 
in fact, as tobacco exposure is associated with their intention to smoke).(49) Continued 
vigilance from researchers therefore seems likely in this area, for instance through close 
monitoring of trends in the respective rates of teen smoking and vaping, since these 
remain the best proxies we have for establishing gateway effects.(50) 
 
As alluded to earlier, some of the public health community remains divided on the topic 
of e-cigarettes,(51) which - it has been argued - may reflect the inherent tension 
between harm reduction and abstinence perspectives towards tobacco.(52,53) Yet 
despite these ongoing areas of contention, a consensus has emerged across the 
substantial majority of the public health and academic community that e-cigarettes - 
while unlikely to be risk-free in absolute terms - are likely to be far less dangerous than 
smoking. The most widely-cited estimate suggests a 95% risk reduction is likely for e-
cigarettes versus smoking.(25,54,55) Systematic syntheses of research in this area 
indicate a lack of credible evidence to date to challenge the resulting recommendations 
that smokers switching to e-cigarettes are likely to receive significant health gains 
compared to those who do not.(24,25) One modelling estimate suggests, for instance, 
that switching smokers onto e-cigarettes would save 6,000 early deaths annually for 
every million smokers who make the transition.(56) Yet news reporting of individual 
studies continues to lead to alarmist headlines, often by conflating e-cigarettes with 
tobacco products.(57) This media influence may partly explain why surveys frequently 
show considerable public uncertainty on the issue. Lay understanding of the likely 
relative risks of vaping compared to smoking is low among adults, for instance, and 
indeed worsening over time; this picture is also reflected in data focusing specifically on 
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 smokers and ex-smokers.(31,58–60) British youngsters have similarly been shown to 
often have inaccurate harm perceptions relating to e-cigarettes and nicotine.(61,62) 
There have therefore been repeated calls by many researchers for clearer evidence on 
relative harms to be provided to the public.(63,64) 
 
Another key question which has generated considerable discussion is how effective e-
cigarettes truly are for quitting smoking, and whether their use is associated with the 
uptake of other routes to quitting, including SSSs. While there are a range of motivations 
reported for e-cigarette use spanning harm minimisation, convenience, enjoyment, 
social acceptability and consideration of others, the vast majority (83-85%) of dual 
users of e-cigarettes and tobacco report using their devices to try to quit 
smoking.(65,66) Indeed, dual users are more likely to want to quit smoking than other 
smokers.(65) So how effective are they for this purpose? Estimates have often 
suggested that e-cigarettes could be having a significant impact on population level quit 
rates,(25,56,67) with one analysis concluding that they may have been contributing up 
to around 57,000 new quits in England every year.(25) The overall evidence base for 
them as quit aids is still fairly limited, however, with most research to date having been 
in the form of prospective cohort studies.(25) A 2016 Cochrane review did find e-
cigarettes containing nicotine to be more effective for quitting than those without 
nicotine but judged the quality of the evidence in the two identified trials as ‘low’ or 
‘very low’.(24) Other recent systematic reviews involving meta-analyses have produced 
conflicting results, most likely due to varying inclusion criteria relating to observational 
studies.(25) The ongoing paucity of randomised research in this field thus remains a 
concern, but one very recent RCT - not yet included in any systematic reviews - was 
notable for comparing e-cigarettes directly to NRT, with both provided alongside 
structured behavioural support. It found highly significant differences (p<0.001), with 
greater one-year abstinence for the e-cigarette group versus the NRT users (RR 1.83, 
95% CI = 1.30 to 2.58).(26)  
 
2.3   Stop smoking services: history and recent challenges 
 
This most recent trial is particularly important for examining e-cigarette use in the 
context of SSSs.(26) As such, it essentially marks the first RCT to contribute towards our 
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 understanding of the relationship between e-cigarettes and the most effective means of 
quitting smoking as yet identified: behavioural support combined with 
pharmacotherapy.(68,69) The English SSSs, which provide such support, have been 
shown to increase a smoker’s odds of quitting by up to four times,(69) while evaluations 
have also demonstrated their high cost-effectiveness.(70) Established in 2000, following 
publication of the UK Government’s 1998 White Paper ‘Smoking Kills’,(71) their original 
aim was to provide access to behavioural support, free at the point of use, as well as 
prescribed pharmacotherapy, for every smoker in the country who wanted help to quit. 
This support has traditionally been provided by qualified practitioners either one-on-
one or in group settings. During several sessions over the course of weeks or months, a 
smoker is encouraged to set a quit date, before being advised on how to prepare for it 
and then given support following the ‘jumping off point’ to manage cravings, to use 
pharmacotherapy correctly and – if desired –  to wean off any nicotine replacement 
products. The services are assessed primarily by a ‘four week quit rate’ measure, with 
85% of reported quits requiring validation through carbon monoxide readings.(72)  
 
This new network of services tripled its reach and impact over the first decade of its 
existence, although, from early on, considerable differences were observed between 
areas in terms of their footfall and quit rates, with the latter also varying markedly 
between individual practitioners.(73–75) This led to the establishment by the 
Department of Health in 2008 of the National Centre for Smoking Cessation and 
Training (NCSCT), designed to tackle differences in practitioners’ training levels and 
their adherence to evidence-based practice.(74,76) The NCSCT role has therefore 
involved upholding standards, providing training, sharing best practice and establishing 
minimum standards for practitioners. This has no doubt played an important part in the 
success of the UK model (and the subsequent development of similar services in 
increasing numbers of countries around the world);(77) evaluations have shown, for 
instance, that the effectiveness of an individual SSS is associated with its uptake of the 
training provided by the Centre.(78) 
 
NCSCT currently recommends that services should have a full-time manager and a ‘core 
group’ of qualified advisers working from evidence-based protocols to provide one-to-
one and group sessions, supplemented by any medications recommended by the 
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 National Institute for Health and Care Excellence (NICE). (72) The NCSCT’s standards 
for services sit alongside commissioning guidance provided by Public Health England 
(PHE) to councils (since April 2013, following the Health and Social Care Act of 2010, 
public health in England has been commissioned through local authorities, rather than 
the 151 Primary Care Trusts that preceded this).(79) Yet each local authority area is 
essentially free to determine what kind of service to commission, or whether to 
commission one at all,(79) and the English network of services has faced major 
structural upheavals in recent years.(11) The considerable cuts made to public health 
budgets and the knock-on reconfigurations of services’ commissioning arrangements 
have very likely played a part in the sustained declines in footfall experienced by 
SSSs,(11,80) which have seen overall attendance rates fall for the last six consecutive 
years, from 2012/13-2017/18.(23) Recent research by Cancer Research UK and ASH 
(using survey data collected in August/September 2018) shows that only 56% of local 
authorities now commission a universal SSS.(11) Many have instead combined their SSS 
with lifestyle services (incorporating, for instance diet, alcohol and physical activity), 
despite evidence now showing that this is a relatively ineffective approach for helping 
people to quit smoking, particularly amongst more disadvantaged groups.(11,81) Other 
areas only provide such support to specific target groups such as pregnant smokers, 
while 3% have even cut all support entirely, leaving over 100,000 English smokers with 
no access to any service at all from their local authority.(11)  
 
2.4   Inequalities and access  
 
2.4.1   Tobacco’s role in health inequalities 
 
Fully understanding the potential impact of these recent changes to English SSSs 
requires situating them in the context of broader work on health inequalities and access 
to healthcare. Over recent decades, researchers have delineated with increasing clarity 
the engrained health inequalities that exist across UK society, as well as the central role 
that smoking plays in exacerbating these. Acheson argued, for instance, that smoking 
was responsible for more than 50% of the difference in the risk of early mortality 
between the most affluent and most deprived parts of the UK.(82) Indeed, smoking has 
subsequently been shown to be closely linked both to deprivation and to lower 
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 education, associations that are sadly increasing over time.(5,7,83) As well as higher 
smoking prevalence, more disadvantaged groups have been shown to have higher levels 
of addiction and lower perceptions of self-efficacy when it comes to quit 
attempts.(84,85) Marmot also famously demonstrated that people in the most deprived 
areas of England were likely to die seven years earlier overall than people in the most 
affluent areas,(86) a gap which is now thought to have grown even two years greater 
since his seminal report.(9) By arguing for much greater focus on the ‘social 
determinants of health’, Marmot’s report drew policy-makers’ attention out towards the 
‘social inequalities’ that drove health inequalities, and an increasing awareness 
developed that the causes of such inequalities were complex and not limited to 
socioeconomics. At a national level, this renewed focus on inequalities may have fed into 
the decision that the 2012 Health and Social Care Act would compel health 
organisations to take account of a requirement to tackle health inequalities. With 
regards to smoking specifically, the ‘Tobacco Control Plan for England’ has a stated aim 
to “reduce the inequality gap in smoking prevalence between those in routine and 
manual occupations and the general population”.(9) There has also recently been an 
increased recognition of health inequalities related to race or ethnicity, which are now 
known to affect these groups at all life stages.(87)  
 
2.4.2   E-cigarettes and inequality considerations 
 
Amidst the vigorous academic and media discussions on e-cigarettes outlined earlier, 
there are some less obvious research gaps related to inequalities that have potentially 
been under-examined to date. The impact that e-cigarettes could be having on smoking-
related health inequalities is, for instance, an arguably neglected area. As part of this 
PhD’s programme of work, a systematic review was thus undertaken to collect and 
analyse the international literature on sociodemographic differences in awareness of e-
cigarettes and prevalence of ever and current use. Full results are outlined in the 
published paper in the next chapter, but in summary, awareness, ever use and current 
use (usually defined as respondents having used e-cigarettes within the last 30 days) 
appeared to be particularly prevalent among older adolescents and younger adults, 
males, and people of white ethnicity. Awareness and ever use were also higher in those 
with intermediate or high levels of education. At the time of the review, data from the 
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 UK was very limited but more recent survey data, brought together in PHE’s ‘Vaping in 
England’ report,1 shows e-cigarette use to be higher in men and amongst 25-34 year 
olds.(30) Although they use different measures, the same surveys broadly agree in 
indicating that vaping is higher amongst lower socioeconomic groups. This is logical 
given the high proportion of vapers who also use tobacco (often termed ‘dual users’) 
and the well-documented inverse relationship between smoking and 
socioeconomics.(5,31) A recent analysis of Smoking Toolkit Study (STS) data assessed 
this with useful granularity, analysing vaping rates separately in all adults, recent ex-
smokers (<1 year since quitting) and longer-term ex-smokers (>1 year since 
quitting).(88) This study underpinned an important point made in the PHE report that: 
 
“The social gradient of vaping in long-term ex-smokers may suggest that those 
from higher social groups are using EC [e-cigarettes] to quit smoking and then stop 
use while those from more disadvantaged groups continue use. If vaping among 
long-term ex-smokers is protective against relapse to smoking, this gradient will 
have a positive impact on health inequalities, if vaping is not protective against 
relapse it may exacerbate health inequalities. No evidence is available on this 
yet.”(30)  
 
Other research has shown that vapers’ preferences for specific generations of devices 
vary by their education level and age.(89)  
 
2.4.3   Stop smoking services: access for vulnerable groups 
 
The concept of access to healthcare is also highly relevant to any discussion of health 
inequalities, given it has been shown to be fundamental to health outcomes and to have 
a direct impact on life expectancy.(90,91) Tudor Hart’s ‘inverse care’ law famously 
stated that services tended to be more available in wealthier areas with less need.(92) 
Yet broader barriers clearly constrain access too: less affluent groups, for instance, are 
less likely to access preventative services even when they are available.(93) Although, 
as a concept, access has not been consistently defined, researchers have increasingly 
                                               
1 A full discussion of the PHE report’s findings in relation to my systematic review is contained in Chapter 
7. 
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 recognised that it involves more than just a simple linear relationship between 
availability and use. More nuanced approaches have therefore emerged in recent years 
that move past cumulative measures of available services and levels of usage.(94) 
Instead, financial, organisational, social or cultural barriers - it has been argued - can all 
come into play in determining the uptake of healthcare by different groups.(95) One 
particularly influential contribution in this area has been the concept of candidacy, a 
synthetic construct first proposed by Dixon-Woods et al. to describe “the ways in which 
people's eligibility for medical attention and intervention is jointly negotiated between 
individuals and health services”.(96) Candidacy is noteworthy for moving beyond 
earlier, more limited and static focuses on service utilisation since it is defined as “a 
dynamic and contingent process, constantly being defined and redefined through 
interactions between individuals and professionals, including how ‘cases’ are 
constructed”.(96)  
 
In terms of access to healthcare for smokers specifically, the provision of effective 
support for people who are trying to quit is clearly vital for tackling the health burdens 
of smoking and for any attempts to reduce associated health inequalities. Indeed, this 
was highlighted internationally as far back as 2003 by the ‘World Health Organization 
Framework Convention on Tobacco Control’ which emphasised in Article 14 that 
signatory countries should endeavour to: 
 
“a) design and implement effective programmes aimed at promoting the cessation 
of  tobacco  use,  in  such  locations  as  educational  institutions,  health  care  
facilities,  workplaces and sporting environments; (b) include diagnosis and 
treatment of tobacco dependence and counselling services on cessation of tobacco 
use in national health and education programmes, plans and strategies,  with  the  
participation  of  health  workers,  community  workers  and  social  workers as 
appropriate; (c)  establish  in  health  care  facilities  and  rehabilitation  centres  
programmes  for  diagnosing, counselling, preventing and treating tobacco 
dependence” (97) 
 
Such services have played a particularly key role in attempts, within the UK and 
elsewhere, to tackle the stubborn health inequalities that are fuelled by smoking’s 
40
 strong association with deprivation and lower education.(5,7,83) Smokers from more 
deprived backgrounds, for instance, were one of the key targets for the English SSSs 
from their inception, along with pregnant women and younger smokers.(98) This focus 
reflected the fact that disadvantaged smokers have historically proved most challenging 
to recruit into behavioural support.(99,100) Today, NICE continues to recommend that 
SSSs target vulnerable groups,(101) and this is now an area where SSSs have had 
considerable success. Several evaluations have demonstrated the services’ effectiveness 
at recruiting smokers from more deprived areas,(74,98) although these disadvantaged 
SSS clients have been shown to be less likely than others to successfully quit, probably 
due to their lower likelihood of completing treatment programmes.(102,103) Indeed, 
service uptake is small across the board: a total of 274,021 smokers set quit dates 
through SSSs in 2017/18, equating to 4.6% of the estimated 5.9m current smokers in 
England.(10,23) The most recent year’s data from NHS Digital show that by far the 
greatest number of quit attempts recorded within SSSs come from the ‘routine and 
manual’ group of smokers (71,635/274,021 in 2017/18, with no other group exceeding 
40,000/274,021), who are also the socioeconomic group most likely to be current 
smokers,(10) though successful quits are highest in four other socioeconomic groups 
(managerial and professional occupations, intermediate occupations, the retired and 
prisoners).(23)  
 
In terms of broader demographic differences, despite men being more likely to be 
current smokers than women (16.4% vs 12.6%),(10) the NHS Digital data show slightly 
higher numbers of females setting quit dates than males (145,281/274,021  vs 
128,740/274,021 in 2017/18), although male users have higher rates of successful 
quits than females (52% vs 49%).(23) In terms of age, smoking rates are highest 
amongst 25-34 year olds, followed by 18-24yr olds, but broadly decline with increasing 
age, with lowest rates seen in the over 65s.(10) Yet more quit dates are set by 45-59 
year olds than other age groups, followed by 18-34 year olds.(23) Meanwhile, a clear 
pattern is evident in rates of actual quits, which increase with advancing age: the over 
60s are therefore the most successful group, with 56% of such smokers reporting 
having quit after using the service.(23) Quit rates appear to be broadly similar across 
ethnic groups, despite large variations in current smoking by ethnicity (7.9% among 
people of Chinese ethnicity through to 20.4% for people self-defining as ‘mixed 
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 ethnic’).(10,23) Geographically, smoking rates range from 3.6% in Rushcliffe to 26.1% 
in Lincoln, while quit rates similarly vary considerably by local authority area, ranging 
from 88% in Staffordshire to 24% in Cumbria.(10,23)  
 
Research is unfortunately still limited on how to improve access to services like these, 
including for vulnerable groups, which is an important gap given barriers to service 
access can have particularly big impacts amongst more disadvantaged groups.(98) 
Internationally, studies to date have often focused on the success of quit attempts 
amongst different groups of smokers once recruited into behavioural support (or other 
community-based quit programmes), rather than the facilitators and barriers that 
actually influence their attendance in the first place.(104,105) A survey of German 
smokers asked about their use of all smoking cessation aids, with the authors 
concluding that the leading reasons for lack of uptake were being ‘overly self-confident’ 
as well as having a perception that such aids were not helpful.(106) Some limited 
quantitative work in the US and qualitative work in the Netherlands has also sought to 
specifically identify why deprived smokers do or do not access behavioural 
support.(107). Within the UK, meanwhile, a small number of qualitative studies have 
examined potential influences on SSS uptake amongst disadvantaged smokers, 
illustrating a range of barriers to attendance, including low awareness of services, as 
well as misperceptions about their availability, effectiveness and cost.(108,109) One 
Scottish study combined interviews with cancer patients, their family members and 
hospital-based health professionals, identifying facilitators and barriers to patients’ quit 
attempts.(110) Influences on smokers included stress, a “desire to maintain personal 
control” and a disconnect between their smoking and their health, including their 
cancer diagnoses. Interviews with clinicians, meanwhile, highlighted barriers that could 
prevent them discussing smoking with patients including concerns about the sensitivity 
of the topic, insufficient opportunities to raise it, a sense of it not being their 
responsibility and a lack of awareness about SSSs.(110)  
 
2.5   Health decision-making and behaviour change 
 
Examining how smokers make decisions about quit routes such as SSSs also requires 
some consideration of the literature on health decision-making, including behaviour 
42
 change. The influential psychological theorist Fishbein defined a belief as “a probability 
judgment that links some object or concept to some attribute” using the example of 
someone who believes that a pill (the object) is a depressant (the attribute).(111) As 
Green et al. explain, beliefs can therefore be broadly defined as “cognitive 
constructs”.(112) For Fishbein, an intention, meanwhile, is “a probability judgement 
that links the individual to some action”, while behaviour is “an observable action that is 
quantifiable on either a dichotomous (i.e. he did/did-not perform action X) or a 
continuous scale (he donated £0 to £X to a charity)”.(111)  
 
A wide array of models and theories, which incorporate beliefs and behaviours in 
various ways, have been proposed for understanding why people make different 
choices relating to their health, as well as how such decisions could best be influenced 
to promote healthier behaviours. A delineation of each of these is beyond the scope of 
this thesis but an overview of some of the most important and relevant is presented 
here. The ‘Health Belief Model’ (HBM) was one of the earliest such health decision-
making models proposed and has been one of the most widely cited of all over the 
years.(112) Posited initially by Hochbaum,(113) and then expanded by 
Rosenstock,(114) it puts beliefs at the heart of health behaviours. In the case of negative 
events, choices are determined by perceptions of: one’s personal susceptibility, the 
seriousness of the event in question, the effectiveness of the course of action 
recommended to avoid it, and the acceptability of the burdens or costs involved in 
taking the recommended action. It was later augmented with further dimensions of ‘self 
efficacy’, ‘health motivation’ and ‘cues to action’ (both internal and external).(112) 
Meta-analyses have, however, cast doubt on how well the HBM predicts behaviour, 
while researchers have criticised its omission of elements such as impulsivity, social 
pressures, intention or self-control.(115–117)  
 
The ‘Stages of Change’ or ‘Trans-theoretical’ model has also proved highly influential, 
described by Armitage, for instance, as “arguably the dominant model of health 
behaviour change, having received unprecedented research attention”.(118) Its cyclical 
nature has led to it being commonly used to study behaviours where people have the 
potential for relapse. As the name suggests, it involves a series of steps or phases that 
people can pass along from ‘precontemplation’ through ‘contemplation’, ‘determination’ 
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 and ‘action’, followed by ‘maintenance’ to protect the person who has made the positive 
choice from ‘relapse’ (failing which, they start back round the cycle again). Stages of 
Change has long been particularly popular in smoking cessation work internationally, 
but it too has had its utility called into question in recent years by systematic review 
findings which have suggested that stage-based interventions for quitting smoking are 
no more effective than others.(119) Other criticism has queried its use in settings 
beyond smoking, pointing to concerns with: its internal validity; the descriptive nature 
of most studies using it; and the ethics of targeting interventions at people deemed to be 
‘change ready’ (thus excluding those deemed to be ‘not change ready’).(120–122) 
 
More recently, the ‘Behaviour Change Wheel’, developed by Michie, van Stralen and 
West, aimed to systematically synthesise this pre-existing multitude of models and 
theories.(123) The COM-B model at its centre posits that behaviour is a product of 
motivation (reflective and automatic brain processes), capability (psychological and 
physical capacities) and opportunity (factors outside or beyond an individual). It seeks 
to facilitate – through the framework’s outer rings, as well as its accompanying 
Behaviour Change Technique Taxonomy – the development of interventions to address 
identified barriers to behaviour change.(124) Despite an uneasiness voiced by Ogden 
that systematisation like this can constrain valuable theory and practice 
variability,(125) the COM-B has been employed as a theoretical framework across a 
broad range of studies in health and beyond. In recent years, for instance, it has been 
used internationally for research areas ranging from auditory rehabilitation to sexual 
counselling and mental healthcare provision.(126–128) Within the smoking cessation 
sector specifically, it has become the central model of smoking behaviour change in 
England, where it underpins the SSS commissioning guidance provided by PHE to local 
authorities.(79) Meanwhile, research in the UK and beyond has applied the framework 
to the uptake of vaping and behavioural support respectively, as well as to smoking-
related behaviours more generally.(116,129–131)  
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 2.6   The relationship between e-cigarettes and stop smoking 
services 
 
Previous research has recommended that behaviour change theories such as COM-B can 
illuminate how smokers’ views on e-cigarettes (particularly views on their potential 
harms) may be influencing psychosocial factors related to decisions to quit 
tobacco.(132) There is equally a need, as argued elsewhere,(133) to better understand 
how smokers’ perceptions of e-cigarettes’ potential risks could be impacting their 
choices around different smoking cessation routes. In particular, the psychological basis 
for smokers’ decisions to use e-cigarettes instead of - or combined with - SSSs is an area 
where very little is known to date. One US cross-sectional survey suggested that 
amongst dual users of combustible tobacco and e-cigarettes, almost all age groups were 
as likely to access behavioural support as other smokers.(134) Similarly, a UK time 
series analysis using data from 2006-2015 also found no clear evidence for an 
association at a population level between e-cigarette use and uptake of behavioural 
support from SSSs. Evidence remains inconclusive, however,(30) and this is therefore a 
particularly important research area to address in light of persistent concerns that e-
cigarette use could be affecting more effective routes to quitting smoking, including 
behavioural support.(30,135,136)  
 
SSS staff themselves perceive the advent of the vaping market as an important factor in 
the declining attendance rates seen by their services, a view echoed by NHS Digital in 
their interpretation of this service attendance data.(23,137) In other words, some 
smokers who would otherwise have accessed SSSs may be choosing to try to quit 
through vaping alone. This perception could even be having a concrete impact on the 
availability of services being provided to smokers. Several councils have tried to use the 
popularity of e-cigarettes within society as part of a rationale for decommissioning their 
local SSS entirely.(138–141) Critics have identified a perceived influence from the 
tobacco industry in these cuts, arguing that such decisions play into industry’s false 
narrative that tobacco control and SSSs have been rendered redundant through 
widespread e-cigarette availability.(139) One national body has also warned that e-
cigarettes cannot be assumed to be ‘picking up the slack’ from the declining uptake of 
other routes to quitting smoking.(142) Similarly, two very recent publications, one a 
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 prospective cohort study of ‘dual users’ and one a cross-sectional survey of long-term 
vapers, suggest significant interest amongst such groups in accessing other cessation 
options for smoking and/or vaping.(143,144) 
 
It is important therefore that e-cigarettes are not viewed reductively as being mutually 
exclusive from other quit options such as behavioural support. There have, after all, 
been significant efforts within England to bring the two quit routes together, combining 
- as PHE puts it - the most popular option for smokers with the most effective.(145) The 
inclusion of e-cigarettes within services is not universally welcomed, however. Several 
international public health bodies, notably including the World Health Organization, 
remain very wary about e-cigarettes and their potential incorporation by health 
services.(146,147) As Chapman points out, the US Preventive Services Task Force 
(which has a similar role to NICE in England) concluded that “current evidence is 
insufficient to recommend electronic nicotine delivery systems (ENDS) for tobacco 
cessation in adults”, advising instead that health professionals point smokers towards 
quit aids with a stronger evidence base.(148) Studies of health professionals in the USA 
and Holland suggest strong concerns about e-cigarettes, with the majority of 
respondents displaying negative attitudes towards them.(149–151) As noted by 
Farrimond and Abraham though,(152) there may be some signs that attitudes are 
starting to shift, with two recent US studies suggesting physicians may be discussing e-
cigarettes with patients more over time and could do so even further if additional 
evidence emerges to support them.(153,154)  
 
In England, policy-makers have certainly been amongst the most liberal in the world 
when it comes to encouraging e-cigarette use as a smoking cessation option.(29) The 
English SSSs have been recommended by several national organisations such as PHE, 
ASH and NCSCT to work with smokers who own their own devices and to provide them 
with the same behavioural support they would give to any other smokers.(25,155,156) 
PHE, for instance, has issued public advice stating that:  
 
“Anyone who has struggled to quit should try switching to an e-cigarette and get 
professional help. The greatest quit success is among those who combine using an 
e-cigarette with support from a local stop smoking service… These [SSSs] should 
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 provide behavioural support to those smokers wanting to quit with the help of an e-
cigarette”.(157)  
 
NICE has meanwhile adopted a fairly nuanced approach. Licensed pharmacotherapies 
containing nicotine are of course already recommended by them to help people in their 
efforts to quit tobacco.(101) Following the EU Tobacco Products Directive, which came 
into force in the UK in May 2016, e-cigarettes can be licensed as either consumer or - if 
they make claims about reducing harm or helping with quitting smoking - medicinal 
devices.(158) The latter route involves considerable regulatory hurdles and, at present, 
no e-cigarettes have to date been licensed by the Medicines and Healthcare products 
Regulatory Agency (MHRA) and recommended by NICE for prescription on the NHS. As 
such, NICE advises that smokers should receive guidance on e-cigarettes from health 
services but does not explicitly specify e-cigarettes as one of its recommended cessation 
tools for SSSs.(101)  
 
Individual services have therefore had to make their own decisions based on the advice 
from these different bodies and in the context of a challenging, often polarised public 
discourse on e-cigarettes within the media. These novel devices have presented a 
particularly unusual challenge for practitioners given they essentially represent a 
market-driven innovation that has not been developed from within the health 
sector.(27) Services certainly deserve credit for having been proactive in this area from 
a very early stage; as far back as 2012/13, some 71% of SSSs reported already having a 
policy in place about advice to be given on e-cigarettes.(159) Yet research on how they 
have been negotiating this terrain in practice - i.e. how far e-cigarettes are in reality 
being incorporated within SSSs - is still very limited to date. A recent systematic review 
with a broad focus on the beliefs and practices of all healthcare professionals regarding 
e-cigarettes showed that most of the research literature in this area comes from the 
USA.(160) The authors found that, overall, healthcare professionals held “diverse views 
about the efficacy of ENDS [e-cigarettes] and expressed wariness over their potential  
health  effects”, with endorsement  of  e-cigarette use  seeming to be decided primarily 
based on “patient health status, the presence of other competing risk factors and patient 
preferences”. In England, a small number of quantitative studies have been undertaken 
specifically with SSS practitioners and clients.(133,159,161) These have focused 
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 primarily on levels of e-cigarette use amongst smokers but also align in indicating an 
unease amongst some SSS practitioners towards e-cigarettes. Beard et al., for instance, 
found in 2014 that 11% of practitioners warned their clients about e-cigarettes’ 
safety.(159) Hiscock et al., meanwhile, showed that the views of practitioners towards 
e-cigarettes had become more positive over time, with 42% agreeing that e-cigarettes 
were ‘a good thing’ in 2016, compared to 15% in 2011.(161) They also concluded, 
however, that “low use of e-cigarettes by clients and practitioner opinions suggest that 
further education of SSS staff is needed if they are to adopt the current service 
recommendations about e-cigarettes”.(161)  Finally, Sherratt et al. showed in a small 
2015 study (n=319) that SSS clients’ perceptions of e-cigarette risks appeared to be 
related to their own current or former e-cigarette use.(133)  
 
Three qualitative studies have also been undertaken in this area. Tamimi interviewed 
15 clients and 13 practitioners in South East England in 2014/15, concluding that “both 
groups demonstrated uncertainty with regards to the status, efficacy and risks 
associated with e-cigarettes”.(162) Sherratt et al. (2015) interviewed 20 SSS-using 
smokers in the North West of England; as with their separate quantitative study,(133) 
they found e-cigarette safety was a primary concern for smokers, with participants 
“largely express[ing] uncertainty regarding e-cigarette safety and efficacy, with some 
evidence of misunderstanding”.(163) Most recently, a 2018 study by Farrimond et al. 
involved 25 SSS staff in the South West of England.(152) Findings suggested that some 
SSSs were badging themselves as ‘e-cigarette friendly’ but that there was no agreement 
over what that meant. The authors also pointed to an ‘ongoing nervousness’ about e-
cigarettes in wider council stakeholders at a local level.(152)  
 
More recent quantitative data that is emerging on the effectiveness of incorporating e-
cigarettes within SSSs is unlikely to be reflected by these earlier studies. Yet, given this 
data is suggesting SSS clients using an e-cigarette may have comparable quit rates to 
clients using other pharmacotherapies, it could be expected to have a significant impact 
on views in this area. In 2016 unadjusted service monitoring data, for instance, smokers 
using e-cigarettes had a median quit rate of 63%, higher than those smokers using other 
pharmacotherapies.(145,161) The 2019 New England Journal of Medicine study 
discussed earlier is the first randomised trial on this issue and showed significant 
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 increases in one-year abstinence for the group of clients using e-cigarettes compared to 
those using NRT.(26) Interestingly, despite this emerging data on the effectiveness of 
combining e-cigarettes and SSSs, routine data suggests very few attendees are using e-
cigarettes in comparison to other pharmacotherapies.(145,161) This may in part reflect 
under-reporting by SSSs who have only recently had to become familiar with capturing 
data on e-cigarettes, in contrast to licensed pharmacotherapies on which they have been 
recording usage for years. Yet, as mentioned above, others see this as suggestive 
evidence that dual users of e-cigarettes and tobacco are less likely than other smokers 
to want to access behavioural support – in other words, that e-cigarettes are 
undermining other, more effective routes to quitting smoking.  
 
2.7   Conclusion 
 
As this chapter has shown, a range of evidence gaps still exist in relation to e-cigarettes. 
These, I would argue, are receiving varying levels of research focus and so being filled at 
different speeds. This thesis aims to address one key area of uncertainty that I believe 
has received particularly insufficient focus to date in comparison to its potential 
implications. It therefore examines the influence that the use of e-cigarettes amongst 
smokers could be having on their likelihood of trying other ways to quit smoking, 
including potential associated impacts on inequalities. 
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 Chapter 3:   Research paper – Systematic review of evidence 
on sociodemographic differences in e-cigarette use 
 
3.1   Introduction   
 
The first of my research papers is presented in this chapter. As an initial step in my 
programme of research, I conducted a systematic review of the evidence base on 
sociodemographic differences in awareness, ‘ever use’ and current use of e-cigarettes. 
This collected data on sociodemographic differences in these outcomes within England 
which I could then assess alongside existing data on sociodemographic differences in 
stop smoking service (SSS) usage (see Chapter 7). It thus allowed Objective A of this 
thesis to be addressed: ‘To understand, within English smokers (the ‘population’), how 
use of e-cigarettes (the ‘exposure’) varies across sociodemographic groups, and to 
consider this in relation to existing data on how use of SSSs varies across the same 
population’. However, given the major, broader research gap in this area, I decided to 
expand the scope of the review to worldwide literature, within which I would still be 
able to assess the specific English picture. The final review, entitled ‘E-cigarettes and 
equity: a systematic review of differences in awareness and use between 
sociodemographic groups’, was published by Tobacco Control in December 2016. The 
article’s online supplementary material - including an example of the electronic search 
strategy and a copy of the full ‘effect direction plot’ - is available at Appendices A and B. 
 
3.2   Research paper cover sheet 
 
The signed cover sheet for this research paper is included on the following page.  
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E-cigarettes and equity: a systematic review
of differences in awareness and use between
sociodemographic groups
Greg Hartwell,1 Sian Thomas,1 Matt Egan,1 Anna Gilmore,2 Mark Petticrew1
ABSTRACT
Objective To assess whether electronic cigarette (e-
cigarette) awareness, ‘ever use’ and current use vary
signiﬁcantly between different sociodemographic groups.
Design Systematic review.
Data sources Published and unpublished reports
identiﬁed by searching seven electronic databases
(PubMed, MEDLINE, Web of Science, EMBASE, Global
Health, PsycINFO, CINAHL Plus) and grey literature
sources.
Study selection Systematic search for and appraisal of
cross-sectional or longitudinal studies that assessed
e-cigarette awareness, ‘ever use’ or current use, and
included subgroup analysis of 1 or more PROGRESS Plus
sociodemographic groups. No geographical or time
restrictions imposed. Assessment by multiple reviewers,
with 17% of full articles screened meeting the selection
criteria.
Data extraction Data extracted and checked by
multiple reviewers, with quality assessed using an
adapted tool developed by the Joanna Briggs Institute.
Data synthesis Results of narrative synthesis suggest
broadly that awareness, ‘ever use’ and current use of
e-cigarettes may be particularly prevalent among older
adolescents and younger adults, males, people of white
ethnicity and—particularly in the case of awareness and
‘ever use’—those of intermediate or high levels of
education. In some cases, results also varied within and
between countries.
Conclusions E-cigarette awareness, ‘ever use’ and
current use appear to be patterned by a number of
sociodemographic factors which vary between different
countries and subnational localities. Care will therefore
be required to ensure neither the potential beneﬁts nor
the potential risks of e-cigarettes exacerbate existing
health inequalities.
INTRODUCTION
Electronic cigarettes (e-cigarettes) are battery-
powered devices which heat a liquid solution,
usually containing nicotine, into an aerosol or
‘vapour’. Such products have proven attractive to
many smokers given that they mimic the behav-
ioural aspects of smoking and can deliver nicotine
while avoiding the vast majority of toxins produced
by the combustion of tobacco (the predominant
risk factor for smoking-related disease).1
E-cigarette use has increased rapidly over recent
years. In Great Britain, for instance, there are an
estimated 2.8 million adults currently using them
(6% of the adult population).2 However, despite
such rapid uptake and their corresponding public
proﬁle, major research questions remain in relation
to their true effectiveness as aids for quitting
smoking and to possible health outcomes arising
from sustained ‘vaping’.3 For instance, the authors
of a recent Cochrane review found only two trials
that followed participants for at least 6 months,
rating their conﬁdence in the evidence as low by
GRADE standards.4 Very little is also known about
variations in e-cigarette awareness and use between
different sociodemographic groups; in other words,
how these outcomes are patterned across society.
The need for such equity-focused analyses is par-
ticularly pressing in light of evidence that smoking
is signiﬁcantly more common in the lowest income
groups and is the leading cause of health inequal-
ities.5 Although it has been argued that e-cigarettes
could reduce inequalities,6 most tobacco control
interventions exacerbate them (only tobacco tax
has been shown to reduce inequalities),7 8 and evi-
dence on diffusion of innovations suggests that
early adopters tend to be more afﬂuent than other
groups.9 This raises the possibility that if e-
cigarettes prove effective at enabling quitting, they
may in fact further widen—rather than reduce—
inequalities in smoking.
Reviews in this area have largely considered
overall population levels of awareness and use,
without drilling down to analyse subgroups,10 or
have been limited to compositional chemical safety
issues.11
Our review therefore aimed to provide the ﬁrst
comprehensive assessment of whether e-cigarette
awareness, ‘ever use’ and current use varied signiﬁ-
cantly across different sociodemographic groups.
METHODS
A full protocol for this systematic review was devel-
oped a priori and is registered with the
PROSPERO international prospective register of
systematic reviews (ID: CRD42015024163) at
http://www.crd.york.ac.uk/PROSPERO.
Search strategy
We searched seven databases (PubMed, MEDLINE,
Web of Science, EMBASE, Global Health,
PsycINFO, CINAHL Plus) for cross-sectional or lon-
gitudinal studies reporting on e-cigarette awareness,
‘ever use’ or current use. No search limits were set
on study design (other than excluding intervention
studies; see below), characteristics of participants or
language of publication, but only studies published
from 2006 onwards were retrieved, reﬂecting the
nascence of viable e-cigarette markets around the
world. Given research into these relatively novel
devices is currently still limited, we were able simply
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to restrict our search syntax to synonyms for e-cigarettes, without
requiring further search ﬁlters, thus reducing the risk of missing
relevant studies. We also undertook a search of 12 grey literature
databases and key websites. Further details of the search strategy
are available in the online supplementary material ﬁle.
Study selection and inclusion criteria
We included cross-sectional or longitudinal quantitative studies
that reported at least one of the following outcomes: e-cigarette
awareness, ‘ever use’ and current use. Studies predominantly
deﬁned awareness as having heard of e-cigarettes, ‘ever use’ as
having tried an e-cigarette at least once in a respondent’s life-
time and current use as having used e-cigarettes within the past
30 days. We included studies that used any form of summary
measure for the included outcomes. Other than the aforemen-
tioned 2006 cut-off, there were no temporal or geographical
restrictions: studies with international, national or subnational
populations were included. Included studies had to sample both
e-cigarette users and non-users, and needed to include subgroup
analysis by one or more PROGRESS Plus sociodemographic
group (PROGRESS Plus is an established taxonomy for classify-
ing sociodemographic differences, with ‘PROGRESS’ standing
for place of residence, race, occupation, gender, religion, educa-
tion level, socioeconomic status and social capital, while ‘Plus’
represents additional categories such as age, disability and
sexual orientation).12 We excluded intervention studies (due to
our focus on real-world behaviour) and studies whose samples
were restricted to e-cigarette users (due to a lack of information
in such studies about the wider population these users were
drawn from) or to patient populations (due to these samples not
being directly comparable to other general population studies in
our review).
After references that were obviously irrelevant had been
removed, abstracts and titles of potentially relevant studies were
independently screened against the eligibility criteria by one of
two reviewers, who also both screened a 10% sample of each
other’s exclusion decisions. The full texts of all remaining
studies were then obtained and assessed independently by two
reviewers. Any discrepancies at each of these stages were
resolved through discussion between the two reviewers, and
with a third reviewer as required.
Data extraction and risk of bias assessment
Following piloting of a data extraction form, one of two
reviewers extracted data and assessed the risk of bias for each
included study. Each reviewer then conducted their own assess-
ment of risk of bias for all of the other reviewer’s studies, and
repeated the data extraction for a 25% sample of these.
Discrepancies were resolved through discussion with a third
reviewer. Data on the following factors were extracted: country,
setting, population, study design, sampling methods, sample
size, response rate, outcome measures reported and demo-
graphic subgroup analyses undertaken.
Risk of bias was assessed by two reviewers, adapting a tool
developed by the Joanna Briggs Institute ( JBI) speciﬁcally for
studies of prevalence.13 We summarised risk of bias using the
resulting 12 criteria and rated each study as high-quality,
medium-quality or low-quality evidence depending on how
many criteria were met.i
We extracted the available outcome measures on e-cigarette
awareness, ‘ever use’ and current use, including the results of
statistical tests (95% CIs or p values) for sociodemographic sub-
group differences, where authors reported them. Studies which
did not report any such statistical tests—and therefore provided
only very weak evidence—were still included, for several
reasons: in the case of one PROGRESS Plus group (occupation),
the only evidence of any kind available came from such a study;
in some circumstances, such studies were the only ones from a
particular setting or country; and a sensitivity analysis showed
that removing these types of studies did not materially affect the
overall conclusions of the review.
In the narrative synthesis we undertook, we presented results
in terms of relative differences in our outcomes between socio-
demographic groups and summarised ﬁndings in an adapted
effect direction plot.14 Meta-analyses were not possible given
the heterogeneity of study designs (longitudinal, cross-sectional
and repeat cross-sectional), settings (35 different countries),
populations (studies often focused, for instance, on speciﬁc age
groups), outcome measures (particularly for current use) and
delineations of PROGRESS Plus subgroups (for instance, the
different spatial categories for ‘place of residence’), as well as
the lack of reported CIs within some studies. Providing point
estimates for worldwide differences in awareness and use would
also have been meaningless and potentially misleading for
anyone seeking to use the results of the review to inform local
or national action. Textual summaries therefore sought to eluci-
date the complexity and breadth of the data. This narrative syn-
thesis of the results used the labels ‘high-quality’, ‘medium-
quality’ and ‘low-quality’ evidence, based on the aforemen-
tioned risk of bias assessment. The studies providing better
quality evidence were emphasised by giving them prominence in
our results summaries; low-quality evidence was reported, par-
ticularly where it was the only evidence available, but it was
treated with caution. Summary ﬁndings reported in the
Discussion section were based on any clear patterns emerging
from the high-quality and medium-quality evidence. Study
quality was also tabulated in the effect direction plot (see online
supplementary table).
RESULTS
We screened 4985 references and assessed the full text of 335
documents (ﬁgure 1). Fifty-eight studies from countries world-
wide met our inclusion criteria: six longitudinal studies, 47
cross-sectional surveys and ﬁve repeat cross-sectional surveys.
Twenty-one of these studies reported on awareness of
e-cigarettes, 43 on ‘ever use’ and 32 on current use (see online
supplementary table). Sample sizes reported ranged from 184 to
79 202 and were drawn from 35 nations around the world (all
high-income countries). All studies used self-reported outcome
measures that were of unknown validity or reliability due to the
lack of research to date on such measures.
Place of residence
Sixteen studies reported subgroup analysis by place of residence,
with 8 studies reporting this for the outcome of e-cigarette
awareness, 10 for ‘ever use’ and nine for current use. Only one
study was rated as high-quality evidence, eight as medium
quality and seven as low quality. Overall, while some differences
were observed, no consistent themes emerged across the high-
quality and medium-quality studies, perhaps because of the very
varied countries and subregions sampled.
The highest quality study found no signiﬁcant difference in e-
cigarette awareness between urban and rural teenage boys in the
iSupplementary appendices with full details on the deﬁnitions used for
the high, medium and low categories are available from the authors.
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USA,15 while two medium-quality European studies found
higher ‘ever use’ in urban areas compared with rural ones.16 17
One of these also reported on current use, ﬁnding this same
urban > rural relationship existed for that outcome in Poland,17
as it did in a medium-quality 2014 study of South Korean high
school students.18 The medium-quality 2013 International
Tobacco Control (ITC) Four-Country Survey showed awareness
and ‘ever use’ of e-cigarettes was higher in the countries where
e-cigarettes were legal (USA and UK) than those where they
were banned (Canada and Australia), though—interestingly—
similar differences in current use were not observed between the
countries.19
Race/ethnicity
Twenty-eight studies reported subgroup analysis by race or eth-
nicity, with nine studies reporting this for the outcome of e-
cigarette awareness, 19 for ‘ever use’ and 14 for current use.
Three studies were rated as high-quality evidence, eight as
medium and 17 as low. Overall, the most consistent ﬁndings
from the better quality studies related to evidence of greater e-
cigarette awareness and use among white populations compared
with other ethnic groups. Almost all studies reporting this
outcome came from the USA.
The 2013 ITC Four-Country Survey showed overall higher
awareness among white/English-speaking adult smokers than
non-white/non-English-speaking ones.19 This ﬁnding of higher
awareness among respondents of white ethnicity was echoed
across adult and teenage samples in all but one of the higher
quality and medium-quality studies that examined the outcome
in the USA.15 20–24 For ‘ever use’, this same association with
white ethnicity existed in four out of the ﬁve higher quality and
medium-quality studies reporting signiﬁcant differences,20 25–27
while there was no such clear pattern of ﬁndings among the
lower quality studies. Fewer studies reported on current use, but
two of the three (medium and low quality) general population
samples of adults in the USA also found higher current use in
white respondents than those of various other ethnic
groups.23 28 A number of other studies of adults reported no
signiﬁcant differences between ethnicities for ‘ever use’,23 29–34
or for current use.27 33 35–38
Occupation
Only one study attempted subgroup analysis by occupation: a
low-quality 2013 European Union (EU) survey that reported on
awareness.39 Although statistical tests were not reported, the
data suggested retired people might be less likely than other
groups to be aware of e-cigarettes.
Gender
Forty-six of the included studies reported subgroup data on gender,
with 15 studies reporting this for the outcome of e-cigarette aware-
ness, 34 for ‘ever use’ and 24 for current use. Four studies were
rated as high-quality evidence, 12 as medium and 32 as low. Overall,
all three outcomes were more prevalent among male respondents in
many of the high-quality and medium-quality studies.
In all seven of the studies that reported statistically signiﬁcant
differences in awareness between males and females—which
were mostly from the USA and four of which were high or
medium quality—this outcome was higher in
males.19 20 22 30 33 40 41 The two high-quality studies that
reported on ‘ever use’ found no signiﬁcant gender differences
between children in Wales or adult smokers in the USA.31 42
However, of the medium-quality studies that reported signiﬁcant
differences, four out of ﬁve samples (from the USA and Poland)
found ‘ever use’ to be greater among males,17 23–26 and three
out of four (from the USA, Poland and South Korea) found the
same to be the case for current use.17 18 23 24 Several other
studies found no signiﬁcant differences for gender.
Figure 1 PRISMA ﬂow chart.
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Education level
Twenty-six studies in the review reported subgroup data on edu-
cation level, with nine studies reporting this for the outcome of
e-cigarette awareness, 18 for ‘ever use’ and 13 for current use.
Three studies were rated as high-quality evidence, seven as
medium and 16 as low. There was a broad pattern among the
higher quality research of awareness and use (particularly ‘ever
use’) being positively associated with higher levels of educational
attainment.
Of the nine studies reporting on awareness (mainly from the
USA), seven found statistically signiﬁcant differences and, in
each case, awareness was higher in subgroups with a greater
level of educational attainment.15 19 21–23 30 33 40 41 For ‘ever
use’, the two high-quality studies (both involving samples of
adult smokers in the USA) also found the least ‘ever use’ in the
groups with the lowest educational attainment,20 31 while ﬁnd-
ings were more mixed in the medium-quality and low-quality
studies, where around half of the studies reported no statistically
signiﬁcant differences between subgroups.19 23 25 27 29 30 43–45
For current use, the ITC Four-Country Survey found that,
overall, participants with higher levels of educational attainment
were more likely to report current use,19 while another medium-
quality study (from the USA) found the inverse.23 Low-quality
studies tended to report higher current use in the least educated
groups,23 28 33 36 or ﬁnd no signiﬁcant results.27 40 45–47
Socioeconomic status
Twenty-three studies reported subgroup analysis by socio-
economic status (SES) of respondents, with ﬁve reporting this
for the outcome of e-cigarette awareness, 18 for ‘ever use’ and
seven for current use. Two studies were rated as high-quality evi-
dence, seven as medium and 14 as low. Overall, no clear pat-
terns emerged in studies reporting SES data.
The medium-quality 2013 ITC Four-Country Survey found
that higher income participants were more likely to report
awareness and ‘ever use’ in the USA, UK, Australia and
Canada.19 However, none of the other high-quality and
medium-quality studies found any statistically signiﬁcant differ-
ences between different SES groups for any of the three out-
comes,16 21 22 25 26 31 42 48 with the exception of a 2014 South
Korean study indicating higher current use among more afﬂuent
high school students.18 Lower quality studies tended to ﬁnd
mixed or non-signiﬁcant results.16 25 26 28 29 31 42 43 48–53
Disability or health status
Only four studies reported data on disability or health status
related to our outcomes, with one study rated as high-quality
evidence, two as medium and one as low. The one study to
report on awareness—a medium-quality 2014 national survey of
adults from the USA—found no signiﬁcant differences by health
status.21 For ‘ever use’, a high-quality 2012 national US study of
adult smokers found that better self-reported health status was
associated with this outcome,20 while a medium-quality 2014
study of adult current and former smokers from eight US
‘market areas’ found no signiﬁcant differences.25 The one (low-
quality 2014 US) study to report on current use found this to be
associated with medical illnesses, greater depressed mood and
greater alcohol use.37
Sexual orientation
Only two studies reported data on sexual orientation related to
our outcomes, with one of these rated as medium-quality
evidence and the other rated as low. The medium-quality
study—a 2014 online survey of adults from the USA—found
that awareness was not associated with sexual orientation.22 The
low-quality 2014 survey from the USA found higher rates of
current use in lesbian, gay and bisexual respondents compared
with respondents who were heterosexual or did not specify a
sexual orientation.28
Age
Forty-eight studies reported subgroup analysis by age of respon-
dents, with 18 reporting this for the outcome of e-cigarette
awareness, 38 for ‘ever use’ and 22 for current use. Three
studies were rated as high-quality evidence, 11 as medium and
34 as low. The overall direction of evidence pointed to older
adolescents and young adults driving levels of awareness and
use of e-cigarettes: ﬁndings from all the higher quality studies
and many of the other studies ﬁtted this pattern.
High-quality and medium-quality studies with samples from
the USA, UK, Canada, Australia and Italy showed greater aware-
ness in older adolescents compared with younger children, and
in younger adults compared with older ones.15 19–21 24 40
Throughout the high-quality and medium-quality studies which
identiﬁed statistically signiﬁcant differences for ‘ever use’ (10
studies from the aforementioned ﬁve countries, plus Poland and
the EU more widely),16 17 19 20 23–25 27 31 40 and for current
use (4 studies from Italy, USA, South Korea and
Poland),17 18 24 40 these outcome measures were again greatest
in older children and younger adults. Lower quality studies
found fewer signiﬁcant differences, often lacking sufﬁcient stat-
istical analysis, but those that did were virtually unanimous in
observing the same patterns of higher use in older adolescents
and younger adults.28–30 36 43–45 51 53–55
DISCUSSION
Principal ﬁndings
We systematically reviewed both published and grey literature
for studies reporting sociodemographic differences in e-cigarette
awareness, ‘ever use’ and current use. We found variability in
social patterning across all outcomes, but have drawn attention
to ﬁndings that tend to recur in the high-quality and medium-
quality studies. Across all the outcomes, we found that e-
cigarettes appear to have achieved greater reach among older
adolescents and younger adults, males and people of white eth-
nicity. For awareness and ‘ever use’, this was also the case for
subpopulations with relatively higher educational attainment.
Studies varied in how they deﬁned these characteristics. For the
other PROGRESS Plus characteristics we examined, ﬁndings
were too inconsistent to enable us to identify a pattern sup-
ported by higher quality evidence, and in the case of sexual
orientation, disability/health status and occupation the evidence
base is still very small. The only previous review to investigate a
related research question included 23 studies and did not
incorporate any quality assessment.56 Hence, studies with con-
ﬂicting ﬁndings were synthesised without reference to the direc-
tion of effects suggested by the best available evidence. That
review did not identify studies that found distinct patterns of
use across racial/ethnic groups, which the authors suggested
could have been due to included studies being underpowered to
test this association. It reported conﬂicting evidence relating to
e-cigarette use when comparing subpopulations with different
educational levels. In common with our review, it highlighted
greater use among young adults.
Strengths and limitations
We have followed Cochrane guidance and PRISMA reporting
standards for systematic reviews. An extensive search was
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performed of published and grey literature from the ﬁrst seven
years that e-cigarette markets have been expanding throughout
the developed world (2006 to October 2014, when our searches
were run). There are, however, limitations to our study. Our
review did not explore e-cigarette use in speciﬁc clinical popula-
tions (we focused on general population samples to ensure we
were comparing like-for-like as far as possible). However, the
best way of demonstrating links between, for instance, mental
illness and e-cigarettes would arguably be through any general
population samples that performed subgroup analysis by mental
health status. Our inclusion criteria would have included such
studies (under the health status/disability PROGRESS Plus sub-
group), but none showed up in our various database searches.
While our quality assessment was based on an established tool
for prevalence studies,13 the tool has been tailored to our
requirements for this review and these adaptations are not vali-
dated. In addition, we appraised studies with reference to our
speciﬁc review question; a study could in theory use robust
methods for addressing its own research question but less robust
methods for addressing the reviews. Like all reviews, we were
limited by the evidence available and its reporting. For instance,
most studies reporting current use deﬁned this as any use of e-
cigarettes within the past 30 days, which might have included
some people who had simply tried e-cigarettes recently rather
than become regular users. Unfortunately, there were insufﬁcient
studies using a tighter deﬁnition to enable us to assess the socio-
demographic determinants of strictly regular e-cigarette use.
There is of course also a risk that publication bias may exist, in
which studies with non-signiﬁcant ﬁndings in relation to aware-
ness and use may be less likely to be published. However, the
large proportion of studies in the review reporting non-
signiﬁcant ﬁndings—and the fact that these were often smaller
studies and often fell into the lower quality of evidence category
—may indicate that this bias is unlikely to be exerting a major
inﬂuence on our review. Similarly, despite our wide-ranging
searches, no eligible low-income or middle-income country
studies came up in our trawls. There is no clear way of assessing
the degree to which this reﬂects a bias in the body of research
that has been conducted versus any bias in the databases we
searched. Our databases certainly will have had an English lan-
guage and high-income country bias, but it is also probable that
there is not yet any signiﬁcant volume of research on e-cigarettes
from low-income and middle-income countries—like all new
technologies, e-cigarettes will have spread much more quickly
among high-income country markets initially. Finally, we took
the decision not to include smoking of conventional cigarettes
as a variable for analysis. Doing so would have pulled in an
extremely large amount of data not directly relevant to our
research question and introduced further heterogeneity (given
differences in how smoking status was recorded across studies).
While it might have allowed us to analyse issues such as the
‘gateway’ hypothesis that young non-smokers may be moving
from e-cigarettes on to tobacco, such questions are already
being addressed effectively through other research more directly
focused on this area.1 6
Implications for research, policy and practice
While e-cigarettes are widely assumed to be safer than combust-
ible tobacco, the long-term health impacts of vaping are as yet
unknown. It is therefore important to understand how far e-
cigarette familiarity and adoption vary between different social
groups, since this can inform monitoring work to ensure any
risks from e-cigarettes do not widen existing health inequalities.
Conversely, studies such as these can also help ensure any
opportunities offered by e-cigarettes as aids for quitting
smoking are distributed fairly across society. The fact that
younger and more educated groups may have been particularly
likely to trial e-cigarettes is of course not a cause for concern in
itself, since this is a common pattern among early adopters of
technologies generally.9 However, greater future research focus-
ing speciﬁcally on e-cigarette users who have successfully quit
smoking would be valuable in helping to monitor any inequality
implications. It would be useful, for instance, to understand
whether these e-cigarette users, like smokers generally, are more
likely to be from lower socioeconomic groups or not. Similarly,
future studies should stratify their ﬁndings by relevant sociode-
mographic groups, to ensure that further subgroup analyses are
possible, and should consider more precise measures of current
use to capture this concept more accurately. For instance, the US
Centre for Disease Control (CDC) deﬁnes ‘frequent smoking’ as
smoking cigarettes on 20 or more days out of the past 30.57
Further studies could adopt this as an easily understandable
metric for e-cigarette use, which would additionally allow for
useful comparisons with US studies. More precision around the
speciﬁc types of e-cigarettes being used—and particularly
whether they contain nicotine or not—would also be valuable
(few studies in our review asked respondents about this), as
would a review speciﬁcally focusing on studies involving
samples of particular patient groups, since these were excluded
from our study. Finally, future research should be sensitive to
the fact that increasing studies will be emerging from
middle-income and low-income countries as e-cigarettes gain
further traction in those markets.
We have not reviewed ﬁndings on quitting/uptake of smoking,
dual usage of e-cigarettes and traditional combustible cigarettes,
or health outcomes. Some of these research questions will, we
assume, be addressed over time as e-cigarette research begins to
consider medium-term and long-term outcomes. Indeed, this
review should help lay the foundations for effective public
health action in this area. While we must wait for evidence of
longer term impacts of e-cigarettes to accumulate, this study
provides a baseline early indication of the reach these products
have established among different population subgroups. It thus
provides an essential ﬁrst step towards monitoring the popula-
tion and health inequality impacts of e-cigarettes with more
clarity and granularity as these technologies diffuse through
societies.
CONCLUSIONS
E-cigarette awareness, ‘ever use’ and current use appear to be
patterned by a number of sociodemographic factors. While the
evidence is frequently inconsistent, our review has allowed us to
What this paper adds
▸ Electronic cigarette (e-cigarette) awareness, ‘ever use’ and
current use are patterned by a number of sociodemographic
factors.
▸ These outcomes appear to be most prevalent in older
children, younger adults, males, people of white ethnicity
and—particularly for awareness and ‘ever use’—those with
relatively higher educational levels.
▸ Further attention may be required to ensure neither the
potential beneﬁts nor the potential risks of e-cigarettes are
allowed to increase existing health inequalities.
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identify older children, younger adults, males and people of
white ethnicity as the groups more likely to be aware of, to have
ever used and to currently use these products. Awareness and
ever use also appear to be greater in people with relatively
higher educational levels. This study thereby highlights the
importance, in research and practice, of carefully recording
sociodemographic determinants of e-cigarette use and potential
outcomes of such use (quitting or uptake of smoking, as well as
health outcomes) to ensure that e-cigarettes do not widen exist-
ing health inequalities.
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 Chapter 4:   Research paper – Population survey of  
e-cigarette use and behavioural support uptake 
 
4.1   Introduction   
 
The second of my research papers is presented in this chapter. For this thesis’s 
quantitative workstream, nationally representative survey data was obtained from new 
questions added to the Smoking Toolkit Study (STS), combined with some existing 
questions from the STS. This paper thus provides the data to address Objective B of this 
thesis: ‘investigating whether, amongst English smokers (the ‘population’), use of e-
cigarettes (the ‘exposure’) is associated with use of SSSs (the ‘outcome’), including in 
comparison to NRT use (the ‘comparator’)’. The paper here, entitled ‘Use of e-cigarettes 
and attendance at stop smoking services: a population survey in England’, was initially 
submitted to the BMJ where it passed several editorial decisions over a number of 
weeks before ultimately being rejected prior to review. This chapter includes the 
version of the paper that, at the time this thesis was examined, was being finalised for 
submission to Thorax. It has since been updated to incorporate minor corrections 
recommended by my Viva examiners. 
 
4.2   Research paper cover sheet 
 
The signed cover sheet for this research paper is included on the following page.  
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Abstract 
 
 
Objectives: To assess any association between dual use of e-cigarettes and 
combustible tobacco with past and planned future uptake of stop smoking services. 
Design: Repeat cross-sectional survey. 
Setting: England. 
Participants: Participants were drawn from the Smoking Toolkit Study, a nationally-
representative, face-to-face survey of adults (16+), between February and November 
2017. Data were aggregated on 2,139 smokers reporting current smoking of 
cigarettes or other tobacco products.  
Main outcome measures: Associations between use of e-cigarettes or nicotine 
replacement therapy (NRT) and past or planned uptake of stop smoking services 
were assessed using multivariable logistic regression. Analyses included adjustment 
for various possible confounders. 
Results: Dual users of combustible tobacco and e-cigarettes were more likely than 
other smokers to report having accessed stop smoking services in the past (AOR 1.43, 
95% CI = 1.08 to 1.90) and intending to take up these services in the future (AOR 1.51, 
95% CI = 1.14 to 2.00). Dual users of combustible tobacco and NRT were also more 
likely than other smokers to report both having accessed stop smoking services in the 
past (AOR 2.10, 95% CI = 1.51 to 2.93) and intending to do so in the future (AOR 2.30, 
95% CI = 1.66 to 3.18). 
Conclusions: Despite speculation that e-cigarette use might deter smokers from 
using stop smoking services, this study found that dual users of combustible tobacco 
and e-cigarettes are more likely to report past uptake and intended future uptake of 
such services, compared to smokers not using e-cigarettes. Smokers who used NRT 
reported similar findings.  
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 What is already known on this topic 
 Attendance at stop smoking services has been declining for six consecutive 
years, despite the effectiveness of these services for supporting smokers to 
quit.  
 Falling attendance has been attributed by some to the growing popularity of e-
cigarettes, and several English local authorities have justified cuts to their 
services by claiming that the prevalence of e-cigarette use amongst smokers 
reduces the need to provide such behavioural support. 
 
What this study adds 
 This repeat cross-sectional survey of English smokers assessed associations 
between use of e-cigarettes and past or planned uptake of stop smoking 
services. 
 Both past and planned uptake of stop smoking services was higher amongst 
those smokers who were also users of e-cigarettes, suggesting that such 
services should continue to be regarded as an important source of support for 
smokers even when they use e-cigarettes. 
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Background 
 
3.2 million adults are estimated to be using e-cigarettes in Great Britain, as of 2018, 
comprising 6.2% of the population and representing an increase of 2.5 million users 
since 2012.(1) Current tobacco smokers who also vape predominantly do so with the 
aim of quitting smoking; e-cigarettes are in fact now the most popular quitting aid in 
England, with approximately a third of smokers who were trying to give up in early 
2019 using one in their most recent quit attempt.(1,2) Behavioural counselling, of the 
kind provided by the English stop smoking services (SSSs), is a far less common choice 
for smokers,(2) despite evidence suggesting such support is the most effective route 
available for quitting smoking when combined with pharmacotherapy.(3–6) Overall 
attendance at these services in England has recently dropped for a sixth consecutive 
year (2012/13-2017/18),(7) which is of particular consequence for smoking-related 
health inequalities since SSSs have proven particularly effective at supporting smokers 
from lower socioeconomic groups to quit.(8,9) It has been suggested that trends in the 
use of e-cigarettes and the use of SSSs may be linked.(7,10,11) We aimed to assess the 
association between dual use of e-cigarettes and combustible tobacco with past and 
planned future uptake of SSSs. 
 
As well as reflecting structural factors such as local authority budget cuts and changes 
to public health commissioning arrangements, the decline in the uptake of SSSs could be 
related to the widespread use of e-cigarettes.(12) Although the SSSs do not prescribe e-
cigarettes, they have been advised by national bodies such as Public Health England 
(PHE), the National Centre for Smoking Cessation and Training (NCSCT) and Action on 
Smoking and Health (ASH) to offer their services to smokers who have purchased their 
own devices and provide them with the same behavioural support they give to those 
who are using licensed pharmacotherapies.(13–16) Unadjusted observational data from 
2016 indicate that smokers using e-cigarettes in conjunction with licensed medicines 
have the highest quit rates of all SSS users.(7,14,17) Yet the number of smokers 
combining their e-cigarettes with SSS behavioural support remains low, as of 
2016/17.(18) Some smokers who would otherwise have accessed the services may 
therefore be choosing to try to quit through vaping alone, either out of personal 
preference or as a result of their local SSS being cut back.(19) Several councils have 
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even posited the popularity of e-cigarettes within society as part of a rationale for 
decommissioning their local SSS entirely,(19–23) despite warnings elsewhere that e-
cigarettes cannot be assumed to be ‘picking up the slack’ from the declining uptake of 
other routes to quitting smoking.(24)  
 
Research has only recently begun to explore the extent to which the use of e-cigarettes 
by smokers may affect the use of behavioural support offered by services such as the 
English SSSs. A US cross-sectional survey suggested that amongst dual users of 
combustible tobacco and e-cigarettes almost all age groups were as likely to access 
behavioural support as other smokers.(25) A UK time series analysis using data from 
2006-2015 also found no clear evidence for an association at a population level between 
e-cigarette use and uptake of behavioural support from SSSs, while not being designed 
to assess possible sociodemographic interactions or understand possible mechanistic 
associations with related knowledge and beliefs.(26) No studies outside the US, 
however, have to our knowledge examined sociodemographic differences in uptake of 
behavioural support amongst dual users of combustible tobacco and e-cigarettes. 
Furthermore, no studies anywhere have examined such smokers’ intended future use of 
this support – a variable with important implications for the long-term viability of these 
particularly effective services – or to control for important knowledge and beliefs that 
could also be influencing uptake of services. Our study therefore aimed to examine past 
and planned future uptake of SSSs among people who dual use e-cigarettes and 
combustible tobacco, selected from a representative sample of English smokers, 
including an exploration of potential sociodemographic differences in these outcomes. 
Specifically, we investigated the following research questions: 
 
1. Is there any association between dual use of e-cigarettes/combustible tobacco 
with previous and planned future uptake of the SSSs? 
2. Does any such association persist after adjusting for related knowledge and 
belief variables, and sociodemographic and smoking characteristics? 
3. Is any such association moderated by sociodemographic group? 
4. To what extent is any such association specific to e-cigarettes, or is it also 
observed with dual use of nicotine replacement therapy (NRT) and combustible 
tobacco? 
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Method 
 
Design 
 
The data for this repeat cross-sectional study were collected through the ongoing 
Smoking Toolkit Study (STS), a monthly cross-sectional survey.(27) Small output areas 
consisting of ~200 households are selected using a random location sampling design, 
and interviewers are then assigned quotas to fulfil within areas set on gender, working 
status and tenure, before face-to-face computer-assisted interviews are conducted with 
one member of each household. Participants are recruited from the general population 
(previous research has demonstrated the STS’s national representativeness on 
smoking-related and sociodemographic characteristics), with each monthly wave 
collecting a sample of approximately 1,700 adults aged 16 or over.(27)  
 
Study population 
 
Data were collected between February and November 2017 from 13,735 adults in 
England, with each wave providing a unique sample of individuals (i.e. no repeat 
interviews took place). The sample was created from those 2,313 respondents, pooled 
from the multiple waves, who reported current smoking of cigarettes (whether factory-
made or hand-rolled) or other tobacco products (such as pipes or cigars) every day or 
regularly, at the time of interview.  
 
Measures 
 
Measurement of e-cigarette and NRT use  
Existing STS questions provided data on current use of e-cigarettes and/or NRT. 
Interviewees were asked the questions “Which, if any, of the following are you currently 
using to help you cut down the amount you smoke?”, “Do you regularly use any of the 
following in situations when you are not allowed to smoke?” and “Can I check, are you 
using any of the following either to help you stop smoking, to help you cut down or for 
any other reason at all?”. Current e-cigarette use was defined as anyone selecting 
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‘Electronic cigarette’ from the lists of possible responses to any of these questions, with 
current NRT use defined as anyone choosing ‘Nicotine gum’, Nicotine lozenge’, ‘Nicotine 
patch’, ‘Nicotine inhaler\inhalator’, ‘Nicotine mouthspray’ or ‘Another nicotine product’ 
from the same lists. Respondents were able to select multiple products if relevant. NRT 
products can be obtained by smokers either over-the-counter or on prescription from 
GPs or SSSs; for the purposes of this study, however, differentiating the source of any 
NRT used was not relevant to our research questions. 
 
Measurement of outcomes 
The primary outcome variables were previous use of SSS (‘past uptake’) and intention 
to access the services in future (‘planned uptake’). Data for these came from 
participants’ answers to the questions: “Have you ever sought help from an NHS stop 
smoking service at any point in the past?” and “How likely or unlikely are you to 
consider seeking help from your NHS stop smoking service at any point in the future?”. 
For the “past uptake” question, responses of ‘Yes’ were coded as 1 and ‘No’ were coded 
as 0. The intended future use question was a single-item measure with five response 
options: (1) ‘Very likely’, (2) ‘Fairly likely’, (3) ‘Neither likely nor unlikely’, (4) ‘Fairly 
unlikely’ and (5) ‘Very unlikely’. For analysis and interpretation, data were 
dichotomised to reflect any reported future intention to access services (1-2) vs no 
reported future intention (3-5). 
 
Measurement of potential confounders  
Our analysis plan specified confounders a priori, with the exception of two sensitivity 
analyses outlined below. Data were used from existing STS questions on 
sociodemographics and smoking-related factors. Sociodemographics included age, 
gender, ethnicity (dichotomised into white vs non-white) and social grade 
(dichotomised into ABC1 vs C2DE, with the former including managerial, professional 
and intermediate occupations, and the latter including small employers and own 
account workers, lower supervisory and technical occupations, semi-routine and 
routine occupations, never workers and long-term unemployed).  
 
Potentially confounding smoking-related factors were also analysed using existing STS 
questions. For intention to quit smoking, the ‘Motivation To Stop Scale’ (MTSS) was 
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used.(28) Participants were thus asked “Which of the following best describes you?”. 
Those answering “I REALLY want to stop smoking and intend to in the next month”, “I 
REALLY want to stop smoking and intend to in the next 3 months” or “I want to stop 
smoking and hope to soon” were coded 1 and those answering “I REALLY want to stop 
smoking but I don't know when I will”, “I want to stop smoking but haven't thought 
about when”, “I think I should stop smoking but don't really want to” or “I don't want to 
stop smoking” were coded 0. Past year quit attempts were assessed by the question 
“How many serious attempts to stop smoking have you made in the last 12 months?”. 
Those reporting no attempts were coded as 0 and those reporting one or more were 
coded as 1. Nicotine dependence was assessed using the established ‘Heaviness of 
Smoking Index’ (HSI), obtained by summing a respondent’s categorised number of 
cigarettes smoked per day and their time from waking until first cigarette of the day 
(the index ranges from 0 to 6: the higher the score, the higher the dependence on 
nicotine).(29) 
 
Participants also answered questions relating to knowledge and beliefs that could 
potentially influence attendance at SSSs or use of e-cigarettes. They were asked: “To 
what extent do you agree or disagree with each of the following statements?  
 
1. I know people who use e-cigarettes;  
2. I know people who have attended NHS stop smoking services;  
3. I think e-cigarettes are a convenient way to quit smoking;  
4. I think NHS stop smoking services are a convenient way to quit smoking;  
5. I think learning how to use e-cigarettes takes up a lot of time;  
6. I think using NHS stop smoking services takes up a lot of time;  
7. I know how to use e-cigarettes if I want to;  
8. I know how to access NHS stop smoking services if I want to;  
9. Most of my family and friends accept my e-cigarette use;  
10. Most of my family and friends accept my smoking;  
11. If I was to use NHS stop smoking services, I would have to travel far;  
12. If I attended an NHS stop smoking service in the future, I think I would be 
made to feel welcome”.  
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We again based response options on five-point Likert scales (‘Strongly agree’, ‘Tend to 
agree’, ‘Neither agree nor disagree’, ‘Tend to disagree’ and ‘Strongly disagree’) and 
dichotomised these into  the first two responses vs all others. For the question “Do you 
think NHS stop smoking services currently offer their support to smokers who are using 
e-cigarettes to try to quit smoking, or not?”, respondents simply chose ‘Yes’ or ‘No’, 
while “Out of these two approaches for quitting smoking, which do you think would be 
more likely to help someone to quit?” had the response options ‘Using e-cigarettes’, 
‘Getting support from NHS stop smoking services’ or ‘Both equally likely’. This was 
dichotomised into those who chose SSSs as the most effective approach vs those who 
chose the other two responses. Finally, participants reporting previous SSS uptake were 
also asked “Overall, to what extent did you find the NHS stop smoking service you 
attended helpful or not for your efforts to quit smoking?”. Response options were ‘Very 
helpful’, ‘Fairly helpful’, ‘Not very helpful’ and ‘Not at all helpful’ which was 
dichotomised into the first two responses versus the final two. 
 
Testing of questions 
Seventeen members of the public with varied experiences of smoking, using e-cigarettes 
and accessing SSSs were recruited purposively at the outset of the research to provide 
some face validity testing of the new survey questions that were proposed to be asked 
through the study. These people reviewed the draft questions by email and submitted 
written feedback on the merits of the questions overall, as well as any specific wording 
within them that could be clearer. Seven subject matter experts (tobacco researchers, 
national policy-makers, survey specialists and SSS staff) were also consulted in the same 
way.  
 
Statistical analyses 
 
Our planned analyses and sample size calculation were pre-registered publicly on Open 
Science Framework (accessible at www.osf.io/ur3j8). Descriptive statistics were 
produced for sociodemographic and smoking-related variables, with chi-squared tests 
(for the categorical variables) and t tests (for the continuous ones) undertaken to 
examine potential differences in these characteristics by use of e-cigarettes or NRT (see 
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Table 1). Primary analyses investigated the impact of dual use (of combustible tobacco 
and e-cigarettes or NRT respectively) on SSS uptake (past or planned respectively), 
adjusting for smoking and sociodemographic co-variables. These furthermore assessed 
interactions between the two dual use variables and key sociodemographics (i.e. age, 
sex, social grade, ethnicity) on past or planned SSS uptake.  
 
These analyses were structured as follows. First, initial multivariable logistic regression 
models (M1) were produced for exploratory analyses of knowledge and beliefs 
concerning e-cigarettes and SSSs. These examined the impact of each knowledge/belief 
variable in turn on uptake of SSSs (past and planned respectively), after adjusting for 
the smoking-related and demographic co-variables. Secondly, we developed unadjusted 
logistic regression models (M2) examining the impact of the two dual use variables on 
the SSS uptake variables to provide crude odds ratios (ORs, with associated 95% 
confidence intervals). Thirdly, we developed the final models (M3) examining the 
impact of each of the dual use variables in turn on each of the SSS uptake variables in 
turn, after adjusting for a priori variables and other statistically significant 
knowledge/belief variables (p<0.05) identified in M1, in order to produce final adjusted 
ORs with associated 95% confidence intervals. In these final models, we also examined 
the interaction between each of the dual use variables and key sociodemographic 
variables (socioeconomic status, age, gender and ethnicity) on each of the uptake 
variables. This involved developing different ‘interaction’ models, each model having 
the interaction term in question (e.g. dual use of combustible tobacco and e-cigarettes x 
sex), which adjusted for all a priori and other statistically significant variables (as in 
M3). Following these pre-registered analyses, some further unplanned sensitivity 
analyses explored, in the M3 models, the impact of including two potentially relevant 
further variables. These therefore involved further adjusting for use of NRT (when 
examining dual use of e-cigarettes and combustible tobacco) or e-cigarettes (when 
examining dual use of NRT and combustible tobacco), as well as adjusting for past 
uptake of SSS (when examining planned future uptake of SSS). All analyses were 
undertaken using SPSS v24. 
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Results  
 
Out of a total of 2,313 current smokers who were interviewed, complete data on key co-
variables (HSI, age and gender) was provided by 2,189 (94.5%) of these (Table 1). 
Those excluded due to such missing data were significantly less likely to be female or 
white (p<0.05) than those who remained in the sample. 
 
Dual users of e-cigarettes and combustible tobacco did not differ from other smokers by 
most sociodemographic characteristics (Table 2), but were significantly more likely to 
be white and to live in the North of England. Dual users of NRT and combustible tobacco 
were significantly older than other smokers, as well as being more likely to have a 
disability or to live in the South of England, but less likely to live in the North of England 
or to be heterosexual. Both groups of dual users were also more likely than other 
smokers to report an attempt to quit smoking within the previous year and an intention 
to quit smoking in the future. 
 
21.6% of participants (472/2189) had accessed a SSS in the past and, similarly, 23.2% 
(508/2189) planned to do so in future. In the unadjusted analyses (Tables 3 and 4), dual 
users of combustible tobacco and e-cigarettes were more likely than other smokers to 
report having accessed the services in the past (OR 1.93, 95% CI = 1.51 to 2.45) and 
intending to access them in the future (OR 1.53, 95% CI = 1.20 to 1.95). Dual users of 
combustible tobacco and NRT were also more likely than other smokers to report both 
having accessed SSSs in the past (OR 2.93, 95% CI = 2.20 to 3.91) and intending to do so 
in the future (OR 3.04, 95% CI = 2.28 to 4.04). 
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Table 1: Sample characteristics 
 
 Study 
sample 
(n=2,189) 
Demographic characteristics 
Age, Mean (SD) 43.5 (17.3) 
Female, % 49.7%  
White, % 90.0%  
Social grade C2DE, % 56.7%  
No post 16 qualifications, % 60.9%  
With disability, % 17.4%  
Heterosexual, % 87.4%  
Region: North, % 32.2%  
                     Central, % 29.7%  
                  South, % 38.1%  
Smoking characteristics 
Current tobacco use, % 100%  
Current e-cigarette use, % 18.2%  
Current NRT use, % 10.2% 
Past SSS use, % 21.6%  
Intended future SSS use, % 23.2%  
Intention to quit smoking, % 33.1%  
Past year quit attempt, % 29.9%  
HSI Index, Mean (SD)  1.72 (1.51) 
  
NRT: nicotine replacement therapy; SD: Standard deviation; North: North East, North West, Yorkshire & Humber; Central: East Midlands, West Midlands, East of 
England; South: London, South East, South West; HSI: Heaviness of Smoking Index (the higher the score, the higher the dependence on nicotine); 
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 Table 2: Sample characteristics by dual use of combustible tobacco/e-cigarettes or combustible tobacco/NRT 
 
 All 
smokers 
(n=2,189) 
 
Dual e-cig/tobacco use 
 Yes                 No 
 
p* 
 
Dual NRT/tobacco use 
  Yes                No 
p* 
 
Tobacco use only 
   Yes                No 
 
p* 
Demographic characteristics 
Age, Mean (SD) 43.5 (17.3) 43.0 (16.5) 43.6 (17.5) 0.555 47.0 (16.9) 43.1 (17.3) 0.001* 43.1 (17.4) 44.6 (16.9) 0.086 
Female, % 49.7%  50.9% 49.4% 0.590 54.3% 49.1% 0.147 48.6% 52.6% 0.109 
White, % 90.0% 93.2% 89.3% 0.019* 90.1% 90.0% 0.961 89.1% 92.6% 0.018* 
Social grade C2DE, % 56.7% 54.6% 57.2% 0.359 54.3% 57.0% 0.439 57.3% 55.0% 0.352 
No post 16 qualifications, % 60.9% 61.7% 60.8% 0.747 60.5% 61.0% 0.896 60.6% 61.9% 0.585 
With disability, % 17.4% 18.9% 17.1% 0.381 22.4% 16.9% 0.038* 16.5% 20.0% 0.058 
Heterosexual, % 87.4% 89.4% 87.0% 0.191 82.5% 88.0% 0.020* 87.6% 86.9% 0.653 
Region: North, % 32.2% 36.8% 31.1% 0.027* 25.6% 32.9% 0.026* 32.2% 32.1% 0.971 
                     Central, % 29.7% 29.1% 29.8% 0.764 29.1% 29.8% 0.851 29.7% 29.6% 0.969 
                  South, % 38.1% 34.1% 39.1% 0.065 45.3% 37.3% 0.020* 38.1% 38.3% 0.943 
Smoking characteristics 
Intention to quit smoking, % 33.1% 51.6% 29.0% <0.001* 58.3% 30.3% <0.001* 25.9% 53.8% <0.001* 
Past year quit attempt, % 29.9% 50.9% 25.2% <0.001* 59.2% 26.6% <0.001* 21.7% 53.3% <0.001* 
HSI Index, Mean (SD)  1.72 (1.51) 1.78 (1.43) 1.71 (1.53) 0.382 1.79 (1.49) 1.71 (1.51) 0.484 1.71 (1.52) 1.77 (1.47) 0.374 
  
NRT: nicotine replacement therapy; SD: Standard deviation; North: North East, North West, Yorkshire & Humber; Central: East Midlands, West Midlands, East of 
England; South: London, South East, South West; HSI: Heaviness of Smoking Index (the higher the score, the higher the dependence on nicotine); Tobacco use only: 
current smokers of combustible tobacco with no current use of e-cigarettes or NRT
89
 After adjustment for demographic characteristics, smoking-related variables, and key 
knowledge and belief variables, these associations all remained statistically significant 
(Tables 3 and 4). 
 
Table 3: E-cigarette or NRT use and past uptake of SSSs  
amongst current smokers of combustible tobacco 
 
 Past uptake of SSS 
% [n] 
OR [95% CI] 
Unadjusted model 
AOR [95% CI] 
Final model* 
Dual e-cig/tobacco use  
No 19.3% (346/1790) 1.00 1.00 
Yes 31.6% (126/399) 1.93 (1.51-2.45) 1.43 (1.08-1.90) 
Dual NRT/tobacco use 
No 19.3% (380/1966) 1.00 1.00 
Yes 41.3% (92/223) 2.93 (2.20-3.91) 2.10 (1.51-2.93) 
 
* Final model controlled for: demographic variables (age, gender, ethnicity, socioeconomic status), smoking-related 
variables (intention to quit, past-year quit attempts, nicotine dependence), and significant knowledge and belief 
variables (knowing people who used e-cigarettes, knowing how to use e-cigarettes, knowing people who had used 
SSSs, thinking SSSs were a convenient way to quit, knowing how to access SSSs, thinking they would be made to feel 
welcome by SSSs, and thinking SSSs were more effective than e-cigarettes) 
 
Table 4: E-cigarette or NRT use and planned uptake of SSSs  
amongst current smokers of combustible tobacco 
 
 Planned uptake of SSS 
%[n] 
OR [95% CI] 
Unadjusted model 
AOR [95% CI] 
Adjusted model* 
Dual e-cig/tobacco use  
No 21.7% (389/1790) 1.00 1.00 
Yes 29.8% (119/399) 1.53 (1.20-1.95) 1.51 (1.14-2.00) 
Dual NRT/tobacco use 
No 20.8% (409/1966) 1.00 1.00 
Yes 44.4% (99/223) 3.04 (2.28-4.04) 2.30 (1.66-3.18) 
 
* Final model controlled for demographic variables (age, gender, ethnicity, socioeconomic status), smoking-related 
variables (intention to quit, past-year quit attempts, nicotine dependence), and significant knowledge and belief 
variables (knowing people who used e-cigarettes, thinking e-cigarettes were more effective than SSSs, knowing 
people who had used SSSs, thinking SSSs were a convenient way to quit, thinking lots of time was needed to access 
SSSs, knowing how to access SSSs, thinking they would be made to feel welcome by SSSs, finding past use of SSSs 
helpful, thinking dual tobacco/e-cigarette users were eligible for SSSs, and thinking SSSs were more effective than e-
cigarettes) 
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 No sociodemographic interactions were observed for social grade, age or ethnicity for 
any outcomes. A significant interaction was observed for gender when examining the 
association between dual combustible tobacco/NRT use with future uptake of SSSs. For 
females, dual combustible tobacco/NRT use significantly increased their odds of 
intending to access an SSS in future (OR 3.40, 95% CI = 2.19 to 5.28), but this was not 
the case for males (OR 1.45, 95% CI = 0.90 to 2.35).  Similar interactions for gender 
were not evident in analyses of any other outcomes.  
 
Sensitivity analyses further adjusted for use of NRT (when examining dual use of e-
cigarettes and combustible tobacco) or e-cigarettes (when examining dual use of NRT 
and combustible tobacco), as well as for past uptake of SSS (when examining planned 
future uptake of SSS). Results were very similar to those produced by the original 
analyses: dual users of e-cigarettes and combustible tobacco remained more likely than 
other smokers to have accessed a SSS in the past (AOR 1.43, 95% CI = 1.08 to 1.91) and 
to plan to do so in the future (AOR 1.40, 95% CI = 1.05 to 1.88), as did dual users of NRT 
and combustible tobacco (AOR 2.10, 95% CI = 1.51 to 2.93 for past uptake, and AOR 
2.03, 95% CI = 1.45 to 2.84 for planned uptake). 
 
Discussion  
 
Amongst current smokers, those who were also using e-cigarettes were more likely to 
report having accessed SSSs in the past and to report an intention to access these 
services in the future. These associations between service uptake and dual use (of 
combustible tobacco and alternative forms of nicotine delivery) were not specific to e-
cigarettes: they could also be found amongst dual users of NRT and combustible 
tobacco.  
 
To our knowledge, this research is the first of its kind to combine data on e-cigarette use 
with data about past and intended future uptake of behavioural support. It therefore 
has particular relevance to current debates around the popularity of e-cigarettes and 
their potential impact on the uptake of SSSs by smokers. Another key strength is its use 
of a representative sample of the English population. Limitations of the study include 
the inability of cross-sectional research to establish causal relationships, though cross-
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 sectional associations can nonetheless be indicative and have an important role to play 
in guiding future research. Our study furthermore relied, in part, on data gathered using 
novel questions. Although there were no relevant established questionnaire tools from 
which to take our new questions regarding SSS uptake, their face validity was tested 
beforehand with a range of smokers reporting varying levels of e-cigarette use. The use 
of self-reported data from a single point in time means recall bias may have affected 
responses around past behaviour, while social desirability bias may have influenced 
reported future actions or answers to knowledge/belief questions.  
 
Future larger studies could attempt to tackle this by using longitudinal cohort designs to 
follow up respondents and assess how far reported intentions to access services 
translate into actual uptake. It is also possible that our finding of a positive association 
between the different dual use groups and intended future SSS uptake reflects residual 
confounding – i.e. this association may be caused by a smoker’s general motivation to 
quit smoking more than anything particularly to do with SSS. This concept of ‘intention 
to quit’ was however captured by the ‘Motivation to Stop Scale’ (MTSS), an established 
variable used regularly for broader published analyses of STS data (28). Finally, some 
caution is needed when generalising our findings to other populations internationally. 
The level and cost of behavioural support available to smokers varies widely 
internationally, while the regulatory framework for e-cigarettes within the UK is 
considerably different to that in many other countries.(11,30,31) Globally, 98 countries 
have national e-cigarette regulations in place, with 29 countries forbidding e-cigarette 
sales entirely.(11) Even amongst nations where sales are permitted, there are very 
diverse legislative approaches being taken on areas such as marketing, labelling, safety 
standards and nicotine limits.(30) For instance, the ‘UK Tobacco and Related Products 
Regulations 2016’ enforced a nicotine cap of 20mg/ml on devices and refills, while the 
US does not have a national limit on nicotine concentrations in this way.(11) 
 
This study aligns with other recent research that has not found e-cigarette use to be 
associated with reduced uptake of behavioural support.(25,26) Our findings in fact 
suggest a modest positive association, with dual users of combustible cigarettes and 
either e-cigarettes or NRT significantly more likely than other smokers to have engaged 
with services previously and to plan to access them in future. A plausible explanation is 
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 that, given the majority of smokers using e-cigarettes or NRT do so in an attempt to quit 
smoking,(14) the increased reports of past and planned SSS uptake among these 
smokers may reflect their willingness to consider other quit methods beyond e-
cigarettes and/or NRT. It is also likely to reflect the fact that some previous SSS users 
will have been introduced to e-cigarettes or NRT by the services directly and given 
encouragement and advice on using them, leading to more sustained use of such 
products compared to non-attenders of services. Alternatively, it is even possible that 
experiences with other satisfying sources of nicotine stimulate thoughts about quitting 
and boost self-efficacy; previous research suggests, for instance, that e-cigarette use can 
encourage quitting, including for smokers who have not previously been contemplating 
it.(32) Finally, this phenomenon may be linked to financial considerations for smokers. 
A wide range of studies have shown that smokers report lower costs of e-cigarettes, 
compared to combustible cigarettes, as a major incentive for using them,(33) while 
other research has demonstrated the responsiveness of e-cigarette demand to price 
changes, suggesting this may be even greater than the equivalent price elasticity of 
(combustible) cigarette demand.(34) It has also been shown that the free or subsidised 
pharmacotherapy offered by the English SSSs is positively associated with quit 
attempts.(35) It is thus plausible that smokers who are motivated to try to switch from 
combustible tobacco to e-cigarettes for economic reasons are likely to also be attracted 
to this offer of free or subsidised pharmacotherapy from SSSs.  
 
The null findings for virtually all interactions with sociodemographics appear surprising 
given the international literature on use of e-cigarettes suggests that that outcome is 
patterned by age, gender and ethnicity.(36) For our study design, however, use of e-
cigarettes was a predictor not an outcome, since we were primarily interested in the 
impact of e-cigarette use on uptake of behavioural support, and only amongst current 
dual users of combustible tobacco and e-cigarettes (rather than all vapers). More 
relevant is the US study in this area which found older dual users (65+) of combustible 
tobacco and e-cigarettes to be more likely than other smokers to report accessing 
behavioural support.(25) It is possible our sample size was not sufficient to detect more 
subtle sociodemographic interactions. Similarly though, it is possible that the behaviour 
of UK smokers in this area simply is not the same as those in the US, given the 
aforementioned international differences in regulatory landscapes and availability of 
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 behavioural support, which are certainly striking when specifically comparing the UK 
with the US. Also of note is the lower proportion of smokers in our sample reporting an 
intention to access behavioural support than the most relevant study from the US 
(~23% vs ~35%).(37) This difference is to be expected, however, given the US study 
only investigated future intention to access such support amongst those smokers who 
intended to quit within the following month. Our research, on the other hand, was 
interested in asking this question to all smokers regardless of the existence or 
timeframe of a quit intention. 
 
Conclusion  
 
We found both past and planned uptake of SSSs were higher amongst those smokers 
who were also users of e-cigarettes, even after controlling for ‘intention to quit’ and 
other potential confounders. So, in summary, rather than wanting to ‘go it alone’, 
smokers using e-cigarettes were more keen to receive additional support to quit 
from SSSs than other smokers. 
 
Our study has clear relevance for ongoing debates about the relationship between e-
cigarette use and the uptake and provision of other quit methods including behavioural 
support. Several national organisations, such as PHE, NCSCT and ASH have 
recommended that local authorities - and the SSSs they commission - should welcome 
and support smokers who wish to use electronic cigarettes in their efforts to quit 
combustible tobacco.(13,15,16) Elsewhere, however, it has been suggested that 
widespread e-cigarette use may be reducing the need for SSSs, an argument that has 
formed part of the rationale for cutting such services in a number of English local 
authorities.(10,19–23) Our findings clearly call into question the credibility of this latter 
position. Rather than assuming that the continued decline in SSS attendance is linked to 
e-cigarette use, alternative explanations should therefore be considered including, for 
example, the significant cuts made to local authority public health budgets that fund 
such services.(38) Dual users of e-cigarettes and combustible tobacco in fact want the 
help to quit smoking that these SSSs offer.  
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 Chapter 5:   Research paper – Population survey of 
knowledge and beliefs about e-cigarettes  
and behavioural support 
 
5.1   Introduction   
 
The third of my research papers is presented in this chapter. As in Chapter 4, this piece 
of work uses nationally representative survey data obtained from new questions added 
to the Smoking Toolkit Study (STS). Whereas the previous paper focused on measuring 
associations between dual use of e-cigarettes/tobacco and stop smoking service (SSS) 
uptake, this paper uses quantitative evidence to assess specific psychosocial factors that 
may be influencing smokers’ decisions on SSS uptake, including the potential role of 
knowledge and beliefs relating to e-cigarettes. This, therefore, provided the data to 
address - in combination with Chapter 6 - Objective C of this thesis: ‘investigating, 
amongst English smokers (the ‘population’) what factors (the ‘exposures’) influence 
decisions to use either e-cigarettes or SSSs (the ‘outcomes’), including the potential 
impact each can have on the other’. The paper here, entitled ‘Knowledge and beliefs 
related to e-cigarettes and behavioural support and associations with support uptake: a 
population survey in England’ had not yet been submitted to a journal for consideration 
at the time this thesis was examined, but was being finalised for submission - to Drug 
and Alcohol Dependence - alongside completion of the thesis. It has subsequently been 
updated to incorporate minor corrections recommended by my Viva examiners. 
 
5.2   Research paper cover sheet 
 
The signed cover sheet for this research paper is included on the following page.  
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Abstract  
 
 
Background:  While attendance rates at stop smoking services (SSSs) have declined 
for the last six years, e-cigarettes have become the most common quit aid chosen by 
English smokers, which has led to claims that these devices may have reduced 
demand for the behavioural support offered by SSSs. We aimed to assess whether 
knowledge and beliefs related to the SSSs and e-cigarettes were associated with 
either previous or planned future use of SSSs.  
Methods:    Current adult smokers in England (n=2,189) provided data through a 
nationally-representative, face-to-face survey between February and November 2017. 
Multivariable logistic regression assessed associations between agreement with 
knowledge and belief statements and past or planned SSS uptake.  
Results:    Knowledge and belief statements about e-cigarettes: Past and planned SSS 
uptake were associated with knowing other people who vaped (AOR 1.79, 95% CI = 
1.35 to 2.38 for SSS past use, AOR 1.43, 95% CI = 1.09 to 1.88 for planned use) and 
believing that e-cigarettes were less effective than SSSs (AOR 1.33, 95% CI = 1.06 to 
1.65 for SSS past use and AOR 2.35, 95% CI = 1.89 to 2.93 for planned use). Past SSS 
use was furthermore associated with knowing how to use e-cigarettes (AOR 2.01, 95% 
CI = 1.54 to 2.63), while planned SSS uptake was also associated with perceiving ‘dual 
users’ of e-cigarettes and combustible tobacco as eligible for SSSs (AOR 1.32, 95% CI = 
1.06 to 1.63). Knowledge and belief statements about SSSs: Past and planned SSS 
uptake were associated with: knowing how to access SSSs (AOR 4.66, 95% CI = 3.25 to 
6.69 for past use and AOR 2.00, 95% CI = 1.49 to 2.68 for planned use); expecting to be 
welcomed by SSSs (AOR 1.99, 95% CI = 1.53 to 2.58 for past use and AOR 2.91, 95% CI 
= 2.19 to 3.87 for planned use); perceiving SSSs as convenient (AOR 1.73, 95% CI = 
1.39 to 2.16 for past use and AOR 3.07, 95% CI = 2.43 to 3.87 for planned use); and 
knowing other people who had used SSSs (AOR 3.39, 95% CI = 2.71 to 4.24 for past use 
and AOR 1.59, 95% CI = 1.27 to 1.99 for planned use). Planned SSS uptake was also 
associated with reporting helpful past experiences of SSSs (AOR 5.61, 95% CI = 3.57 to 
8.82) and negatively associated with believing SSS attendance required lots of time 
(AOR 0.61, 95% CI = 0.47 to 0.79).  
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Conclusions:     Perceptions of e-cigarette effectiveness and familiarity with vaping 
(both knowing how to vape oneself and knowing others who vape) are positively 
associated with decisions to access SSS support. Such decisions are similarly 
associated with familiarity with SSSs themselves, as well as with perceptions of SSSs 
(including convenience, likely time commitments and anticipated welcome) and 
valence of any previous SSS uptake.  
 
Keywords: Stop Smoking Services, Access, E-cigarettes, Knowledge, Beliefs 
 
 
 
Background 
 
Current evidence indicates that behavioural counselling, of the kind provided by stop 
smoking services (SSSs) within England, is the most effective route for quitting smoking 
when combined with pharmacotherapy.(1–3) Attracting smokers to SSSs has 
nonetheless proved increasingly challenging in recent years, with the overall number of 
people accessing them in England recently dropping for a sixth consecutive year 
(2012/13-2017/18).(4) E-cigarettes have meanwhile become increasingly popular with 
English smokers and are now their most commonly used quit aid: as of 2018, 14.9-
18.5% of current smokers vape,(5) and the majority of these are doing so in order to try 
to quit smoking.(6,7)  
 
Previous qualitative research suggests that smokers, particularly from disadvantaged 
backgrounds, are influenced by both internal and external factors when deciding 
whether to attend SSSs.(8–10) Beliefs about the effectiveness of SSSs are particularly 
influential, as well as fears about how smokers will be received or welcomed by the 
services (including their expectations of being judged by practitioners, for instance).  
 
Service monitoring data, as well as the first randomised trial in this context, suggest that 
smokers using e-cigarettes may have amongst the highest successful quit rates of all SSS 
users.(4,6,11) This has led to calls from several national organisations for SSSs to 
welcome those smokers who wish to quit tobacco using e-cigarettes, even if the services 
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cannot prescribe such devices themselves.(12–14) Existing research has generally 
studied e-cigarettes in isolation from other quit methods, however. Little is known, for 
instance, about how smokers’ knowledge and beliefs about e-cigarettes could relate to 
their decision-making around other smoking cessation options. Understanding the 
factors influencing such decisions is a particularly important research gap given 
ongoing debate about whether e-cigarettes could be depressing uptake of potentially 
more effective routes to quitting tobacco, including behavioural support.(5,15,16)  
 
Our study aimed to examine whether knowledge and beliefs about e-cigarettes and 
SSSs, which could potentially influence uptake of SSS behavioural support, were 
associated with either previous or planned use of these services. This included an 
exploration of potential differences in these outcomes between sociodemographic 
groups and between ‘dual users’ of e-cigarettes and combustible tobacco versus other 
smokers. Our specific research questions were: 
 
1. Are there any associations between knowledge and beliefs about e-cigarettes 
and SSSs with previous and planned use of the services? 
2. Do any such associations persist after adjusting for sociodemographic and 
smoking characteristics? 
3. Are any such associations moderated by dual use of e-cigarettes or 
sociodemographic group? 
 
Method 
 
Design 
 
This was a repeat cross-sectional study using data collected between February and 
November 2017 via the Smoking Toolkit Study (STS), a long-running monthly survey. 
For each monthly wave of the STS, a sample of approximately 1,700 adults (aged 16+) is 
recruited from the general English population. Sampling is a hybrid between random 
location and quota: small output areas of approximately 200 households are stratified 
by a geodemographic ordering of the population and randomly selected. Within areas, 
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trained interviewers undertake face-to-face interviews with a single member of a 
household until pre-specified quotas are fulfilled tailored to the areas. The national 
representativeness of the STS across a range of smoking-related and sociodemographic 
characteristics has been shown previously.(17) 
 
Study population 
 
The sample for our specific study constituted the 2,313 respondents, pooled across 
monthly waves between February and November 2017, who were currently smoking 
combustible cigarettes (either hand-rolled or factory-produced) or other tobacco 
products (e.g. pipes or cigars) daily or regularly at the point at which they were 
interviewed. 
 
Measures 
 
New questions were added to the STS relating to uptake of SSSs (both past and 
planned), as well as knowledge and beliefs that could potentially influence attendance 
at these services. Seventeen members of the public with varied experiences of smoking, 
using e-cigarettes and accessing SSSs were recruited purposively at the outset of the 
research to provide some face validity testing of the new survey questions that were 
proposed to be asked through the study. These people reviewed the draft questions by 
email and submitted written feedback on the merits of the questions overall, as well as 
any specific wording within them that could be clearer. Seven subject matter experts 
(tobacco researchers, national policy-makers, survey specialists and SSS staff) were also 
consulted in the same way.  
 
The data on SSS uptake were provided by answers to the questions: “Have you ever 
sought help from an NHS stop smoking service at any point in the past?” and “How likely 
or unlikely are you to consider seeking help from your NHS stop smoking service at any 
point in the future?”. For the former question, we coded ‘Yes’ responses as 1 and ‘No’ 
responses as 0. For the planned uptake question, we used a single-item measure with 
five possible responses: ‘Very likely’, ‘Fairly likely’, ‘Neither likely nor unlikely’, ‘Fairly 
unlikely’ and ‘Very unlikely’. For the purposes of analysis, we dichotomised data into 
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any reported intention to access SSSs in future (’Very likely or ‘Fairly likely’) vs no 
reported intention (all other responses). 
 
Data on knowledge and beliefs – including around e-cigarettes – that could be 
influencing attendance at SSSs were obtained from answers to further questions. 
Participants were asked “To what extent do you agree or disagree with each of the 
following statements?  
 
1. I know people who use e-cigarettes; 
2. I know people who have attended NHS stop smoking services;  
3. I think e-cigarettes are a convenient way to quit smoking;  
4. I think NHS stop smoking services are a convenient way to quit smoking;  
5. I think learning how to use e-cigarettes takes up a lot of time;  
6. I think using NHS stop smoking services takes up a lot of time;  
7. I know how to use e-cigarettes if I want to;  
8. I know how to access NHS stop smoking services if I want to;  
9. Most of my family and friends accept my e-cigarette use;  
10. Most of my family and friends accept my smoking;  
11. If I was to use NHS stop smoking services, I would have to travel far;  
12. If I attended an NHS stop smoking service in the future, I think I would be made 
to feel welcome”. 
 
We again based response options on five-point Likert scales (‘Strongly agree’, ‘Tend to 
agree’, ‘Neither agree nor disagree’, ‘Tend to disagree’ and ‘Strongly disagree’) and 
dichotomised these into the first two responses versus all others. For the question “Do 
you think NHS stop smoking services currently offer their support to smokers who are 
using e-cigarettes to try to quit smoking, or not?”, respondents simply chose ‘Yes’ or 
‘No’, while “Out of these two approaches for quitting smoking, which do you think 
would be more likely to help someone to quit?” had the response options ‘Using e-
cigarettes’, ‘Getting support from NHS stop smoking services’ or ‘Both equally likely’. 
This was dichotomised into those choosing SSSs as the most effective approach versus 
those choosing the other two responses. Finally, participants reporting previous SSS 
uptake were also asked “Overall, to what extent did you find the NHS stop smoking 
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service you attended helpful or not for your efforts to quit smoking?”. Response options 
were ‘Very helpful’, ‘Fairly helpful’, ‘Not very helpful’ and ‘Not at all helpful’ which was 
dichotomised into the first two responses versus the final two. 
 
We specified potential confounders a priori within our analysis plan. For smoking-
related and sociodemographic variables, data were available from existing STS 
questions which use well-established classifications and scales. The ‘Motivation To Stop 
Scale’ (MTSS), for instance, asks “Which of the following best describes you?”.(18) We 
coded ‘intention to stop smoking’ as 1 for any participants answering “I REALLY want to 
stop smoking and intend to in the next month”, “I REALLY want to stop smoking and 
intend to in the next 3 months” or “I want to stop smoking and hope to soon” and coded 
it as 0 for anyone answering “I REALLY want to stop smoking but I don't know when I 
will”, “I want to stop smoking but haven't thought about when”, “I think I should stop 
smoking but don't really want to” or “I don't want to stop smoking”. Similarly, we 
assessed nicotine dependence using the established ‘Heaviness of Smoking Index’ (HSI). 
This sums a smoker’s categorised number of cigarettes smoked per day and the time 
they go between waking and having their first cigarette (the index ranges from 0 to 6, 
with higher scores indicating higher nicotine dependence).(19) The STS also provided 
our data on past year quit attempts via answers to the question “How many serious 
attempts to stop smoking have you made in the last 12 months?”. We coded as 0 any 
smokers who reported zero attempts and coded as 1 any who reported one or more 
such attempts.  
 
Sociodemographic variables were gender, age, ethnicity (which we dichotomised into 
white versus non-white) and social grade (which we dichotomised into ABC1 vs C2DE, 
with the former including managerial, professional and intermediate occupations, and 
the latter including small employers and own account workers, lower supervisory and 
technical occupations, semi-routine and routine occupations, never workers and long-
term unemployed). 
 
For interaction analyses, these measures were also combined with data on use of e-
cigarettes, provided by the existing STS questions: “Which, if any, of the following are 
you currently using to help you cut down the amount you smoke?”, “Do you regularly 
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use any of the following in situations when you are not allowed to smoke?” and “Can I 
check, are you using any of the following either to help you stop smoking, to help you 
cut down or for any other reason at all?”. ‘Dual use’ of e-cigarettes and combustible 
tobacco was therefore classified as any respondent choosing ‘Electronic cigarette’ from 
the response options provided for any of these three questions. 
 
Statistical analyses 
 
Summary descriptive tables were created for the outcomes plus all other key variables. 
We then used logistic regression to conduct analyses of how past and planned SSS 
uptake varied by each knowledge/belief variable, after adjusting for smoking-related 
and demographic co-variables. First, unadjusted models (M1) examined the association 
of each knowledge/belief variable with each of the SSS uptake variables to provide 
crude odds ratios (ORs) with associated 95% confidence intervals. Secondly, final 
models were developed (M2) examining the adjusted association of each of the 
knowledge/belief variables on each of the SSS uptake variables, after adjusting for a 
priori variables (age, gender, ethnicity, social grade, intention to quit, past-year quit 
attempts and nicotine dependence), in order to produce final adjusted ORs with 
associated 95% confidence intervals.  
 
We then used the M2 models to also examine interactions between each of the 
knowledge/belief variables and dual use of e-cigarettes or key sociodemographic 
variables (age, gender, ethnicity and socioeconomic status) on each of the SSS uptake 
variables. This involved developing different ‘interaction’ models, each model having 
the interaction term in question (e.g. ‘thinks SSSs are convenient way to quit’ x sex), 
which adjusted for all a priori variables (as in M2). Statistical corrections (such as 
Bonferroni or Siddak’s) were not applied given these were exploratory analyses 
designed to inform hypothesis-generating for future studies. All analyses were 
undertaken as outlined in advance in our analysis plan (pre-registered on Open Science 
Framework, accessible at www.osf.io/ur3j8). SPSS v24 was used to conduct all analyses. 
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Results  
 
Of the 2,313 participants interviewed, 2,189 (94.5%) provided complete data on our 
key co-variables (HSI, age and gender). Participants excluded as a result of missing data 
on these variables (5.0% due to incomplete HSI data, 0.4% for age data and 0.1% for 
gender) were significantly more likely to be male and not of white ethnicity (p<0.05) 
compared to those forming the final sample. Participant characteristics are shown in 
Table 1. 
 
Table 1: Sample characteristics 
 
 Study 
sample 
(n=2,189) 
Demographic characteristics 
Age, Mean (SD) 43.5 (17.3) 
Female, % 49.7%  
White, % 90.0%  
Social grade C2DE, % 56.7%  
No post 16 qualifications, % 60.9%  
With disability, % 17.4%  
Heterosexual, % 87.4%  
Region: North, % 32.2%  
                     Central, % 29.7%  
                  South, % 38.1%  
Smoking characteristics 
Current tobacco use, % 100%  
Current e-cigarette use, % 18.2%  
Current NRT use, % 10.2% 
Past SSS use, % 21.6%  
Intended future SSS use, % 23.2%  
Intention to quit smoking, % 33.1%  
Past year quit attempt, % 29.9%  
HSI Index, Mean (SD)  1.72 (1.51) 
  
NRT: nicotine replacement therapy; SD: Standard deviation; North: North East, North West, Yorkshire & 
Humber; Central: East Midlands, West Midlands, East of England; South: London, South East, South West; 
HSI: Heaviness of Smoking Index (the higher the score, the higher the dependence on nicotine); Tobacco 
use only: current smokers of combustible tobacco with no current use of e-cigarettes or NRT 
 
Out of 2,189 smokers, 21.6% had accessed a SSS in the past and 23.2% planned to do so 
in future. Results of analyses are shown in Table 2.   
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Table 2: Knowledge/beliefs and past or planned SSS uptake amongst current smokers 
 
Agreement with 
knowledge/belief statements 
 Ever use of SSS Planned future use of SSS 
 % reporting SSS 
ever use (n) 
Model 1: OR  
(95% CI) 
Model 2: AOR 3 
(95% CI) 
% reporting SSS 
planned use (n) 
Model 1: OR  
(95% CI) 
Model 2: AOR 3 
(95% CI) 
E
-c
ig
a
re
tt
es
 
Knows people who use e-cigs 
No  
Yes 
14.6% (75/512) 
23.7% (397/1677) 
1.00 
1.81 (1.38-2.37) 
1.00 
1.79 (1.35-2.38) 
16.6% (85/512) 
25.2% (423/1677) 
1.00 
1.69 (1.31-2.19) 
1.00 
1.43 (1.09-1.88) 
Thinks e-cigs are convenient way to quit 
No  
Yes 
21.0% (279/1327) 
22.4% (193/862) 
1.00 
1.08 (0.88-1.33) 
1.00 
1.03 (0.83-1.28) 
21.4% (284/1327) 
26.0% (224/862) 
1.00 
1.29 (1.06-1.58) 
1.00 
1.22 (0.98-1.51) 
Thinks lots of time needed to learn to use e-cigs 
No  
Yes 
21.8% (428/1961) 
19.3% (44/228) 
1.00 
0.86 (0.61-1.21) 
1.00 
0.77 (0.54-1.11) 
23.2% (454/1961) 
23.7% (54/228) 
1.00 
1.03 (0.75-1.42) 
1.00 
1.03 (0.73-1.45) 
Knows how to use e-cigs  
No  
Yes 
14.3% (91/637) 
24.5% (381/1552) 
1.00 
1.95 (1.52-2.51) 
1.00 
2.01 (1.54-2.63) 
17.7% (113/637) 
25.5% (395/1552) 
1.00 
1.58 (1.25-2.00) 
1.00 
1.28 (1.00-1.65) 
Thinks family & friends accept e-cig use 1   
No  
Yes 
28.9% (33/114) 
33.0% (93/282) 
1.00 
1.21 (0.75-1.94) 
1.00 
1.16 (0.70-1.91) 
35.1% (40/114) 
27.7% (78/282) 
1.00 
0.71 (0.44-1.13) 
1.00 
0.67 (0.41-1.10) 
S
to
p
 s
m
o
k
in
g
 s
er
v
ic
es
 
Knows people who have used SSS 
No  
Yes 
14.3% (210/1471) 
36.5% (262/718) 
1.00 
3.45 (2.79-4.26) 
1.00 
3.39 (2.71-4.24) 
18.7% (275/1471) 
32.5% (233/718) 
1.00 
2.09 (1.70-2.56) 
1.00 
1.59 (1.27-1.99) 
Thinks SSSs are convenient way to quit 
No  
Yes 
16.4% (170/1037) 
26.2% (302/1152) 
1.00 
1.81 (1.47-2.24) 
1.00 
1.73 (1.39-2.16) 
12.5% (130/1037) 
32.8% (378/1152) 
1.00 
3.41 (2.73-4.25) 
1.00 
3.07 (2.43-3.87) 
Thinks lots of time needed to access SSS 
No  
Yes 
21.7% (352/1622) 
21.2% (120/567) 
1.00 
0.97 (0.77-1.22) 
1.00 
0.96 (0.75-1.22) 
24.9% (404/1622) 
18.3% (104/567) 
1.00 
0.68 (0.53-0.86) 
1.00 
0.61 (0.47-0.79) 
Knows how to access SSS  
No  
Yes 
6.8% (37/541) 
26.4% (435/1648) 
1.00 
4.89 (3.44-6.94) 
1.00 
4.66 (3.25-6.69) 
12.0% (65/541) 
26.9% (443/1648) 
1.00 
2.69 (2.03-3.57) 
1.00 
2.00 (1.49-2.68) 
Thinks family & friends accept smoking  
No  
Yes 
22.2% (199/896) 
21.1% (273/1293) 
1.00 
0.94 (0.76-1.15) 
1.00 
0.99 (0.79-1.23) 
26.0% (233/896) 
21.3% (275/1293) 
1.00 
0.77 (0.63-0.94) 
1.00 
0.86 (0.69-1.07) 
Thinks would have to travel far to use SSS  
No  
Yes 
22.1% (419/1899) 
18.3% (53/290) 
1.00 
0.79 (0.57-1.08) 
1.00 
0.72 (0.52-1.00) 
23.6% (448/1899) 
20.7% (60/290) 
1.00 
0.84 (0.62-1.14) 
1.00 
0.89 (0.65-1.23) 
Thinks would be made to feel welcome by SSS 
No  
Yes 
14.0% (91/652) 
24.8% (381/1537) 
1.00 
2.03 (1.58-2.61) 
1.00 
1.99 (1.53-2.58) 
10.4% (68/652) 
28.6% (440/1537) 
1.00 
3.45 (2.62-4.53) 
1.00 
2.91 (2.19-3.87) 
Found past use of SSS helpful 2   
No  
Yes 
N/A N/A N/A 
20.8% (36/173) 
60.2% (180/299) 
1.00 
5.76 (3.73-8.88) 
1.00 
5.61 (3.57-8.82) 
Thinks dual e-cig/tobacco users eligible for SSS 
No  
Yes 
20.8% (283/1359) 
22.8% (189/830) 
1.00 
1.12 (0.91-1.38) 
1.00 
1.10 (0.88-1.36) 
20.9% (284/1359) 
27.0% (224/830) 
1.00 
1.40 (1.14-1.71) 
1.00 
1.32 (1.06-1.63) 
E
-c
ig
s 
v
s 
S
S
S
s Thinks e-cigs are more effective than SSS 
No  
Yes 
21.9% (406/1855) 
19.8% (66/334) 
1.00 
0.88 (0.66-1.18) 
1.00 
0.85 (0.62-1.15) 
25.1% (466/1855) 
12.6% (42/334) 
1.00 
0.43 (0.31-0.60) 
1.00 
0.40 (0.28-0.57) 
Thinks SSS are more effective than e-cigs 
No  
Yes 
20.2% (287/1421) 
24.1% (185/768) 
1.00 
1.25 (1.02-1.55) 
1.00 
1.33 (1.06-1.65) 
17.9% (254/1421) 
33.1% (254/768) 
1.00 
2.27 (1.85-2.78) 
1.00 
2.35 (1.89-2.93) 
1 n=396, as question only asked to respondents reporting current use of e-cigs; 2 n=472, as question only asked to respondents reporting any past ever use of SSS; 3 Model 1 was 
unadjusted, while Model 2 controlled for demographic variables (age, gender, ethnicity, socioeconomic status) and smoking-related variables (intention to quit, past-year quit 
attempts, nicotine dependence)  
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 In the final adjusted models (M2), two knowledge/belief variables related to e-
cigarettes were associated (p<0.05) with both having accessed SSSs in the past and 
planning to do so in future: knowing people who used e-cigarettes (AOR 1.79, 95% CI = 
1.35 to 2.38 for past uptake and AOR 1.43, 95% CI = 1.09 to 1.88 for planned uptake) 
and thinking that e-cigarettes were less effective than SSSs (AOR 1.33, 95% CI = 1.06 to 
1.65 for past uptake and AOR 2.35, 95% CI = 1.89 to 2.93 for planned uptake). One 
further e-cigarette variable was associated only with past use of SSS: knowing how to 
use e-cigarettes (AOR 2.01, 95% CI = 1.54 to 2.63). Similarly, one such variable was 
associated only with planned SSS uptake: thinking dual users of e-cigarette and 
combustible tobacco users were eligible for SSSs (AOR 1.32, 95% CI = 1.06 to 1.63). 
 
With regards to knowledge/belief variables related to the SSS themselves, four of these 
were associated with both having accessed SSSs in the past or planning to do so in 
future: knowing people who had used SSSs (AOR 3.39, 95% CI = 2.71 to 4.24 for past 
uptake and AOR 1.59, 95% CI = 1.27 to 1.99 for planned uptake); thinking that SSSs 
were a convenient way to quit smoking (AOR 1.73, 95% CI = 1.39 to 2.16 for past uptake 
and AOR 3.07, 95% CI = 2.43 to 3.87 for planned uptake); knowing how to access SSSs 
(AOR 4.66, 95% CI = 3.25 to 6.69 for past uptake and AOR 2.00, 95% CI = 1.49 to 2.68 
for planned uptake); and thinking they would be made to feel welcome by SSSs (AOR 
1.99, 95% CI = 1.53 to 2.58 for past uptake and AOR 2.91, 95% CI = 2.19 to 3.87 for 
planned uptake). Two further SSS variables were associated only with planned uptake: 
having found past use of SSSs helpful (AOR 5.61, 95% CI = 3.57 to 8.82); and thinking 
lots of time was needed to access SSSs (AOR 0.61, 95% CI = 0.47 to 0.79; NB: inversely 
associated, unlike the others). 
 
In analyses of interaction effects, interactions (p<0.05) were observed in relation to 
several e-cigarette variables. These interaction analyses showed that for smokers in 
higher social grades the odds of having accessed SSSs in the past were associated with 
knowing people who used e-cigarettes (AOR 2.80, 95% CI = 1.70 to 4.60) but this was 
not the case for those in lower social grades (AOR 1.40, 95% CI = 0.99 to 1.98). 
Meanwhile, for smokers in lower social grades, odds of planned SSS uptake were 
negatively associated with the belief that e-cigarettes were more effective than SSSs 
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 (AOR 0.23, 95% CI = 0.13 to 0.41), but this was not the case for those in higher social 
grades (AOR 0.67, 95% CI = 0.42 to 1.07). The odds of planned SSS uptake were also 
negatively associated with a belief that lots of time was needed to access such services 
with a larger negative association among smokers who were ‘dual using’ e-cigarettes 
with their combustible tobacco (AOR 0.34, 95% CI = 0.20 to 0.60) compared with those 
who were not (AOR 0.72, 95% CI = 0.54 to 0.96). 
 
Further interaction effects were observed in relation to several SSS variables. The 
association between having accessed SSSs in the past and the belief that the SSSs were a 
convenient way to quit was greater for men (AOR 2.32, 95% CI = 1.65 to 3.27) than for 
women (AOR 1.39, 95% CI = 1.04 to 1.86). Conversely, intending to access SSSs in future 
and having judged past use of SSSs to be helpful was more strongly associated for 
women (AOR 8.40, 95% CI = 4.49 to 15.71) than for men (AOR 3.36, 95% CI = 1.73 to 
6.51). Finally, the association between future SSS uptake and the belief that one would 
be made welcome by the SSSs was found to be greater for lower social grades (AOR 
4.04, 95% CI = 2.67 to 6.12) than for higher ones (AOR 2.03, 95% CI = 1.36 to 3.03).  
 
Discussion  
 
Our study uses a large, nationally representative sample of the English population to 
generate evidence-based hypotheses in relation to an important research gap: what 
knowledge and beliefs influence smokers when deciding whether or not to access 
behavioural support, the most effective route available to quitting smoking.(1) 
Specifically, our results demonstrate that knowledge and beliefs about e-cigarettes and 
SSSs are often closely intertwined. In this discussion, we place these findings within the 
context of wider literature, to suggest possible explanations for these cross-sectional 
relationships, before suggesting hypotheses for future, larger studies to explore.  
 
Our study marks an important quantitative contribution to a largely qualitative 
evidence base. To our knowledge, it constitutes the only quantitative study to date to 
examine how knowledge and beliefs about e-cigarettes may be influencing past or 
future uptake of behavioural support. It thus provides a first contribution to filling an 
important research gap, given ongoing debate as to whether e-cigarettes’ popularity 
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 could be depressing uptake of more effective routes to quitting.(12,15,16) Smokers in 
our adjusted analyses who reported having acquaintances who used e-cigarettes were 
more likely to have accessed SSSs in the past and to plan to do so in future, while past 
SSS use was also associated with reported knowledge of how to use e-cigarettes oneself. 
This result aligns with recent survey findings that exposure to other people’s e-cigarette 
use may have some beneficial effects on smokers’ quitting motivation and 
behaviour,(20) perhaps by normalising attempts to quit, as well as with broader 
research suggesting e-cigarettes are not viewed by smokers as being in competition 
with, or mutually exclusive from behavioural support.(21,22) Indeed, recent studies 
have indicated that both current and ex-smoking vapers have an appetite to access 
other forms of treatment such as behavioural support.(23,24)  
 
Knowledge and beliefs about the SSSs themselves were also associated with past and 
future service uptake. In this respect, our study builds on qualitative findings about the 
importance of organisational and logistical barriers to service attendance.(8,10) We 
found, for instance, that perceptions of SSSs’ convenience and of time commitments 
involved were significant influences on whether a smoker planned to attend the 
services. Our finding regarding the importance of the kind of welcome a smoker 
anticipates from SSSs also reinforces previous insights into how services need to 
promote themselves as being non-judgmental about people’s smoking behaviours.(8,9) 
One previous mixed methods study has suggested that expectations of SSS effectiveness 
are a strong predictor of motivation to use these services.(25) Our own study expanded 
this to include comparative views on e-cigarettes, showing that believing SSSs were 
more effective than e-cigarettes predicted both past and planned use of the services.  
 
Our analysis of sociodemographic interactions revealed two instances with clear 
differences between smokers from different socioeconomic backgrounds, where 
variations in smoking-related behaviours are common.(26,27) The fact that the 
association of past SSS uptake with knowing people who used e-cigarettes was 
significant only for smokers in higher and not lower social grades may reflect residual 
confounding around motivation to quit. We aimed to reduce the risk of such residual 
confounding by capturing the concept of ‘intention to quit’ as precisely as possible 
through the MTSS, an established scale frequently used for broader published analyses 
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 of STS data.(18) Nonetheless, the finding may simply reflect the lower motivation to 
quit observed elsewhere among smokers from lower social grades,(20) and a similar 
greater willingness among higher social grade smokers to experiment with multiple 
quit aids or routes. Higher social grades appeared, after all, no less likely to plan to 
attend SSSs even if they believed e-cigarettes were a more effective option, perhaps 
suggesting this greater propensity to try different options. 
 
Limitations of our study include the fact that causal relationships cannot be established 
through cross-sectional research, though exploratory analyses such as ours can 
nonetheless be influential in indicating directions of travel for future research. We also 
had to rely on self-reported data collected using new questions, as no validated survey 
tools existed on this particular topic. To compensate for this, our questions were 
developed with subject matter expert input and had their face validity tested in advance 
with a range of smokers who reported varying levels of vaping. Finally, future cohort 
study designs could follow up participants over time, to assess how far intention to 
access services translates into actual uptake. However, in the absence of such studies, 
reported intentions are the best proxies we have to establish future attendance, not 
least since meta-analytic evidence has demonstrated the direct, albeit attenuated link 
between changing intentions and changing behaviours.(28) 
 
Our findings show that reported knowledge and beliefs about vaping have significant 
associations with planned SSS uptake, including the perception that dual users of e-
cigarettes and tobacco are eligible for SSS support. From this, we can hypothesise that 
changing these beliefs about eligibility for SSSs - for instance through the provision of 
clearer information to the public about SSS eligibility criteria - may influence intentions 
to access these services. Furthermore, results suggest a hypothesis that social 
connections with other vapers may also be important in influencing knowledge of 
different quit routes and normalising quitting behaviour, perhaps through discussions 
with these friend and family ‘precedents’. This may in turn influence smokers’ own 
thoughts about quitting, including the intention of some to access SSSs. 
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 Conclusion  
 
In summary, current smokers’ knowledge and beliefs about e-cigarettes and SSSs 
were often closely intertwined. Their plans to access behavioural support were 
associated with their vaping knowledge/beliefs (including their views on e-
cigarettes’ effectiveness and knowing people who vaped), as well as with their 
knowledge/beliefs about the support itself (included services’ expected 
convenience, warmth of welcome and time commitments).  
 
Interaction analyses suggested that, for some of these variables, differences existed 
between smokers of different sexes, social grades and levels of e-cigarette use. These 
findings suggest several hypotheses that have clear relevance for decision-makers, 
commissioners and practitioners alike, and thus merit testing by future studies. For 
instance, the extent to which vaping beliefs may have a bearing on service attendance 
will be of considerable interest across the smoking sector as they add weight to recent 
and repeated calls for SSSs to be ‘e-cigarette friendly’.(12–14) More broadly, in the 
context of six years’ of declining uptake,(4) SSSs will no doubt find this study and 
associated future research valuable for informing efforts to recruit more smokers 
through the doors of their highly effective services. 
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Chapter 6:   Research paper – Qualitative study of decisions 
to use e-cigarettes or behavioural support 
 
6.1   Introduction   
 
The fourth of my research papers is presented in this chapter. For this qualitative 
workstream, a series of semi-structured interviews was held with current and ex-
smokers reporting a range of levels of e-cigarette use and a range of attendance 
histories at stop smoking services (SSSs). Concurrent interviews took place with SSS 
staff and key stakeholders in the same three geographic areas. The previous paper 
(Chapter 5) used quantitative evidence to assess specific psychosocial factors that could 
be influencing smokers’ decisions on SSS uptake, including the potential role of 
knowledge and beliefs relating to e-cigarettes. This qualitative paper built on this 
through in-depth analysis of smokers’ views on these issues, as well as through the 
incorporation of professionals’ perspectives, thus enabling a richer understanding of 
many of the issues highlighted in Chapter 5. Furthermore, this workstream provided 
interviewees with opportunities both to introduce new viewpoints and to voice more 
nuanced opinions about some of the topics included previously in my survey questions. 
The data collected – in combination with Chapter 5 - therefore enabled me to address 
Objective C of this thesis: ‘investigating, amongst English smokers (the ‘population’) 
what factors (the ‘exposures’) influence decisions to use either e-cigarettes or SSSs (the 
‘outcomes’), including the potential impact each can have on the other’. The paper here, 
entitled ‘Understanding decisions to use e-cigarettes or behavioural support to quit 
tobacco: a qualitative study of current and ex-smokers and stop smoking service staff’, 
at the time this thesis was examined, was in the process of being sent for peer review by 
the first journal approached, Addiction. It has subsequently been updated to incorporate 
minor corrections recommended by my Viva examiners. Supplementary material 
relating to this qualitative workstream is available at Appendices C to G. 
 
6.2   Research paper cover sheet 
 
The signed cover sheet for this research paper is included on the following page.  
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 Abstract  
 
 
Aim    To examine factors influencing current and ex-smokers’ decisions to use e-
cigarettes or behavioural support, including the potential impact of any differences in 
perspectives between smokers and their local stop smoking services (SSSs).  
Design    Semi-structured qualitative interviews. Setting    SSSs and surrounding local 
areas in England, UK. Participants    Interviewees (n=46) were current or recent 
smokers (n=29) and SSS staff or stakeholders (n=17). Measurements    Interview 
topic guides explored influences on smokers’ choice of quit method and 
characteristics of support offered by their local SSSs. Analysis    Principles of 
framework analysis were adapted, with the COM-B model of behaviour change used 
to frame findings. Findings    Current and ex-smokers were similar to SSS 
professionals in showing a range of individual views on the potential risks of long-
term vaping; findings informed the development of a ‘vaping’ typology. For smokers, 
these differing views on risk appeared to be motivating them to use (or not use) e-
cigarettes while, for professionals, they seemed to be influencing the advice and 
support offered by SSSs in relation to e-cigarettes. Smoker and SSS interviewees 
differed, however, in their perceptions of whether local services provided information 
about e-cigarettes and whether they offered support to clients who had quit tobacco 
to then quit any ongoing addiction to e-cigarettes or NRT. Other important influences 
on smokers’ uptake of quit aids included: cost considerations, past experiences and 
concerns about e-cigarettes/NRT maintaining nicotine addiction. Conclusions    
Smokers’ decisions to use e-cigarettes and behavioural support appear to be 
determined by a range of influences. In particular, both smokers and SSS 
professionals display very varied views about the potential risks of e-cigarettes, 
which has relevance for the provision of behavioural support as well as the uptake of 
vaping. SSSs seeking to attract more ‘dual users’ of tobacco and e-cigarettes may use 
these findings to inform their recruitment efforts. 
 
Keywords: Smoking, E-cigarettes, Stop smoking services, Behavioural support, 
Qualitative, COM-B  
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 Background 
 
The majority of adult smokers report a desire to quit and, between 2015 and 2019, 
around 30% attempted to do so in a given year (1,2). The UK stop smoking services 
(SSSs) were established in 1999 to provide pharmacotherapy and behavioural support 
to any smokers desiring additional assistance to quit. The services have been repeatedly 
evaluated and shown to increase a smoker’s odds of success up to fourfold (3,4), yet 
their attendance rates have been dropping for six consecutive years, from 2012/13-
2017/18 (5). In contrast, e-cigarettes are by far the most common aid used by UK 
smokers trying to quit (2), with an estimated 3.2 million adults now vaping, as of 2018, 
up from 700,000 in 2012 (6). The evidence base for e-cigarettes is inevitably still 
emerging however, particularly in relation to their effectiveness as quit aids and their 
health impacts for long-term users (7). 
 
Service monitoring data and other SSS reporting suggest that smokers who combine 
behavioural support with e-cigarettes may have amongst the highest quit rates of all SSS 
users (8,9). There have thus been repeated calls by national bodies for SSSs to welcome 
smokers using e-cigarettes and to provide them with behavioural support (10,11). Many 
SSSs do now brand themselves ‘e-cigarette friendly’, but surveys of services in recent 
years have suggested that advice provided on e-cigarettes varies across England and 
that many individual practitioners continue to have concerns about recommending 
vaping (8,12–14).  
 
While previous research has examined broad reasons for e-cigarette use amongst 
vapers (15–17), and – to a more limited extent – general influences on SSS uptake (18–
20), there is currently little knowledge about how decisions to use e-cigarettes might 
relate to decision-making around accessing behavioural support. This is particularly 
important to understand in light of concerns that e-cigarettes could potentially 
undermine the uptake of more effective routes to quitting smoking, such as SSSs (5,21–
23). 
 
Models of behaviour change, which have always been integral to the SSSs’ work (24,25), 
offer a useful way of understanding smokers’ decision-making in this area. The Stages of 
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 Change model, for instance, has long been influential internationally in smoking 
cessation work, despite systematic research casting doubt on its effectiveness (26). The 
COM-B model, part of the wider Behaviour Change Wheel framework (27), is now more 
favoured within the smoking cessation sector in the UK and beyond (28,29), and also 
underpins Public Health England’s SSS commissioning guidance for local authorities 
(30). COM-B posits that behaviour is a product of motivation (reflective and automatic 
brain processes), capability (psychological and physical capacities), and opportunity 
(factors external to an individual). Previous research has demonstrated its applicability 
to the uptake of vaping and behavioural support respectively (28,31), as well as to 
smoking-related behaviours more generally (27).  
 
This paper aims to examine factors influencing smokers’ decisions to use e-cigarettes or 
behavioural support, including the potential impact of any differences in perspectives 
between smokers and their local SSSs. It uses the COM-B model to frame these factors 
thematically and to understand any inter-relations between them. 
 
Methods  
 
Ethical approval was received from an NHS Research Ethics Committee (REC), as well as 
the host university’s REC. Data were collected through 46 semi-structured interviews in 
three sites with 29 current and ex-smokers and 17 SSS staff and stakeholders 
(stakeholders included local authority commissioners and public health consultants).  
 
Interviews were conducted from October 2017 to August 2018 at three research sites in 
England, each comprised of an SSS and its corresponding catchment area (see Table 1 
and Supporting information).1 The three sites were selected for broad geographical 
diversity (North, Central and South England) as well as to capture a range of local SSS 
policies towards e-cigarettes, based on advice from a small number of national and 
regional smoking experts. Smoker interviews were conducted in participants’ homes or 
a public place of their suggestion. Staff and stakeholder interviews were conducted at 
SSS premises or local authority offices.   
                                               
1 The ‘supporting information’ included with this paper when it was submitted to Addiction were the 
participant recruitment grid and topic guides, available respectively at Appendices C and G of this thesis. 
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 Table 1: Participant characteristics 
Smokers (n=29) 
Age (years)  
    Mean (range) 43(18-67) 
Gender  
    Male 10 
    Female 19 
Smoking  
    Current 12 
    Ex 17 
Vaping  
    Current 12 
    Ex 5 
    Never 12 
SSS use  
    Current 6 
    Ex 11 
    Never 12 
Staff & stakeholders (n=17) 
Gender  
    Male 5 
    Female 12 
Role  
    Manager 3 
    Practitioner 9 
    Stakeholder 5 
 
 
SSS staff provided flyers to service-using smokers who then contacted the lead 
researcher for further details if considering participating. Non-users of SSSs were 
recruited through snowball recommendations from service users or via local 
newspaper and Facebook advertising. Participants were eligible if they were currently 
using tobacco or e-cigarettes or had used either regularly within the previous 18 
months. SSS staff and stakeholder interviewees were identified through discussions 
with service managers and staff members at team meetings. Participants all gave 
written informed consent to be interviewed.  
 
All interviews were conducted in person by the lead researcher using a topic guide 
(Supporting information). The guide for smokers focused on potential influences on 
their use of e-cigarettes and SSSs; the guide for SSS staff and stakeholders explored the 
policy their SSS had in place regarding e-cigarettes and how this was translated into 
practice. All interviews were audio recorded before being transcribed verbatim. Total 
transcript time equalled 28 hours, 38 minutes: current and ex-smoker interviews lasted 
from 22-49 minutes (median 35), while staff and stakeholder interviews lasted from 23-
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 51 minutes (median 42), Participants were offered a £20 shopping voucher to 
compensate them for their time.  
 
Data were analysed using the principles of framework analysis, which has been shown 
to be applicable for studying influences on the uptake of behavioural support and 
vaping (32–34), including the role health professionals may play in such decisions (35). 
Using the COM-B framework, we identified data from smokers about their ‘motivation’, 
‘capability’ and ‘opportunities’ to access different quit routes. Data from SSS staff and 
stakeholders provided additional insights into factors influencing opportunities for 
quitting that lay within the services’ control. A sample of transcripts were carefully 
examined in order to produce initial coding frames for the smoker and staff interviews 
respectively. These brought together deductive codes from the topic guides with 
inductive codes from the reviewed transcripts and were discussed and agreed within 
the research team. All transcripts were then coded line by line by the lead author within 
NVivo 12, with the two coding frames undergoing minor refinements as required during 
this process. Matrices were exported to Excel to facilitate visualisation of the dataset by 
codes and cases. The research team then discussed several iterations of the analysis to 
refine underlying themes and patterns. A typology relating to vaping behaviour was 
developed inductively and agreed during this process. Quotations are shown below 
from smoker (S) and SSS professional (P) interviews. 
 
Findings  
 
Influences on use of e-cigarettes 
 
In relation to smokers’ views and experiences of e-cigarettes, a simple typology 
emerged during data analysis (Table 2). Interviewees with recent, regular e-cigarette 
use split into ‘Finite’ and ‘Forever’ vapers.  Forever vapers expressed no specific 
concerns about being addicted to vaping, nor a motivation to end that addiction. Finite 
vapers, in contrast, were motivated to quit vaping at some point in their lives (some 
were currently trying to do so, whilst others said they planned to quit in future); many 
had concerns that e-cigarettes could carry long-term health risks and that users were 
130
 essentially prolonging nicotine addiction. Non-vapers, meanwhile, split into those who 
were ‘Sceptical’ about people vaping and those who were ‘Supportive’ of this. Sceptical 
non-vapers expressed strong doubts about e-cigarettes’ safety and addictiveness, 
reporting no intention to vape in future, while the Supportive non-vapers believed e-
cigarettes to be safer than smoking and sometimes expressed future intentions to start 
vaping. 
 
Table 2: Views expressed about vaping within different groups of interviewees 
 
 
Intention to 
stop vaping in 
future 
Intention to 
start vaping 
in future 
Concern 
about possible 
risks from 
long-term 
vaping 
Belief that 
long-term 
vaping could 
carry even 
more risks 
than smoking 
Concerns that 
vapers were 
still essentially 
addicts 
Vapers 
‘Finite’ Yes - Mixed No Mixed 
‘Forever’ No - No No No 
Non-vapers 
‘Supportive’ - Mixed No No No 
‘Sceptical - No Yes Mixed Mixed 
 
 
Current and ex-smokers who had used e-cigarettes regularly: ‘Finite’ and 
‘Forever’ vapers 
Alongside a difference in motivation to quit e-cigarettes (see Table 2), vaping 
interviewees showed varying confidence and willingness to use (what they perceived to 
be) evidence from experts to inform their assessments of risk. Although vapers in both 
groups believed that vaping was a safer choice relative to smoking, they differed in their 
perceptions of the evidence of absolute risks from e-cigarettes. Unlike Forever vapers, 
Finite vapers repeatedly expressed concerns about a perceived lack of definitive 
evidence on e-cigarettes, which seemed to make it hard to feel capable of establishing 
whether or not they were harmful. These concerns motivated them to want to quit 
vaping: 
 
“I don't think I will vape long term because I still feel like there's not enough 
research about it”  
(S1: Ex-smoker, current vaper, SSS user, female) 
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 Finite vapers often also worried that vaping was, in essence, prolonging an addiction or 
introducing a new one: 
 
“It got to one point I actually felt like I was addicted to my e-cig and cigarettes 
independently…and I couldn’t, couldn’t give either of them up.”  
(S15: Ex-smoker, recent vaper, SSS user, male) 
 
Attitudes towards vaping were not solely informed by interviewees’ considerations of 
risk and addiction, however. Across both groups of vapers, interviewees perceived e-
cigarettes as effective for cutting down or quitting smoking. There were recurrent views 
that patience and experimentation with different models of e-cigarette were key to 
finding a model that matched personal preferences. Vape shops were sometimes seen as 
important and convenient sources of expertise on what model to try and how they 
might use it: 
 
“I think it takes a bit of learning, what to do and how, but if you go to an e-cigarette 
vape shop then they’ll explain everything and it’s, I think it would be easier than 
going to the NHS Stop quitting service” 
(S19: Current smoker, current vaper, non-SSS user, female) 
 
The perception that vaping was less expensive than smoking was also identified as a 
factor that increased opportunities (through economic availability) and motivation for 
vaping amongst both Finite and Forever interviewees:  
 
“The other factor if I’m honest was because cigarettes are just going to go on going 
up…I’m retired now, I’m on a pension and e-cigarettes are cheaper” 
(S25: Ex-smoker, current vaper, non-SSS user, female) 
 
Current and ex-smokers who had never used e-cigarettes regularly: 
‘Sceptical’ and ‘Supportive’ non-vapers 
Amongst the Sceptical non-vapers, perceived limited capability to make an informed 
choice about the health risks of e-cigarettes was again a recurring theme linked to 
different understandings and interpretations of – and confidence in – research evidence. 
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 Like the Finite vapers, Sceptics expressed significant concerns about the lack of testing 
which had been undertaken on e-cigarettes’ potential harms. Many even believed e-
cigarettes could be more dangerous than smoking, sometimes attaching greater 
significance to the strength of evidence on a harm rather than the severity of the harm 
itself: 
 
“I think it’s very cleverly worded, all the [e-cigarette] posters, 95% safer than 
tobacco. But what about that 5% I think…Tobacco is not good but then you know 
where you stand with tobacco, done many research…  Well yeah, it’s got the links to 
lots of horrible diseases.”   
(S8: Current smoker, non-vaper, SSS user, female) 
 
Sceptics tended to voice doubts, often based on their own experiences, about the 
effectiveness and cost-effectiveness of e-cigarettes as smoking quit aids. Several also 
echoed concerns of Finite vapers that e-cigarette use was not true quitting, sometimes 
likening this disapprovingly to harm reduction practices such as substituting heroin 
with methadone. They frequently maintained that vapers were fundamentally still 
smokers: 
 
“You're not really quitting smoking, you're quitting smoking cigarettes, but you're 
still a smoker as such aren’t you, because you're vaping?”  
(S23: Current smoker, non-vaper, non SSS user, female) 
 
In contrast, the Supportive non-vapers reported far more confidence in assessing the 
relative risks of vaping versus smoking, describing the difference between the two as 
‘black and white’ or making clear statements such as: 
 
“I think vaping is very much safer than tobacco and cigarettes” 
(S6: Current smoker, non-vaper, SSS user, male) 
 
Some even expressed an intention to take up vaping in future: 
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 “I’m thinking of getting a vape, so I can still be included, and at break times go 
outside.  It might sound silly, but it’s like a social glue for me” 
 (S4, Ex-smoker, non-vaper, SSS user, male)  
 
Influences on uptake of behavioural support 
 
Current and ex-smokers 
Factors influencing SSS uptake were largely similar across vaping and non-vaping 
interviewees. Motivation to use SSSs appeared to be closely linked to past use of such 
services: virtually all current smokers who expressed no future intentions to access 
SSSs had never accessed them previously. Conversely, interviewees who had accessed 
SSSs almost unanimously reported positive experiences, which appeared to be key 
incentives for those wishing to use them again. The benefits of one-on-one contact with 
an adviser were frequently cited, with SSSs often described as safe spaces, offering 
reprieves from the public judgment felt by smokers, as well as a sense of support and 
hope:  
 
“You feel so warm going in.  And they really inspire you… while you’re in there you 
can actually believe.  Sometimes I wish that I was just there all the time because 
then I wouldn’t want to smoke”.  
(S6: Current smoker, non-vaper, SSS user, male) 
 
The subsidisation of stop smoking pharmacotherapies was also cited as a key 
motivation for wishing to access SSSs:  
 
“That’s the only place where you’re going to get it free. That plays a big factor for 
me, the fact that it was, the NRT was free, because it helps me financially.”  
(S2: Ex-smoker, vaper, SSS user, female) 
 
For other interviewees however, and particularly those who had never accessed SSSs, 
the provision of pharmacotherapy acted as a de-motivating factor. There was 
sometimes an equating of SSSs with simply the distribution of nicotine replacement 
therapy (NRT) – i.e. without any concept of behavioural support around that – which 
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 was therefore unappealing to those who perceived NRT as inappropriate for 
themselves. Concerns here echoed some of the distrust about e-cigarettes maintaining 
nicotine addiction, with several interviewees dismissing NRT from SSSs as a ‘backward 
step’: 
 
“You get addicted to them, they’re just as bad as smoking…that’s what I heard so I 
never tried them.”  
(S26: Current smoker, recent vaper, non SSS user, male) 
 
Some interviewees from the Sceptical group also emphasised self-reliance and cold 
turkey approaches to quitting.  Getting SSS support was seen as ‘giving in’, as 
demonstrating a kind of ‘victim’ mentality, or as failing to confront your smoking 
problem ‘internally’.  
  
“I like to think I’m quite strong willed.  So, I wouldn’t want to, I don’t know, I don’t 
want to have to give in and have to go get help to quit, I’ll do it on my own.”  
(S20: Ex-smoker, non-vaper, non SSS user, female) 
 
In terms of their perceived capability to use behavioural support, many interviewees 
were confident that they could identify (e.g. through the internet) local SSSs to attend if 
desired. Interviewees sometimes reported feeling ‘inundated’ by SSS adverts 
‘everywhere’, yet some had nonetheless not appreciated that such services would be 
available in their local area. Others suggested that awareness of a SSS did not always 
come with an acceptance of its relevance for themselves: 
 
“I see it all in the notices around, it just never registered really…I've probably seen 
them all around and just dodged it”  
(S11: Ex-smoker, current vaper, SSS user, female) 
 
Participants’ perceptions of their own time resources emerged as another common 
barrier to accessing SSSs, in terms of both the short-term waiting (e.g. on phone calls) 
involved in booking slots and the long-term waiting that could then be required before 
appointments were available. This issue could be interpreted both as one of opportunity 
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 (since long waiting times are barriers to availability) and also capability (since 
interviewees differed in their tolerance of waiting). Some interviewees voiced 
frustration at making a decision to quit but then having to wait days or even weeks for 
appointments, which could also impact smoking levels in the meantime: 
 
“In that time period I think, oh I've got two weeks now until I have to stop smoking, 
so if anything, I smoked more.  Because I was cramming them in, knowing that I 
was actually going to stop smoking and the appointment was imminent”.  
(S14: Ex-smoker, non-vaper, SSS user, female) 
 
Conversely, physical distance to travel to SSSs was rarely viewed as a restriction since 
people generally felt they lived close to available services.  
 
Finally, in terms of SSSs’ perceived incorporation of e-cigarettes, across all groups, 
smokers who had accessed SSSs generally did not feel their service was particularly 
forthcoming on the topic of vaping. Rather, they suggested a reticence about e-cigarettes 
from SSSs, reporting that practitioners either provided no information on vaping or only 
discussed the topic if smokers raised it themselves:  
 
“They said, they wouldn’t mention it to me, until I mentioned it... And, yeah, not too 
much was said about e-cigarettes”.  
(S4: Ex-smoker, non-vaper, SSS user, male) 
 
When e-cigarettes were discussed, the small number of smokers who reported SSSs 
pro-actively introducing them to e-cigarettes had gone on to find vaping helpful. 
Interviewees across all groups also felt that ex-smokers who were now exclusively 
vaping ought to have opportunities to access SSS support for help to quit their e-
cigarette use. Several vapers interviewed expressed an interest in accessing their SSS 
for this kind of support if their own efforts to ‘wean’ themselves off e-cigarettes failed: 
 
“Maybe they'll have more information on how I could help me to stop the actual 
vaping… sometimes they have better ideas than you have yourself” 
(S1: Ex-smoker, current vaper, SSS user, female) 
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 SSS professionals 
Table 3 summarises key findings from SSS professional interviews. 
 
Table 3: Summary of SSS positions on e-cigarettes and individual staff views 
  
View service as 
‘e-cig friendly’ 
Eligibility of  
ex-smoking vapers  
for SSS support 
Individual staff 
concerns about 
possible risks from 
long-term vaping 
Staff and 
stakeholders 
Site A Yes No No 
Site B Yes Capacity-dependent Mixed 
Site C Yes Yes Yes 
 
 
Across the three sites, interviewees reported eagerness to attract more dual users of 
tobacco and e-cigarettes to their services, yet the extent to which they felt able to 
publicise these opportunities to smokers varied between different areas, as did 
individual views on vaping. Site A interviewees described their service as “very 
enthusiastic” and “completely broadminded” about e-cigarettes and even as going 
beyond “the official line” in terms of their willingness to recommend them. 
Furthermore, no interviewees expressed reservations about advocating vaping. The 
manager, for instance, was explicit in supporting people using nicotine for pleasure and 
rejected the idea that vaping should also be curtailed at the point of quitting smoking: 
 
“Some are still hung up on the idea of people using nicotine recreationally, so they’ll 
come at it as it’s OK just for quitting, but they must stop at the end of their 12 
weeks.  Well it’s nothing to do with them, recreational nicotine is not the big demon 
that people imagine”.  
(P4: SSS Manager, Site A) 
 
Site B interviewees described the SSS as “fairly enthusiastic” or “quite positive” about e-
cigarettes, with the manager stating that the service was not as proactive about vaping 
as some other areas due to insufficient resources. Some interviewees there were wary 
about advocating e-cigarettes:  
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 “Vaping isn’t a longer-term solution, it’s something that we hope will encourage 
people to, number one, avoid the harmful effects of tobacco but then also eventually 
stop smoking completely”  
(P17: Council-employed public health consultant, Site B) 
 
At Site C, although interviewees here as elsewhere often described their service policy 
as “e-cig friendly”, all practitioners interviewed expressed some reservations about e-
cigarettes encouraging continued nicotine addiction. One explained, for instance, that 
the team tended to advise people to vape outdoors partly because they felt this was less 
“habit forming”. There were further differences across sites regarding how much 
opportunity for support SSSs offered to ex-smokers, now vaping, who wished to quit 
their e-cigarette use too. Site A reported that they would not formally help such people, 
since they were not funded to do so. Site B’s manager reported that individual 
practitioners would help as far as able to if they had capacity, whereas Site C 
interviewees described such people as “totally eligible” for full support. 
 
Across all three sites, staff reported routinely asking smokers about their knowledge or 
past use of e-cigarettes. Participants from each site also described explaining to 
smokers with bad experiences of vaping that they could consider trying other devices or 
flavours. Staff often depicted vape shop workers as sources of expert advice and even 
potential partners:  
 
“They’ve tried something that their friend suggested and they haven’t liked it so 
they’ve stopped. And so I said … there’s so many … the work we wanted to do with 
shops was to almost have like a, when you go into a deli that people could try 
different flavours and different strengths” 
(P11: SSS Practitioner, Site C)   
 
Discussion 
 
Our study found that both smoker and SSS participants reported a range of individual 
views on the potential risks of long-term vaping; these appeared to be key factors 
influencing – for smokers – their use of e-cigarettes, and – for services – the scope of 
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 advice and support they provided in relation to e-cigarettes. Conversely, the two groups 
differed in their perceptions of how much opportunity services were providing for 
educating smokers about e-cigarettes and for helping with ongoing nicotine addiction 
after quitting smoking. Further important influences reported by smokers on their use 
of e-cigarettes often overlapped with influences on their use of SSS.  
 
Capability 
 
The range of views amongst current and ex-smoker interviewees on potential risks 
from long-term vaping underpinned our typology and appeared to be particularly 
relevant for the capability dimension of the COM-B framework. The different attitudes 
towards vaping we observed appeared to be linked, for instance, to variations in 
people’s perceived capability to assess the risks of e-cigarette use, which caused 
particular concerns for Sceptical non-vapers. This study thus provides qualitative 
insights into quantitative findings on harm perceptions that have previously indicated a 
lack of evidence on e-cigarettes as a leading concern of smokers, especially among 
never-vapers (36). As interviewees from this Sceptical group had generally not accessed 
SSSs, where information on relative harms is provided, there appears to be a need for 
credible, consistent communication to non-service attending smokers about the likely 
size of risk reduction seen with e-cigarettes versus smoking. This could in fact be 
welcomed by smokers, given previous research showing appetite among them for such 
information (31).  
 
Evidence of risk was not the only form of knowledge shown to influence vaping, 
however. Understanding different e-cigarette devices and practices was also regarded 
as important for facilitating vaping. Indeed, some vapers echoed the widespread view 
among SSS staff that vape shop workers were ‘experts’ on these issues who should be 
consulted (interestingly, neither group of interviewees expressed concerns about 
potential associated conflicts of interests).  
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 Opportunity 
 
Our findings suggest that opportunities to access SSSs, for ex-smokers who are now 
regular vapers, may be being influenced by different e-cigarette policies adopted in 
individual areas. SSS interviewees at all sites described their services as ‘friendly’ or 
‘welcoming’ to smokers who wished to use e-cigarettes to quit. Our study supports 
previous research however (8,12–14), in observing ongoing hesitancy amongst many 
staff towards e-cigarettes, as well as variability in support for ex-smoking vapers. SSS 
interviews suggested that the level of support provided to these vapers reflected not 
just publicly stated service-wide policies but also individual practitioners’ own views on 
risks from long-term vaping. This could of course deter Finite vapers, who wish at some 
point to end their nicotine addiction, from seeking help from local SSSs. It also marks a 
clear contrast to our smoker interviews where views were expressed, across all groups 
in our typology, that such vapers should be eligible for some form of structured support 
to quit their e-cigarette use. 
 
There appeared to be further disconnects between the perceptions of SSS staff that they 
were open and forthright about e-cigarettes, and the reported experiences of smokers 
who had used these services. This suggests that SSS attitudes towards e-cigarettes, as 
well as being diverse, are not always being communicated fully to service users. This 
variability in advice is of course understandable though given that services have been 
grappling with how to incorporate an unlicensed but unprecedentedly popular quit aid 
into their service alongside traditional licensed pharmacotherapy.  
 
Finally, distance to travel to services, unlike an earlier study (18), was not reported as a 
barrier, which may have reflected the predominantly urban catchment areas of two of 
our SSSs. Perceptions of available time, as observed elsewhere (18), often appeared to 
be a more pressing potential barrier though, as well as occasional misunderstandings of 
what an SSS involved and the fact that services were available locally.  
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 Motivation 
 
Motivations for using or avoiding e-cigarettes and SSSs often appeared to overlap, 
which may be of interest for SSSs’ efforts to attract ‘dual users’ of tobacco and e-
cigarettes. For instance, contrasting attitudes towards both e-cigarettes and the NRT 
provided by SSSs often reflected views on whether switching from smoking to these 
alternatives represented a successful quit or simply maintenance of nicotine addiction. 
Consistent advice on this issue would thus be helpful, particularly as even SSS staff hold 
contrasting views that inform practice. In particular, SSSs may wish to offer clearer 
reassurances to prospective clients about what support they can provide – following 
successful quitting of tobacco – to then wean ex-smokers off any nicotine-containing 
products (such as e-cigarettes or NRT) they transition onto. In this respect, our typology 
may be useful for practitioners when assessing the attitudes and specific goals of each 
smoker in relation to ongoing nicotine use. 
 
Motivation to vape also appeared, as found by others (37), to be influenced by 
interviewees’ own positive or negative experiences of vaping, just as motivation to use 
SSSs was usually linked to interviewees’ reported accounts of previous service use. This 
is unsurprising given interviewees who had attended SSSs were almost unanimous in 
finding the experience positive and helpful, even if they had not ultimately quit tobacco.  
 
Limitations and strengths 
 
Our study has some limitations. Data were collected from only three research sites all 
within the UK and, as such, findings are not necessarily generalisable to other settings. 
While COM-B was a helpful framework for analysis, we faced challenges, similar to 
previous research (31), with some issues that could not be neatly categorised as 
‘capability’, ‘motivation’ or ‘opportunity’, but rather involved multiple concepts. 
Repeat/longitudinal interviews could show more definitively how individual smokers’ 
behavioural support uptake and vaping interrelated over time. We did however benefit 
from studying SSSs in three separate regions, since previous similar research has 
focused on single areas (38–40). Furthermore, all interviews were conducted using a 
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 single consistent interview method (face-to-face) rather than incorporating phone 
interviews, as in these earlier studies.  
 
Our proposed typology aligns to some extent with one previously proposed in this area 
which sorted e-cigarette users into groups termed ‘vaping as pleasure’, ‘vaping as 
medical treatment’ and ‘ambivalent e-cigarette use’(41). In particular, broad similarities 
are shared between the first group and our Forever vaper category, as well as the 
second group and our Finite vapers.  Our own typology benefited, however, from 
expanding beyond vapers to incorporate all smokers, thus giving it wider relevance for 
SSS practitioners. To our knowledge, this is also the largest study of its kind to combine 
interviews with smokers and their local SSS staff. As such, results are likely to be 
valuable to SSSs while informing future research on decision-making around smoking 
cessation routes. 
 
Conclusion 
 
SSSs seeking to attract more dual users of tobacco and e-cigarettes may wish to use 
these findings to inform their recruitment efforts. Services should also consider 
whether they can offer clearer reassurances to prospective clients about any support 
they provide – following successful quitting of tobacco use – to then wean ex-smokers 
off nicotine-containing products they may transition onto. In this respect, the typology 
outlined may be useful for quickly assessing the attitudes and specific goals of 
individual smokers in relation to ongoing nicotine use. Finally, findings suggest varying 
approaches being taken – often as a result of capacity/cost pressures – towards the 
eligibility of ex-smoking vapers to access SSSs. Vapers who wish to end their ongoing 
nicotine addiction may therefore have greater options for support with this in some 
parts of the country than others. 
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Chapter 7:   Discussion and Conclusion 
 
7.1   Introduction   
 
This thesis aimed to investigate whether the use of e-cigarettes amongst smokers could 
influence their use of stop smoking services (SSSs) and, if so, how this was occurring. 
In order to achieve this aim, it had the following objectives: 
 
 Objective A: To understand, within English smokers (the ‘population’), how use of 
e-cigarettes (the ‘exposure’) varies across sociodemographic groups, and to 
consider this in relation to existing data on how use of SSSs (the ‘comparator’) 
varies across the same population [i.e. In summary, how is e-cigarette use (the 
‘exposure’) patterned across society compared to SSS use (the ‘comparator’)?]; 
 Objective B: To investigate whether, amongst English smokers (the ‘population’), 
use of e-cigarettes (the ‘exposure’) is associated with use of SSSs (the ‘outcome’), 
including in comparison to NRT use (the ‘comparator’) [i.e. In summary, is e-
cigarette use (the ‘exposure’) associated with SSS use (the ‘outcome’)?]; 
 Objective C: To investigate, amongst English smokers (the ‘population’) what 
factors (the ‘exposures’) influence decisions to use either e-cigarettes or SSSs (the 
‘outcomes’), including the potential impact each can have on the other [i.e. In 
summary, what factors (the ‘exposures’) influence e-cigarette or SSS use (the 
‘outcomes’)?]. 
 
7.1.1 Objective A: “How is e-cigarette use patterned across society 
compared to SSS use?” 
 
I first addressed Objective A by conducting a systematic review to examine an 
important research gap around which sociodemographic groups were most likely to be 
aware of e-cigarettes, to have tried them (‘ever use’) and to be regularly using them 
(‘current use’). No geographical or time restrictions were imposed on my searches of 7 
electronic databases, as well as the wide trawl of grey literature sources. A total of 4,985 
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 titles and abstracts were screened, followed by 335 full texts, leading to 58 studies 
being included. Existing data were already available on the sociodemographic groups 
that were most likely to use SSSs given routine data collection by services had provided 
statistics on this for several years.(1) This Discussion chapter builds on the literature 
review in Chapter 2 to place my systematic review findings from Chapter 3 within the 
context of what is already known about sociodemographic differences in SSS uptake. 
 
7.1.2 Objective B: “Is e-cigarette use associated with SSS use?” 
 
My quantitative workstream collected cross-sectional survey data from over 2,000 
smokers through new questions added into UCL’s existing Smoking Toolkit Study (STS). 
This addressed Objective B by assessing associations between e-cigarette use and past 
or planned uptake of SSSs. Sociodemographic differences were furthermore examined 
by including interaction terms as part of this work.  
 
7.1.3 Objective C: “What factors influence e-cigarette or SSS use?” 
 
The STS data also provided evidence towards Objective C, since several of my survey 
questions collected information about knowledge and beliefs - including in relation to e-
cigarettes - that could be influencing smokers’ SSS attendance. My qualitative 
workstream then involved 46 interviews with current and ex-smokers, as well as SSS 
professionals, at three research sites in order to further address Objective C. Interviews 
with the current and ex-smokers provided rich qualitative insights into influences on 
their decision-making regarding these quit routes, such as the central importance of 
perspectives about the potential harms from vaping. Interviews with professionals, 
meanwhile, highlighted how both their services’ formal policies and their own views on 
e-cigarettes could be influencing the attendance of different potential client groups.  
 
In this discussion, I first provide a summary of the findings relating to each objective, 
drawing out additional insights and examining how the quantitative and qualitative 
results relate to each other. Findings are situated in the context of previous studies, 
while research, policy and service implications are also considered. Finally, the chapter 
provides a conclusion to the thesis as a whole.  
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 7.2   Summary of findings and comparison with existing literature 
 
7.2.1   Objective A: “How is e-cigarette use patterned across society 
compared to SSS use?”  
 
Sociodemographic differences in e-cigarette use 
My systematic review (Chapter 3) marked an important contribution to understanding 
in this area, since it essentially constituted the first comprehensive review and 
synthesis of the global literature on which sociodemographic groups were using e-
cigarettes more than others. Across the 58 studies that met the inclusion criteria, there 
was variability in social patterning of the outcomes within and between countries, but 
some clear findings emerged. Across all outcomes, e-cigarettes appeared to achieve 
greater reach among older adolescents and younger adults, males and people of white 
ethnicity. For awareness and ever use, this was also the case for subpopulations with 
relatively higher educational attainment. The only previous review in this area also 
identified higher rates of e-cigarette use amongst young adults but found no clear 
patterning by race/ethnicity or education levels.(2) This earlier review included far 
fewer studies, however, due to less comprehensive searches, and also did not 
incorporate any critical appraisal within its methods. My paper was therefore the first 
rigorous systematic review to tackle this question. 
 
In terms of research published subsequent to my review, a 2018 Australian online 
survey (n=1,116) has echoed my findings in concluding that young males are 
particularly likely to be regular vapers, while similarly observing no associations with 
socioeconomic status (SES, which the authors calculated from participant’s postcodes 
using the Australian ‘Socio-Economic Indexes for Areas [SEIFA] classification’).(3) 
Recent US studies in this area have also indicated that the association I found between 
ever e-cigarette use and higher education may now be extending to current use. 
Friedman and Horn, for instance, found in a 2018 analysis of 50,000 25 to 54 year olds 
that more educated smokers were more likely to have switched to exclusive e-cigarette 
use than less educated ones.(4) Similarly, Glover et al. found current use of e-cigarettes 
to be greatest in respondents with college-level educational attainment in 2018, 
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 compared to lower educated groups.(5) As the Discussion section of my systematic 
review suggests, early adopters of technologies are known to be generally more likely to 
come from younger age-groups and to have higher education levels and SES.(6) It could 
therefore be expected that such groups would also be likely to be the first in society to 
move from ever use to current use. 
 
In terms of the specific picture for the UK, at the time of my review there were only 
limited data on e-cigarette use by sociodemographic groups. Studies included in the 
review that had solely UK samples were all graded by the critical appraisal process as 
being in the lowest quality group, barring one high quality study of 1,601 children from 
Wales, which found no significant differences in ever use of e-cigarettes by gender or 
SES.(7) The low quality studies generally found no significant differences between 
sociodemographic groups for the outcomes they considered, with the exception of: a 
small study of 256 SSS attendees in Liverpool that observed greater current use of e-
cigarettes in females; a large British study (n=12,432) that found greater ever use in 
younger adults than older ones; and a separate study of British adult smokers (n=4,117) 
that identified greater ever use amongst higher socioeconomic groups.(8–10) The last of 
these findings was supported at the time of my review by longitudinal English data 
showing a clear socioeconomic gradient of higher e-cigarette use amongst more affluent 
groups.(11) This same dataset from UCL showed no clear associations with age but 
suggested marginally higher rates in women than men. 
 
As outlined in Chapter 2, more recent English data was brought together in Public 
Health England’s (PHE’s) ‘Vaping in England’ report.(12) This concurs with the overall 
findings of my systematic review in showing that, across all four of the surveys it 
included, e-cigarette use was higher in men and amongst 25-34 year olds. The other 
sociodemographic variable explored in the PHE report is SES. Here, the four surveys - 
despite using different measures - broadly align in showing vaping rates to be greater 
amongst lower socioeconomic groups, with the biggest users being the ‘lower 
supervisory and technical occupation’ category. Interestingly, this clear association with 
SES was not apparent across the overall literature included within my systematic 
review and is in contrast to the two British studies identified in my trawls, which 
suggested either no associations with SES or that ever use was greater amongst higher 
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 socioeconomic groups.(7,9) It is also in contrast to the more recent American studies 
outlined above.(4,5) Two explanations seem plausible. Firstly, the triangulation of four 
datasets within the PHE report may have more closely approached the ‘underlying 
reality’ in England than the limited sources available at the time of my review, 
particularly since the latter were of variable quality according to the review’s grading 
system. Yet it also possible that the PHE findings reflect the development of the vaping 
market in the intervening years (which has clearly become more saturated now that e-
cigarette uptake has plateaued in the UK),(11) as well as the characteristic ‘diffusion of 
innovation’ process - mentioned above - that one expects from a new technology like e-
cigarettes. So while the early innovators in this case may have tended to be from higher 
SES or higher educational backgrounds, as time has gone on, later adopters from lower 
SES or lower educational backgrounds may have begun to dominate the market. Given 
the high proportion of vapers who are also still using tobacco,(11) it would thus be 
unsurprising that vaping prevalence now reflects the established inverse relationship 
between smoking and socioeconomics.(13) The US, however, may well be ‘lagging 
behind’ the UK on the innovation diffusion curve, given the much more conservative 
regulatory approach being taken there and the strong warnings about e-cigarettes that 
have been voiced by some of their most prominent public officials, including the 
Surgeon General.(14,15)  
 
Sociodemographic differences in SSS use 
In terms of how these data correspond with sociodemographic uptake of behavioural 
support, the picture is a complex one. International literature is limited, but one 2008 
US study found that uptake of behavioural support was more likely amongst smokers 
with higher SES and education levels.(16) UK research does not echo this, however. A 
2009 study of STS data did not find a significant socioeconomic gradient in the use of 
SSSs, with the authors hypothesising that this may have been in part due to the 
subsidisation of pharmacotherapies in the UK, which is not mirrored in the US.(17) A 
rigorous evaluation of the first ten years of SSSs’ work meanwhile found that they had 
been “successful in reaching economically disadvantaged smokers, with more than half 
of those treated being eligible for free prescriptions” (SSSs also improved their balance 
between male and female smokers during this time and attracted an increasing 
proportion of smokers from ethnic minority groups).(18) A previous systematic review 
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 highlighted two observational studies which similarly showed that SSSs were used by a 
greater proportion of smokers from lower SES areas than higher ones.(19–21) 
Meanwhile, STS data analysis has historically shown no difference in quit attempts by 
SES but has found a significant social gradient in the success of quit attempts, with much 
higher quit rates being observed for smokers from higher social grades in 2012 (20.4% 
vs 11.4% for lower social grades).(13) Part of the explanation may be, as Hiscock et al. 
posit, that the features of behavioural support (the most effective quit route a smoker 
can take) may favour high SES groups, for instance through referral processes or the 
timing and design of treatment programmes.(13,22) Lower SES smokers have also been 
shown to be less likely to complete courses of smoking cessation pharmacotherapies 
and programs of behavioural support, so adherence to treatment will surely be another 
factor in these observed socioeconomic differences.(22–24)  
 
In terms of the current picture in England, as outlined in Chapter 2, NHS Digital’s most 
recent data (2017/18) show that the ‘routine and manual’ group of smokers are 
comfortably the most likely socioeconomic group to record a quit attempt with SSSs, 
while 45-59 year old smokers are the most likely age group to make an attempt 
(followed by 18-34 year olds).(25) Women are more likely to attempt quitting than men 
and - as would be expected given the UK’s overall population demographics - white 
smokers are by far the biggest users of SSS support. Yet there are striking gender 
differences within ethnic groups, as around 80% of the Asian or Asian British group 
who attempt to quit are male, compared to only around 40% of white service users. In 
terms of rates of successful quits, the picture is very different. Men outnumber women 
on this measure, for instance, while Asian or Asian British smokers are the ethnic group 
most likely to succeed in quitting. Quit rates furthermore increase with increasing years, 
with the over 60s thus being the most successful group. With regards to 
socioeconomics, retirees are the most likely smokers to quit, with the ‘never worked or 
long term unemployed’ group being the least successful, despite recording the second 
highest number of attempts.(25)  
 
Comparing the sociodemographics of e-cigarette use and SSS use 
Table 1 presents a broad summary of the most recent English data available regarding 
which sociodemographic groups are currently the main users of e-cigarettes and SSSs 
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 respectively.(12,25,26) This sets the most recent data compiled in the 2019 PHE ‘Vaping 
in England’ report alongside the latest NHS Digital SSS monitoring data (2017/18) and 
the findings of my systematic review in Chapter 3. These data sources are presented 
together for ease of reference, but it is important to point out that my own review 
findings were based on a synthesis of global literature (and showed that minimal 
studies with English samples had been published at that point in time), whereas the 
data shown from the other two sources in the table has a specifically English scope.  
 
Table 1: Summary of latest data on sociodemographic subgroups reporting highest 
current use of e-cigarettes and stop smoking services  
Sociodemographic 
factor 
E-cigarettes 
Stop smoking 
services 
Hartwell et al.  
2016 review 
PHE  
2019 report 
NHS Digital  
2018 data 
Age Young adult 25-34 years 45-59 years 
Gender Male Male Female 
Socioeconomic status Insufficient data Lower SES  Lower SES 
Ethnicity White Insufficient data White 
 
Data sources: Hartwell et al. 2016 review;(26) PHE ‘Vaping in England’ report;(12) and NHS Digital 
statistics.(25) 
 
Taken together, these sources suggest some important differences in the appeal that e-
cigarettes and SSSs may be holding for various groups of smokers. With respect to 
gender, men are more likely to be current smokers than women (16.4% vs 12.6%),(27) 
and the PHE report’s most recent English data from 2018 support the findings from my 
systematic review that e-cigarettes appeal to men more than to women, but the 
opposite appears to be true for SSSs within the NHS Digital 2017/18 data.(12,25) E-
cigarettes also seem to have a greater appeal to younger adults (25-34 year olds), which 
may reflect this being the age group with the highest smoking rates overall, whereas 
SSSs’ main client base is the 45-59 year old age group. There appear to be broader 
similarities between the two quit routes in terms of the ethnicities and socioeconomic 
statuses of their users, however. While UK-specific data regarding ethnicity were 
extremely limited within my systematic review (the single small, low quality study 
included found no significant differences in e-cigarette current use between different 
ethnicities),(8) the review as a whole showed higher prevalence of ever and current use 
amongst people of white ethnicity, which is also the ethnicity that makes up the 
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 substantial majority of SSS users; most current smokers in England are, after all, of 
white ethnicity, which in turn reflects the overall population structure of a country 
which was approximately 81% ‘White British’ at the last census.(27,28) In terms of 
socioeconomics, lower income groups appear to now be the most likely to use both SSSs 
and e-cigarettes respectively, as of 2018. These associations are of course probably 
driven in large part by the inverse social gradient seen in smoking prevalence, since 
‘routine and manual’ is also the socioeconomic group whose members are most likely to 
be current smokers.(13,27) Importantly though, these lower socioeconomic groups are 
not necessarily the ones having the most success with breaking their addictions in 
either case. As shown above, despite the high attendance rates seen at SSSs in 2017/18 
from lower income smokers, it is the ‘never worked or long term unemployed’ group 
that fares worst in terms of successfully quitting, a relationship observed in STS 
analyses as well as NHS Digital’s routine data.(13,25) For e-cigarettes, as stated in 
Chapter 2, the ‘Vaping in England’ PHE report suggests that:  
 
“The social gradient of vaping in long-term ex-smokers may suggest that those 
from higher social groups are using EC [e-cigarettes] to quit smoking and then stop 
use while those from more disadvantaged groups continue use”.(12)  
 
As the authors point out, this will need to be monitored closely in the future as it has the 
potential to either narrow or exacerbate health inequalities depending on whether e-
cigarettes prove in the long-run to be protective (or not) against smoking relapse. 
 
7.2.2   Objective B: “Is e-cigarette use associated with SSS use?”  
 
Associations between e-cigarette use and SSS uptake 
The manuscript for my first quantitative paper (Chapter 4) shows how this objective 
was addressed through the analysis of data from new questions added into the existing 
STS survey for the purposes of this PhD. Notably, the paper represents the first national 
survey to examine concerns that the availability of e-cigarettes could undermine future 
uptake of behavioural support, the most effective route to quitting tobacco.(12,29-30) 
In summary, the ‘dual users’ of tobacco and e-cigarettes were in fact significantly more 
likely than other smokers to report both having accessed SSSs in the past and intending 
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 to take up these services in the future. The same was true of ‘dual users’ of tobacco and 
nicotine replacement therapy (NRT). 
 
In particular, the examination of future intentions to access SSSs makes my paper 
unique. The limited research in this area to date has generally focused on past use of 
SSS,(31,32) yet future attendance intentions are also crucial to understand given their 
relevance for the long-term viability of these struggling services. Reported intention 
does not necessarily translate into future action, of course, but it is the best available 
proxy and can provide valuable insights for efforts to change behaviour and improve 
health outcomes. In Fishbein’s words, “the single best predictor of whether or not a 
person will engage in a particular behaviour is his intention with respect to that 
behaviour”.(33) Indeed, meta-analytic evidence has subsequently demonstrated the 
partial but direct link between changes in intentions and changes in behaviours.(34)  
 
As outlined in Chapter 4, two previous studies, one from the UK (2016) and one from 
the US (2018), although inconclusive, have not identified associations between e-
cigarette use and past uptake of behavioural support.(31,32) The one exception was 
dual users of tobacco and e-cigarettes aged 65+ years in the US study who were more 
likely than non e-cigarette users to have accessed such support.(32) My findings suggest 
a broader positive association between dual tobacco/e-cigarette use and past SSS 
uptake than these studies. They also indicate that e-cigarettes are similar to NRT in this 
respect, with both being markers of a greater likelihood of having accessed SSSs in the 
past and planning to do so in future. As described in my results paper, there are a 
number of possible explanations for these associations. They may reflect, for instance: a 
broader willingness amongst these ‘dual users’ to try different quit methods; an 
educative or motivational effect from previous encounters with SSSs; a positive 
influence from e-cigarette experiences on quit intentions; or similar financial 
considerations influencing both e-cigarette and SSS uptake. The divergence from the 
findings of the two previous studies could meanwhile reflect the different study designs, 
settings (in the case of the US study) or the fact that my data collection was two years 
more recent than theirs, a sizeable timeframe in the context of an ever-shifting 
technology. Perceptions of e-cigarettes amongst both smokers and the general public 
are, after all, far from stable and our more recent data may potentially reflect a slowing 
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 in public enthusiasm towards e-cigarettes. STS data shows, for instance, that e-cigarette 
use for quitting peaked in 2016 (a year after these previous studies’ data collections 
ended), and that declining amounts of smokers believe that vaping is safer than 
smoking.(11) UK smokers may still use e-cigarettes more than other quit aids,(11) but 
the initial explosion in demand certainly seems to have waned, and claims that the 
country is still “hopelessly smitten” with e-cigarettes do not seem credible.(35)  
 
Given this apparent ‘cooling off’ towards e-cigarettes shown by STS data, our findings 
may therefore reflect an increasing inclination amongst dual users to buttress their 
vaping with other smoking cessation options. There may also be a socioeconomic 
dimension within this too. Smokers from lower socioeconomic groups are the most 
likely to access SSSs,(25) while - as outlined above - it has also been posited that vapers 
from such backgrounds are the ones most likely to struggle to quit ongoing e-cigarette 
use.(12) The apparently increasing levels of scepticism towards e-cigarettes may 
therefore be partly driven by those smokers from lower socioeconomic groups who 
have found it harder to quit vaping and also have fewer ex-vapers in their social circles. 
The increased odds of SSS uptake for dual e-cigarette/tobacco users may therefore 
reflect lower socioeconomic groups’ increased likelihood of accessing SSS, as well as 
their potentially increased likelihood of disenchantment with e-cigarettes. My 
interaction analyses did not record a significant difference in this area, however, so this 
may be too speculative. 
 
Sociodemographic differences in associations 
Interaction analyses in fact suggested there were no major differences between 
sociodemographic groups for these outcomes with the single exception of gender when 
examining the association between dual use of tobacco/NRT with future SSS uptake. 
Among females, such dual tobacco/NRT use increased their odds of intending to access 
a SSS in future (AOR 3.40, 95% CI = 2.19 to 5.28), whereas this was not evident in males 
(AOR 1.45, 95% CI = 0.90 to 2.35). It is not obvious how to interpret this. One plausible 
explanation relates to the facts that: a) female smokers are more likely to access SSSs 
overall than males ones; and b) NRT can be obtained either from a SSS or elsewhere 
(e.g. via a GP or over-the-counter).(25) The interaction observed could therefore simply 
reflect the fact that female smokers in any given sample are slightly more likely than 
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 male users: a) to be in the midst of SSS behavioural support programs (such smokers 
would probably have reported a future intention to access SSS use since we did not 
include a specific question for current/ongoing SSS use); and b) to have obtained any 
NRT from a SSS rather than elsewhere. Whatever the explanation may be though, it is a 
finding that does not appear to have particularly evident research or policy 
implications. 
 
7.2.3   Objective C: “What factors influence e-cigarette or SSS use?”  
 
For my qualitative workstream, I conducted semi-structured interviews with current 
and ex-smokers, as well as SSS professionals in the same geographic areas. Analysis was 
based on the principles of framework analysis.(36) Framework analysis is a type of 
thematic analysis which has already been shown to be fruitful for previous studies into 
influences on smoking cessation, including those comparing professional and 
patient/client perspectives.(37–39) It has the advantage over grounded theory of giving 
researchers opportunity to examine concepts that are already of particular interest, 
based on previous relevant literature, while still allowing scope for themes to emerge 
inductively from transcripts.(36,40) It is often linked to quantitative work and is 
particularly suited to ‘policy relevant’ research such as my own where objectives need 
to be set in advance to obtain funding.(41) Perhaps most importantly though, its 
pragmatic, matrix-based techniques are ideal for projects like mine, in which qualitative 
data from different groups of interviewees need to be compared and contrasted (for 
instance, my comparisons of the perspectives of smokers and SSS professionals, or of 
SSS professionals in different geographical areas).(36)  
 
I situated my findings within the widely-recognised COM-B framework of behavioural 
change. This thesis was focused on both past behaviour in relation to tobacco quit 
routes and future intended/envisaged behaviour in this same area, and there are clearly 
a complex range of factors that influence such behaviour. While these can be 
conceptualised or categorised in different ways, COM-B was identified at the outset of 
my programme of research as the most persuasive and robust model of behaviour 
change in this field. Yet COM-B proved much more fruitful in relation to this PhD’s 
qualitative workstream than its quantitative one.  
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While COM-B informed the development of the survey questions asked through the 
quantitative work, these were primarily influenced by close reading of the relevant 
scientific literature in this area, followed by input from subject matter experts and my 
PhD supervisors. While all my final questions arrived at could arguably be fitted into the 
COM-B model, this felt like it would be rather forcing the data, as questions often 
seemed to straddle more than one of the capability, opportunity and motivation 
categories. To take an example, the question about ‘knowing people who use e-
cigarettes’ could be relevant to motivation (since hearing about peers’ positive or 
negative experiences with e-cigarettes could make someone more or less interested in 
trying vaping themselves), but it could also relate to a person’s capability (since seeing 
other people using e-cigarettes will confer some knowledge about how to use these 
devices and which ones to opt for). Similarly, it even has implications for opportunities 
to vape (since people who have peers that use e-cigarettes will get more opportunities 
to ‘have a try’ on someone else’s device than people without vaping peers). Attempting 
to categorise the questions in this way therefore seemed to be a rather subjective 
process and one which did not add any obvious utility for my quantitative analysis or 
the presentation of those findings. Rather, I found that it was sufficient and more logical 
for the purposes of my quantitative work to simply split my analysis into factors that 
could potentially influence smokers’ use of e-cigarettes and those that could potentially 
influence their use of SSSs; given this workstream’s tight focus on a small number of 
survey questions, attempting to break down the limited number of factors further by 
capability, opportunity or motivation could have made the presentation of the results 
more bitty and confusing for readers.  
 
On the other hand, the COM-B model proved of clear value for my qualitative 
workstream where, by employing it to structure my findings, I was able to categorise 
logically the diverse array of influences on their decision-making that were reported by 
smokers. It also provided a coherent conceptual framework for analysing the SSS 
professional interviews alongside the smoker ones. While there were still a few 
occasions where it was not possible to fit a concept neatly into just one of the three 
capability, opportunity or motivation categories (as highlighted explicitly at points in 
Chapter 6’s paper), this process did prove feasible and helpful in a way that it simply did 
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 not with the quantitative work. It was far easier, for instance, to ascertain from direct 
quotations and their context within a broader interview which category a concept truly 
belonged in, given this workstream was dealing with richly nuanced interview data as 
opposed to fixed survey question responses. COM-B was thus employed specifically 
during the mapping and interpretation phase of my qualitative analysis as a means of 
categorising my findings. I wanted to integrate COM-B only towards the end of the 
analytical process in this way, since this approach avoided the risk of my analysis being 
constrained or directed too much by a pre-existing model, plus my paper was not 
designed to be an interrogation of the COM-B model itself. 
 
In summary, both smoker and SSS interviewees showed a range of individual views on 
the potential risks of long-term vaping. On the smoker side, these appeared to motivate 
people’s decisions about taking up vaping, while for staff they appeared to influence the 
advice and support individual services provided in relation to e-cigarettes. As I outline 
in the paper, the study thus provides some rich qualitative insights into previous 
quantitative findings about harm perceptions which have highlighted a lack of evidence 
on e-cigarettes as a leading concern for smokers, particularly among those who have 
never vaped (like most interviewees in the ‘sceptical’ group of my typology).(42) This 
workstream also directly addresses a recommendation for further research from the US 
study by Salloum et al. mentioned above, namely that:  
 
“More investigation is needed, including qualitative studies, of perceptions about 
evidence-based pharmacological and behavioral cessation therapies, as well as 
investigation into patient-provider interactions related to e-cigarette use”.(32)  
 
My second quantitative paper (Chapter 5) used data from the same STS participants as 
in Chapter 4 to generate hypotheses about the knowledge and beliefs - including in 
relation to e-cigarettes - that appear to be influencing smokers’ uptake of SSSs. To my 
knowledge, it is unique as a quantitative study in examining these particular issues. 
Overall, holding beliefs about e-cigarette effectiveness and reporting familiarity with 
vaping were associated with decisions to access SSSs. On the service side, reporting 
familiarity with SSSs and holding various beliefs about them were also associated with 
uptake. The two clearest interaction results related to SES, which seems logical given 
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 the entrenched, long-documented correlation between smoking rates and this 
particular sociodemographic variable.(13) The first of these findings showed that the 
odds of having accessed SSSs in the past were significantly increased for smokers in 
higher SES grades when they reported knowing people who had used e-cigarettes (OR 
2.80, 95% CI = 1.70 to 4.60), whereas this was not the case for those in lower SES grades 
(OR 1.40, 95% CI = 0.99 to 1.98). This apparent influence that social contacts can have 
echoes another recent quantitative study which showed that having vaping 
acquaintances appeared to have positive impacts on smokers’ inclination and attempts 
to quit.(43) The second interaction result showed that the odds of planned SSS uptake 
were significantly decreased for lower SES smokers when they believed e-cigarettes to 
be more effective than SSSs, but that this was not the case for higher SES smokers.  
 
Taken together, this may suggest that lower SES smokers view cessation options in 
more mutually exclusive terms, while higher SES smokers may be more willing to 
experiment with a quit route even if they do not necessarily think it is the most effective 
available. A mechanism for these various findings might potentially be found in the PHE 
report’s aforementioned suggestion about the social gradient of vaping in long-term ex-
smokers.(12) That suggests that amongst smokers with acquaintances who have used e-
cigarettes, those from higher social grades might plausibly be more likely to have seen 
such ‘dual users’ successfully quit their vaping as well as their smoking. In the same 
way, lower SES smokers might be more likely to have seen vaping acquaintances 
struggle to shake an ongoing nicotine addiction, which could understandably make 
them more cynical about other smoking cessation options.  
 
Mixed methods: convergence 
Taken together, my qualitative and quantitative findings provide further important 
insights relating to Objective C, both in terms of where the results from different 
methods align with each other and where they diverge. Firstly, there were a number of 
areas where the quantitative and qualitative results clearly complemented each other. 
The STS data showed, for instance, that respondents generally felt confident about 
accessing SSSs, with 75.3% agreeing with the statement “I know how to access NHS stop 
smoking services if I want to”. This was echoed in the qualitative workstream where 
many smokers conveyed a self-assurance that they could identify local SSSs to attend if 
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 they desired. The power of smartphones and the internet were frequently cited by these 
qualitative interviewees, for instance, in the sense that people felt there was nothing 
stopping anyone from simply searching online for SSSs if they wanted to know more. 
Indeed, there was sometimes even a sense of being ‘inundated’ by adverts and posters 
for the services.  
 
Previous qualitative research has indicated the impact that logistical and organisational 
barriers can have on service attendance.(44,45) In my interviews, as in previous studies 
into smoking cessation services,(46,47) time commitments emerged as a particularly 
important barrier for smokers. This was evident both in terms of the short-term waiting 
time that could be required ‘hanging on the telephone’ to book appointments and the 
longer-term waiting time that might be required before the first appointments were 
available. The quantitative results similarly indicated that ‘believing SSS attendance 
required lots of time’ was inversely associated with intention to access services (AOR 
0.61, 95% CI = 0.47 to 0.79). Conversely, distance to travel to services was not a concern 
for any interviewees. I hypothesise in Chapter 6 that this could be due to the 
predominantly urban catchment areas of my three research sites. However, it is notable 
that, in my quantitative analysis (Chapter 5), the statement ‘I think I would have to 
travel far to use SSSs’ was not significantly associated with either past or planned SSS 
uptake, suggesting this was again not a barrier in this much larger, nationally 
representative sample. Also evident from my quantitative results was the far greater 
popularity of e-cigarettes over SSSs, which has been shown previously in broader 
analyses of STS data.(11) Out of my sample, 76.6% of respondents reported knowing 
people who used e-cigarettes, while only 32.8% had acquaintances that had used SSSs. 
Again, this echoed findings in my qualitative interviews where smokers rarely reported 
knowing anyone who had used SSSs, but having some friends or family members who 
vaped was very common. 
 
Perceptions of how receptive SSSs are to smokers who are trying to quit using e-
cigarettes is a further area where both workstreams aligned. The second quantitative 
paper shows that, strikingly, 62.1% of current smokers disagreed with the question “Do 
you think NHS stop smoking services currently offer their support to smokers who are 
using e-cigarettes to try to quit smoking, or not?”, suggesting a widespread perception 
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 that e-cigarette users are not welcome at services. This adds weight to the qualitative 
paper’s finding that SSSs, despite being widely encouraged to be ‘e-cigarette 
friendly’,(48–50) do not appear to be communicating their policies on e-cigarettes 
particularly clearly to SSS users. Previous research has indicated the importance of 
services being perceived to be non-judgmental.(19,44) Taken together, the possible 
implication is that this disconnect or misunderstanding could be depressing SSS uptake; 
respondents who thought SSSs did offer support to smokers using e-cigarettes were, 
after all, more likely to intend to access SSSs (AOR 1.32, 95% CI = 1.06 to 1.63). The 
concept of candidacy, mentioned in Chapter 2 is particularly relevant here, since it 
describes “the ways in which people’s eligibility for medical attention and intervention 
is jointly negotiated between individuals and health services”.(51) This may be 
particularly relevant in this context where the widespread badging of SSSs as ‘e-
cigarette friendly’ has clearly not been sufficient to convince many smokers that ‘dual 
users’ are indeed eligible. This may in part be due to the ‘e-cigarette friendly’ message 
not being able to be promulgated adequately by SSSs. For instance, interviewees at one 
service in my study reported having constraints put on their e-cigarette messaging due 
to anxious comms colleagues. This therefore particularly reflects the ‘operating 
conditions’ element of Dixon-Woods et al.’s framework which describes how candidacy 
can be impacted by the local or organisational context within which services operate 
and the associated availability of resources.(51) 
 
Mixed methods: divergence 
In other areas, the quantitative and qualitative data show interesting divergences. The 
quantitative results, for instance, suggest a confidence among smokers that barriers to 
e-cigarette use are low: only 10.4% of people felt that “learning how to use e-cigarettes 
takes up a lot of time”, while 70.1% agreed with the statement “I know how to use e-
cigarettes if I want to”. This marks a clear area of difference from my qualitative 
interviews where current and ex-smokers who vaped often talked about the importance 
of patience and the need to try various models or liquid strengths in order to find 
something that was personally suitable: 
 
“I think it takes a bit of learning, what to do and how” 
(S19: Current smoker, current vaper, non-SSS user, female) 
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 “Get a starter kit, see how you get on.  But persevere, I didn’t last year, but you 
really need to.  Give it two or three days”  
(S24: Ex-smoker, vaper, non-SSS user, female) 
 
“They’re absolutely for, in my experience, 100% effective. When you find the right 
one.  I think there’s a danger in giving it, throwing it away, thinking oh that didn’t 
work for me, vaping doesn’t work for me.  But I would always say to somebody and 
I have advised people who I've tried to encourage, try different vapes, try different 
settings, go in a shop and get some advice, have a go on something, don’t just think 
that the disposable one that’s actually rubbish is all there is”  
(S27: Ex-smoker, vaper, non-SSS user, female) 
 
It is important to note though that this theme emerged in interviews with the vaping 
interviewees, some of whom were ex-smokers, whereas the quantitative sample 
consisted solely of current smokers, of whom only 18.2% were currently vaping. This 
discrepancy may therefore suggest that amongst current smokers as a whole, there is a 
somewhat over-confident attitude towards e-cigarettes which does not mirror the 
experience of those smokers who actually do take up vaping. Furthermore, in the 
qualitative interviews, amongst those participants who had accessed SSSs in the past, 
there were almost unanimous reports of positive experiences, with only one person 
expressing predominantly negative views about their contact with their local service. 
The quantitative data suggest a slightly less homogenous picture, with 63.3% of the 472 
respondents who had accessed SSSs reporting that they had found their experiences 
‘very helpful’ or ‘fairly helpful’, while 36.7% therefore reported their encounters with 
the services had been ‘not very helpful’ or ‘not at all helpful’. 
 
Comparison of smoker/professional perspectives and uniqueness of 
research 
The inclusion of SSS staff and stakeholder interviews within my qualitative research 
was a particular strength of this PhD, since it allowed for the investigation of areas 
where misunderstandings or misaligned perceptions between SSSs and their potential 
clients could be affecting service uptake. Previous qualitative research in this area has 
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 tended to focus on either service users or service staff in isolation from each 
other.(52,53) Only one other previous study, by Tamimi in 2018, has combined 
interviews with both SSS staff and smokers.(54) My own study therefore sought to build 
on this existing research to provide stronger evidence in this area. Not only did I employ 
more consistent data collection (solely using face-to-face interviews rather than some 
phone interviews), but my research sites had a broad geographical spread across 
Northern, Central and Southern England, rather than being situated in a single region 
like these three previous studies. In addition to Tamimi’s focus on e-cigarette use, my 
work also explored at length influences on attendance at SSSs, thus providing insights 
into how decisions on the two options related to each other. Finally, by recruiting 
almost twice as many participants as Tamimi, I was able to capture a much broader 
range of smokers with varied experiences of quitting smoking, using e-cigarettes and 
accessing SSSs (as shown by my recruitment matrix in Appendix C), as well as a wider 
range of voices on the SSS side, which included service managers and key stakeholders, 
rather than solely practitioners. In terms of smokers, for instance, Tamimi’s study only 
included current vapers, whereas my own research also incorporated smokers who 
were not vaping to obtain a broader sense of the barriers that might impede e-cigarette 
use, as well as the facilitators that can prompt it.  In terms of SSS professionals, as 
outlined in Chapter 6, my findings in this respect support previous studies in observing 
ongoing nervousness amongst many staff towards e-cigarettes.(53,55–57)  
 
My study aligned with Tamimi’s, however, in identifying heterogeneity in vapers’ 
attitudes towards e-cigarettes and, in particular, towards their absolute health risks, 
while finding more unified attitudes towards their risks relative to smoking. The 
previous study reported, for instance, that “all participants believed e-cigarettes to be 
less harmful than smoking”,(54) while my own findings similarly showed that vapers 
across my sample felt long-term vaping was a safer choice relative to smoking. Indeed, 
my study was able to show an important further nuance that, although vapers aligned in 
believing e-cigarettes to be the less harmful choice, some still felt sufficiently 
uncomfortable with their nicotine addition to want to give it up (the ‘finite’ vapers), 
whilst others lacked any intention to do so (the ‘forever’ ones). My study similarly 
expanded on this previous research by setting these views alongside those of non-
vaping smokers, revealing that the ‘sceptical’ group of these non-vapers held far more 
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 mixed views, with many believing that vaping could be even more harmful than 
smoking. Furthermore, by placing findings within the COM-B framework, I was able to 
highlight differences in smokers’ perceived capabilities to make informed judgments. 
Brose et al. concluded in a 2015 study into harm perceptions of vaping that “clear and 
balanced information on the relative harm of e-cigarettes and cigarettes is needed”.(58) 
Sadly, four years on, this recommendation remains as valid as ever. 
 
7.3   Limitations 
 
To avoid duplication, limitations already outlined in Chapters 3 to 6 are not repeated in 
full here, but a summary is provided below for reference. 
 
The systematic review (Chapter 3):  
 
 may have been affected by publication bias, in which studies with non-significant 
findings in relation to awareness and use were less likely to be published;  
 identified no eligible low-income or middle-income country studies with its 
trawls, and there was no clear way of assessing the degree to which this reflected 
a bias in the body of research that had been conducted versus any bias in the 
databases searched; 
 focused on general population samples so did not explore e-cigarette use within 
specific clinical populations and also did not include smoking of conventional 
cigarettes as a variable for analysis; 
 employed quality assessment based on an established tool for prevalence 
studies, but this tool was tailored to the review’s requirements and adaptations 
were not validated; 
  was limited, like all reviews, by the evidence available and its reporting. 
 
The quantitative workstream (Chapters 4 and 5): 
 
 relied, in part, on data gathered using novel questions for which there were no 
relevant established questionnaire tools; 
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  may have been affected by recall bias (in data regarding past behaviour) and 
social desirability bias (in data regarding future actions or knowledge/belief 
statements); 
 may have been affected by residual confounding in relation to the concept of 
‘intention to quit’ or other variables; 
 was unable, like all cross-sectional research, to establish causal relationships. 
 
The qualitative workstream (Chapter 6):  
 
 collected data from only three research sites, all within the UK and - as such - 
findings were not necessarily generalisable to other settings;  
 faced challenges with some issues that could not be neatly categorised within the 
COM-B framework as ‘capability’, ‘motivation’ or ‘opportunity’, but rather 
involved multiple concepts; 
 was unable to explore how individual smokers’ behavioural support uptake and 
vaping interrelated over time, which repeat/longitudinal interviews could have 
shown more definitively.  
 
The following additional points are also worth noting. A potential limitation of my 
quantitative workstream is the fact that the smokers who were removed from the 
sample due to having incomplete data on our key variables - age, gender and heaviness 
of smoking (HSI) - were significantly more likely to be male and of non-white 
ethnicities. This seems unlikely to have markedly affected findings though; the 
percentage of such smokers removed from the sample was only 5.5% (5.0% due to 
incomplete HSI data, 0.4% due to age data and 0.1% due to gender data), which is a 
small and fairly standard proportion for such exclusions.  
 
Across both my workstreams, but particularly my quantitative one, the precise badging 
of the services was an area that risked inaccuracy and potential confusion. In my STS 
data collection, questions referred to “NHS stop smoking services” rather than ‘local 
stop smoking services’ or simply ‘stop smoking services’. This decision was taken based 
on advice received from senior academics and subject matter experts at UCL and NCSCT 
that these services were often still referred to (and thought of by the public) as ‘NHS 
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 stop smoking services’. This was confirmed during face validity testing of my questions, 
where respondents were asked whether they felt references to “NHS stop smoking 
services” or “local stop smoking services” would be clearer. There was a clear view 
across these testers that the former was a more readily understandable term for the 
services in question.  
 
Finally, the generalisability of this work beyond the UK needs careful consideration 
depending on the context of individual countries concerned. The regulation of e-
cigarettes is, after all, an area where there are wide differences internationally, as is the 
provision of behavioural support akin to that provided by England’s SSSs.(59)  
 
7.4   Implications and recommendations 
 
As outlined in Chapter 1, this thesis aimed to investigate whether, amongst English 
smokers, the use of e-cigarettes could be influencing their use of SSSs and, if so, how this 
was occurring. Chapter 3 thus details how the use of e-cigarettes varies across different 
sociodemographic groups, before Chapter 4 shows that e-cigarette use amongst 
smokers is indeed associated with their use of SSSs. Finally Chapters 5 and 6 delineate, 
using both quantitative and qualitative data, the varied factors that influence smokers’ 
decisions to use e-cigarettes or SSSs. As well as addressing my original aim, these 
findings suggest a number of implications and recommendations for policy, practice and 
research alike. 
 
My systematic review (Chapter 3) outlines a number of implications for researchers in 
particular. I describe the findings, for instance, as “an essential first step towards 
monitoring the population and health inequality impacts of e-cigarettes with more 
clarity and granularity”, while also suggesting that future studies should consider “more 
precise measures of current use to capture this concept more accurately” as well as 
“more precision around the specific types of e-cigarettes being used”. On this note, I 
would recommend researchers now consider the comprehensive set of proposals that 
have subsequently been outlined by Pearson et al. for assessing e-cigarette ever use, 
frequency of use, device type and related items.(60) 
 
168
 I believe the findings from my main quantitative paper (Chapter 4) have clear relevance 
for decision-makers across England. As the introduction to that chapter outlines, it has 
been suggested that widespread e-cigarette use may be reducing the need for SSSs, an 
argument that has formed part of the rationale for cutting services in a number of local 
authorities.(61–64) Our findings, however, cast doubt on the credibility of this position, 
showing that - rather than wanting to ‘go it alone’ - smokers are keen to receive 
additional support from these services even when they are already using e-cigarettes to 
try to quit. My paper in fact echoes the conclusions of the RCT into e-cigarettes and 
behavioural support recently published in the New England Journal of Medicine (NEJM), 
which found that “among dual users who want to stop smoking, there seems to be a high 
level of interest in smoking-cessation treatments.”(65) This follows other recent studies 
which have indicated that smokers themselves do not seem to view e-cigarettes as 
being in isolation from, or in competition with SSSs;(31,32) indeed, both dual users and 
ex-smoking vapers have now been shown to have ongoing interest in accessing other 
forms of treatment including behavioural support.(66,67)  
 
This therefore ought to give pause for thought to any local authorities planning to make 
similar decommissioning decisions, as well as to national policy-makers who provide 
guidance to local government. In this respect, my findings also lend weight to 
recommendations in a Lancet comment that “Government authorities should resist any 
cost-cutting suggestions to decrease support for the SSS on the basis of the obvious and 
well documented benefits achieved when smokers are enrolled in these services.”(68) 
In particular, given SSSs’ strong cost-effectiveness has been well established for years, 
ongoing cuts in this area will inevitably be a false economy leading to greater burdens 
on the NHS from smoking-related conditions in the future.(69) Finally, these findings 
should also be of considerable interest to wider international audiences. Uptake of SSSs 
has, after all, declined across the EU as a whole in recent years,(30) while countries 
everywhere are each having to grapple with how to regulate e-cigarettes appropriately 
alongside other routes to quitting smoking.(59)  
 
My qualitative workstream is unique in its examination of smokers’ decision-making 
regarding the most effective quit route available (behavioural support with 
pharmacotherapy) and the most popular (e-cigarettes). As part of this, it investigates 
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 the potential influence of SSSs themselves on such decisions by smokers. By unpacking 
exactly how various views on risk influence e-cigarette uptake, my study provides 
researchers with a qualitative complement to recent quantitative data showing the 
central role played by harm perceptions in this area.(42) These findings have 
implications for decision-makers, commissioners and practitioners alike. SSSs, for 
instance, in the context of six years of declining service uptake,(25) could use these 
findings to inform their efforts to attract more ‘dual users’ of tobacco and e-cigarettes 
through their doors. Similarly, national and local policy-makers may wish to reflect on 
our study’s implication that ex-smoking vapers - who are often uncomfortable with 
their ongoing nicotine addiction - may be being forgotten in parts of the country where 
SSS policies do not provide them with access or where SSSs have been completely 
discontinued. Finally, the insights about difficulties smokers report in making informed 
choices about e-cigarettes reinforce the need for clearer information provision about 
the likely relative risks of switching from tobacco to vaping.(58) Any such messaging 
should also incorporate recent research about communicating scientific uncertainty in 
relation to e-cigarettes.(70)  
 
More broadly, my findings again have relevance for audiences internationally. At a 
conceptual level, the COM-B framework that underpins my paper is internationally 
recognised, informing research and practice in many other countries. From a policy 
perspective, very recent research shows significant proportions of European long-term 
vapers think that health professionals could help them stop their e-cigarette use and 
would be interested in using cessation services,(66) yet the variable provision of such 
behavioural support for vapers is a key finding of our paper. Meanwhile, another recent 
study has demonstrated that - in Australia, Canada, England and the United States - 
discussions between smokers and health professionals about vaping products appear to 
be infrequent.(71) My paper provides some rich qualitative insights into these 
discussions, outlining disconnects between the perspectives of practitioners and 
smokers on several fundamental issues. In particular, it appears that there is scope for 
SSSs to be clearer to prospective clients about what level of support they will be able to 
offer them - after they quit tobacco - to then help them taper off any quit aid products 
used, including NRT or e-cigarettes. I would therefore fully echo the broader point made 
by Wells et al. that “there is an evident need for services, supported by policy-makers, to 
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 better convey to the public…what can be offered and how this will work”.(37) Several of 
my interviewees had doubts about SSSs, for instance, since they felt people simply 
remained addicted to nicotine patches afterwards. The typology developed in my 
qualitative paper may assist practitioners with this by allowing them to quickly assess 
what an individual smoker’s specific views are in relation to continuing using nicotine 
after quitting tobacco. A previous typology has been proposed in this area,(72) as 
discussed in Chapter 6, and mine aligns with it to a large extent but has the advantage of 
expanding beyond vapers to incorporate all smokers, thus giving it wider applicability 
to the work of SSSs. 
 
The most similar previous study to mine concluded that “stop smoking services need to 
recognise the potential benefits gained by using e-cigarettes as a harm reduction tool 
and focus on stopping smoking rather than stopping nicotine”.(54) I would argue, 
however, that a more nuanced approach is required. As outlined in my qualitative 
paper, national policy-makers may wish to reflect on my study’s implication that ex-
smoking vapers – who are sometimes uncomfortable with their ongoing nicotine 
addiction – may be ‘falling through the cracks’ in parts of the country, with no access to 
any specialist support. It is, of course, understandable that some SSSs may be unwilling 
to take these people on as clients; services are, after all, frequently needing to absorb 
deep budget cuts that require them to prioritise their resources carefully. Furthermore, 
SSS interviewees frequently cited the importance of PHE’s figure of an estimated 95% 
lesser risk of vaping compared to smoking,(73) so they are therefore likely to often take 
the view that they should spend their limited resources tackling the much graver health 
threats of smoking. In addition, SSS outcomes are judged primarily by a ‘four week quit 
rate’ measure that requires 85% of reported quits to be validated via clients’ readings 
on carbon monoxide meters. Ex-smoking vapers do not therefore fit comfortably into 
this monitoring regime. As one SSS interviewee explained, the bottom line was that 
supporting someone to quit vaping:  
 
“wouldn’t be something that we would count as a quit if you like, if we did contract 
monitoring based on the service specification”  
(P12, Council-employed public health commissioner, Site B). 
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 Yet this does beg the policy question: whose responsibility are these vapers? At the 
moment, this appears to be a ‘grey area’ of policy, or a ‘limbo land’ as one SSS 
interviewee put it memorably: 
 
“It's one of those real grey areas because we're the only people who, we're the best 
people to deal with it, but it's not something that we're there for, particularly.  
Which does leave people stuck in a limbo land where they've gone from smoking 
just to nicotine and now they can't get off that… so it's a real tricky one because it's 
like, yeah you need to go back and start smoking before we can see you, which is 
the wrong idea”. 
(P1: SSS Manager, Site B) 
 
The view from smokers themselves on this question was clear within my research. 
Interviewees across all groups of my typology felt that such people ought to be eligible 
for SSS support to help quit vaping, with people often pointing to the fact that NHS 
support was available for other addictions, that vaping still carried some harms or that 
any addiction was painful to break: 
 
“It's still very much an addiction… Rehab, you get rehab for alcoholics, gamblers, 
drug addicts, but you don’t get a rehab for smokers and you get the smoking clinics, 
which really help so why can't they help the people that want to come off the 
vaping.”  
(S14: Ex-smoker, non-vaper, SSS user, female) 
 
“It’s still nicotine, it’s still causing you harm.  So, yeah, I think they should… I think 
there should be support afterwards, when you want to stop them.  Because any 
drug, any addiction is, it’s torture to come off”.  
(S29: Smoker, non-vaper, non SSS user, male) 
 
Despite these arguments, support to current tobacco smokers should surely remain the 
top priority, given the overwhelming weight of current evidence suggesting smoking 
carries substantially greater risks than vaping.(73)  
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 This issue of vaping in ex-smokers also has important wider implications, not least since 
rates of ongoing, long-term use are very high for e-cigarettes. Among participants in the 
2019 NEJM RCT, for instance, 80% of smokers who quit tobacco using e-cigarettes were 
still vaping one year later, compared to only 9% of NRT users who were still using NRT 
at this one year mark.(65) Taken together with the recent PHE report’s suggestion that 
it may be most likely to be ex-smokers from lower socioeconomic groups who struggle 
to quit their vaping long-term,(12) this must surely be an area where further research 
focus is needed, given the potential for social inequity of impacts. In this context, further 
studies are also needed into whether ongoing vaping in ex-smokers has a protective 
effect against relapse back to tobacco or is in fact a risk factor for this, as has recently 
been warned.(74) If the latter scenario does prove to be the case, the need to provide 
further cessation support to ex-smoking vapers should become an even more urgent 
priority. As my own systematic review concludes, it is imperative that future studies 
help maintain vigilance to ensure that the opportunities offered by e-cigarettes “are 
distributed fairly across society” and “do not widen existing health inequalities”.(26) 
 
In summary, the implications of my thesis for various audiences are as follows. 
 
 
PRACTICE 
 
SSSs should consider: 
 Using the findings from Chapters 5 and 6 about factors that influence smokers’ 
decision-making to inform their efforts to attract more ‘dual users’ of tobacco 
and e-cigarettes through their doors. 
 Providing clearer information about the likely relative risks of switching from 
tobacco to vaping, given the confusion in this area highlighted in Chapter 6. 
 Giving greater clarity to prospective clients (in light of Chapter 6’s findings) 
about what level of support they will be able to offer them – after they quit 
tobacco – to then help them taper off any quit aid products used, including NRT 
or e-cigarettes.  
 Using the typology outlined in Chapter 6 to help them quickly assess what an 
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 individual smoker’s specific views are in relation to continuing using nicotine 
after quitting tobacco. 
 
Local authorities should consider: 
 Giving their support to SSSs to help them address the first three 
recommendations above around recruitment and information provision. 
 Reviewing any SSS cuts for which e-cigarette prevalence has formed part of the 
rationale, given the findings outlined in Chapter 4 that – rather than wanting to 
‘go it alone’ – smokers are keen to receive additional support from these services 
even when they are already using e-cigarettes to try to quit. 
 
POLICY 
 
National organisations (DHSC and PHE) should consider: 
 Giving more explicit, vocal support (in light of Chapter 4’s findings) to SSSs in the 
face of such service reductions and, resisting – as also recommended by the 
Lancet – “any cost-cutting suggestions to decrease support for the SSS on the 
basis of the obvious and well documented benefits achieved when smokers are 
enrolled in these services”.(68) 
 Clarifying the policy ‘grey area’ around support for the proportion of ex-smoking 
vapers who may be uncomfortable with their ongoing nicotine addiction. 
Specifically, the differing approaches being taken on this issue by SSSs 
documented in Chapter 6 suggest national guidance from PHE would be valuable 
on what assistance these people may require and whose responsibility it is to 
deliver this. In financial terms, however, support to current tobacco smokers 
should unequivocally remain the top priority; i.e. no funds should be diverted 
from local SSSs’ core work, given current evidence suggests smoking carries far 
greater risks than e-cigarettes. Rather, any efforts in this area should be 
supported by new funds and only if such monies cannot be better invested in 
tackling tobacco smoking. 
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RESEARCH 
 
Researchers should consider: 
 Designing studies to specifically examine the sociodemographic profile of ex-
smokers who continue vaping long-term.  
 Conducting further studies into whether ongoing vaping in ex-smokers has a 
protective effect against relapse back to tobacco or is in fact a risk factor for it, 
given the centrality of this issue to policy decisions around e-cigarettes. 
 
 
 
7.5   Conclusion 
 
This thesis has examined a hitherto largely neglected research gap: whether e-cigarettes 
might be impacting attendance rates at SSSs and, if so, how this is occurring. Amidst a 
number of important findings, one stands out as particularly urgent. My research 
suggests that local authorities making partial or complete cuts to their SSSs on the basis 
that e-cigarettes are now such a popular, widely-available quit aid should rethink. This 
thesis in fact adds to a growing evidence base that smokers using e-cigarettes remain 
keen to access the most effective route to quitting available: behavioural support from 
SSSs. Given the clear social gradients observed in smoking and vaping rates,(12,13) 
removing opportunities to access such support services can also be expected to have 
direct, retrograde health impacts for some of the most vulnerable in society.  
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APPENDICES 
APPENDIX A – Systematic review: example of full electronic search 
strategy (MEDLINE) 
 
Search terms used Limits 
 
electronic cigarette or electronic 
cigarettes or e-cigarette or e-cigarettes 
or e cigarette or e cigarettes or 
ecigarette or ecigarettes or electronic 
nicotine delivery or vape or vaper or 
vapers or vaping or vaporiser or 
vaporizer or vapouriser or vapourizer 
or smokeless cigarette or smokeless 
cigarettes or vapor cigarette or vapor 
cigarettes or vapour cigarette or vapour 
cigarettes or digi-cigarette or digi-
cigarettes or digi cigarette or digi 
cigarettes or digital-cigarette or digital-
cigarettes or digital cigarette or digital 
cigarettes or vaporette or vaporettes or 
vapourette or vapourettes 
 
2006 onwards 
Research on humans 
 
Search dates were from 01/01/06 (reflecting the nascence of viable e-cigarette markets 
around the world) to 27/10/14 (the cut-off date when our final searches were run).    
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APPENDIX B – Systematic review: effect direction plot 
 
Ordered by PROGRESS Plus sub-group criteria, and then grouped by evidence quality 
 
Key: ●  = outcome reported, statistically significant difference found; ○ = outcome reported, no statistically significant difference found; 
◌ = outcome reported, no indication of any test for statistical significance; [blank box] = outcome not studied 
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Key findings 
PLACE OF RESIDENCE 
Pepper 2013 (1) USA H 421 male adolescents ○    
Adkison 2013 (2) UK, USA, Canada, Australia M 5,939 adult smokers ● ● ○ 
USA & UK > Australia & Canada (awareness); USA & UK > Canada (ever use); 
USA > Australia (ever use) 
Gallus 2014 (3) Italy M 3,000 adults ● ○ ● 
Northern Italy & Central Italy > Southern Italy (awareness); Southern Italy > 
Central Italy (current use) 
Giovenco 2014 (4) USA M 2,136 current/recent smokers  ○ ○  
Goniewicz 2012 (5) Poland M 20,240 high school/uni students  ● ● Urban > rural 
King 2014 (6) USA M 14,758 adults ○ ○ ○  
Lee 2014 (7) South Korea M 75,643 high school students   ● City & metropolitan city > province 
Tan 2014 (8) USA M 9,080 adults ○    
Vardavas 2014 (9) EU member states M 26,566 adults ● ● 
 Individual countries: various international differences (awareness & ever use); 
Large towns > rural (ever use); North & East Europe > West Europe (ever use) 
Agaku 2014 (10) EU member states L Adults in 25 countries   ● Individual countries: various international differences a 
Agaku 2014 (11) USA L 60,192 adults   ○  
Douptcheva 2013 (12) Switzerland L 5,081 men  ●  German region > French region b 
McMillen 2012 (13) USA L 3,240 adults  ○   
Pepper 2014 (14) USA L 17,522 adults ○    
Popova 2013 (15) USA L 7,776 adult current/recent smokers  ○   
Regan 2013 (16) USA L 41,240 adults ○ ○ ○  
RACE / ETHNICITY 
Kasza 2013 (17) USA H 6,110 adult smokers  ○   
Pearson 2012 (18) USA H 19,026 adult smokers ● ●  White > African American 
Pepper 2013 (1) USA H 421 male adolescents ●   Other races > Hispanic 
Adkison 2013 (2) UK, USA, Canada, Australia M 5,939 adult smokers ● ○ ○ White/English > Non-white/Non-English c 
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Key findings 
Amrock 2014 (19) USA M 24,658 high school students ● ● ● 
White, Mixed/Multiple race > Black (awareness); Hispanic > Asian (ever & current 
use) d 
Emery 2014 (20) USA M 17,522 adults ●   White > Hispanic, Other 
Giovenco 2014 (4) USA M 2,136 adult current/recent smokers  ● ○ White > Other races (ever use) e 
King 2014 (6) USA M 14,758 adults ● ○ ● White > Black (awareness); White > Hispanic (current use) f 
Lippert 2014 (21) USA M 15,264 adolescents  ●  Other races > Black, Mexican-American 
Richardson 2014 (22) USA M 
1,487 adult current/former 
smokers 
 
● 
 
White > Hispanic 
Tan 2014 (8) USA M 9,080 adults ●   White > Hispanic 
Agaku 2014 (11) USA L 60,192 adults   ● ‘Other, Non-Hispanic’, White > Other races d,g 
Camenga 2014 (23) Connecticut & NY, USA L 3,102 high school students   ◌  
Camenga 2014 (24) Connecticut & NY, USA L 4,766 high school students   ● Mixed results 
Choi 2013 (25) Minnesota, USA L 2,624 adults ○ ○   
Czoli 2014 (26) Canada L 1,188 young adults  ○ ○  
Grana 2014 (27) USA L 1,549 adult smokers   ○  
Hayes 2014 (28) USA L 2,376 adult smokers   ○  
Hyland 2013 (29) New York, USA L 2 schools  ○ ○  
Li 2013 (30) h New Zealand L 840 adult current/recent smokers  ○   
McMillen 2012 (13) USA L 3,240 adults  ○   
Pokhrel 2014 (31) Hawaii, USA L 307 undergrad students  ● ● Filipino > White 
Pokhrel 2013 (32) Hawaii, USA L 1,685 adult smokers  ●  White > Native Hawaiian 
Popova 2013 (15) USA L 7,776 adult current/recent smokers  ●  Asian > White 
Regan 2013 (16) USA L 41,240 adults ● ○ ○ White > African, Hispanic 
Sherratt 2014 (33) Liverpool, England L 256 adult smokers   ○  
Sutfin 2013 (34) North Carolina, USA L 4,857 undergrad students  ●  Hispanic, Other > White 
Vickerman 2013 (35) USA L 7,966 adult smokers  ●  White > Other races 
OCCUPATION 
EU 2012 (36) 27 EU member states L 26,751 adults ◌    
GENDER 
CHETS 2014 (37) Wales H 1,601 children  ○   
Kasza 2013 (17) USA H 6,110 adult smokers  ○   
Pearson 2012 (18) USA H 19,026 adult smokers ●   Men > Women 
Pepper 2013 (1) USA H 421 male adolescents ○    
Adkison 2013 (2) UK, USA, Canada, Australia M 5,939 adult smokers ● ○ ○ Men > Women c 
Amrock 2014 (19) USA M 24,658 high school students ○ ● ● Men > Women d 
Emery 2014 (20) USA M 17,522 adults ●   Men > Women 
Gallus 2014 (3) Italy M 3,000 adults ● ○ ○ Men > Women 
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 Giovenco 2014 (4) USA M 2,136 adult current/recent smokers  ○ ○  
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Key findings 
Goniewicz 2012 (5) Poland M 20,240 high school/uni students  ● ● Males > Females 
King 2014 (6) USA M 14,758 adults ○ ● ● Women > Men f 
Lee 2014 (7) South Korea M 79,202 high school students   ● Males > Females 
Lippert 2014 (21) USA M 15,264 adolescents  ●  Men > Women 
Richardson 2014 (22) USA M 
1,487 adult current/former 
smokers 
 
● 
 
Men > Women 
Tan 2014 (8) USA M 9,080 adults ○    
Vardavas 2014 (9) EU member states M 26,566 adults  ○   
Agaku 2014 (11) USA L 60,192 adults   ● Men > Women d,g 
Agaku 2014 (10) Multiple countries L Adults in 25 countries   ● Mixed results in different countries a 
ASH Wales 2014 (38) Wales L 740 adolescents ○ ○ ○  
Biener 2013 (39) USA L 5,150 adults  ○ ○  
Brown 2014 (40) UK L 4,117 adult smokers  ○   
Camenga 2014 (23) USA L 3,102 high school students   ◌  
Cho 2011 (41) Seoul, South Korea L 4,341 middle/high school students  ●  Males > Females 
Choi 2013 (25) Minnesota, USA L 2,624 adults ● ●  Men > Women 
Czoli 2014 (26) Canada L 1,188 young adults  ○ ○  
Dautzenberg 2013 (42) Paris, France L 3,409 high school students  ○   
Dockrell 2013 (43) UK L 12,432 adults  ○ ○  
EU 2012 (36) 27 EU member states L 26,751 adults ◌    
Grana 2014 (27) USA L 1,549 current/recent smokers   ● Women > Men i 
Hyland 2013 (29) New York, USA L 2 schools  ○ ○  
Kinnunen 2013 (44) Finland L 3,535 adolescents ◌ ◌   
Kralikova 2013 (45) Czech Republic L 1,738 smokers  ● ● Men > Women 
Krishnan-Sarin 2014 (46) Connecticut, USA L 4,780 middle/high school students  ●  Males > Females 
Kvaavik 2014 (47) Norway L 629 adult current/former smokers   ● Men > Women j 
Li 2013 (30) h New Zealand L 840 adult current/recent smokers  ○   
Martinez-Sanchez 2014 
(48) 
Barcelona, Spain L 1,291 adults 
 
○ ○ 
 
McMillen 2012 (13) USA L 3,240 adults  ○   
Pearson 2011 (49) USA L 3,638 adults ● ●  Men > Women 
Pokhrel 2014 (31) Hawaii, USA L 307 undergrad students  ○   
Pokhrel 2013 (32) Hawaii, USA L 1,685 adult smokers  ○   
Popova 2014 (15) USA L 7,776 adult current/recent smokers  ●  Women > Men 
Regan 2013 (16) USA L 41,240 adults ● ● ○ Men > Women (aware); Women > Men (ever use) 
Sherratt 2014 (33) Liverpool, England L 256 adult smokers   ● Females > Men 
Sochor 2014 (50) Brno city, Czech Rep L 966 adults   ● Men > Women 
Stillman 2014 (51) USA L 723 flight attendants   ● Men > Women k 
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Key findings 
Sutfin 2013 (34) North Carolina, USA L 4,857 undergrad students  ●  Men > Women 
Vickerman 2013 (35) 6 states, USA L 7,966 adult smokers  ◌   
WHO 2013 (52) Qatar L 8,398 adults ◌ ◌ ◌  
EDUCATION LEVEL 
Kasza 2013 (17) USA H 6,110 adult smokers  ●  Intermediate > lower education 
Pearson 2012 (18) USA H 19,026 adult smokers  ●  Higher > lower education 
Pepper 2013 (1) USA H 421 male adolescents ○    
Gallus 2014 (3) Italy M 3,000 adults ● ● ○ Higher > lower education (aware); Intermediate > lower education (ever use) 
Adkison 2013 (2) UK, USA, Canada, Australia M 5,939 adult smokers ● ○ ● Higher > lower education c 
Emery 2014 (20) USA M 17,522 adults ●   Higher > lower education 
Giovenco 2014 (4) USA M 2,136 adult current/recent smokers  ○ ○  
King 2014 (6) USA M 14,758 adults ○ ○ ● Less than high school > High school f 
Richardson 2014 (22) USA M 1487 adult current/former smokers  ○   
Tan 2014 (8) USA M 9,080 adults ●   Higher > lower education 
Agaku 2014 (11) USA L 60,192 adults   ● Lower > higher education d,g 
Choi 2013 (25) Minnesota, USA L 2,624 adults ● ○  Higher > lower education 
Czoli 2014 (26) Canada L 1,188 young adults  ● ● Lower > higher education (ever use); Higher > lower education (current use) 
Douptcheva 2013 (12) Switzerland L 5,081 men  ●  Secondary > tertiary or primary b 
Grana 2014 (27) USA L 1,549 smokers   ● Lower > higher education 
Li 2013 (30) h New Zealand L 840 adult current/recent smokers  ○   
Martinez-Sanchez 2014 
(48) 
Barcelona, Spain L 1,291 adults 
 
○ ○ 
 
McMillen 2012 (13) USA L 3,240 adults  ●  Intermediate > lower education 
Pearson 2011 (49) USA L 3,638 adults ● ●  Higher > lower education 
Pokhrel 2013 (32) Hawaii, USA L 1,685 adult smokers  ○   
Popova 2013 (15) USA L 7,776 adult current/recent smokers  ○ ● Intermediate > higher education 
Regan 2013 (16) USA L 41,240 adults ● ● ● Higher > lower education (aware); Lower > higher education (ever & current use) 
Sherratt 2014 (33) Liverpool, England L 256 adult smokers   ○  
Sochor 2014 (50) Brno city, Czech Republic L 966 adults   ◌  
Stillman 2014 (51) USA L 723 flight attendants   ○  
Vickerman 2013 (35) USA L 7,966 adult smokers  ●  Higher > lower education 
SOCIOECONOMIC STATUS 
CHETS 2014 (37) Wales H 1,601 children  ○   
Kasza 2013 (17) USA H 6,110 adult smokers  ○   
Adkison 2013 (2) UK, USA, Canada, Australia M 5,939 adult smokers ● ● ○ Higher > lower income c 
Emery 2014 (20) USA M 17,522 adults ○    
Lippert 2014 (21) USA M 15,264 adolescents  ○   
Lee 2014 (7) South Korea M 79,202 high school students   ● Higher > lower weekly allowance 
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Key findings 
Richardson 2014 (22) USA M 
1,487 adult current/former 
smokers 
 
○ 
  
Tan 2014 (8) USA M 9,080 adults ○    
Vardavas 2014 (9) EU member states M 26,566 adults  ○   
Agaku 2014 (11) USA L 60,192 adults   ● Lower > higher income d,g 
Brown 2014 (40) UK L 4,117 adult smokers  ●  Higher > lower SES i 
Dockrell 2013 (43) UK L 12,432 adults  ○ ○  
Douptcheva 2013 (12) b Switzerland L 5,081 men  ○   
King 2013 (53) USA L 10,739 adults ○ ○   
Kinnunen 2013 (44) Finland L 3,535 adolescents  ●  Mixed results 
Li 2013 (30) New Zealand L 840 adult current/recent smokers  ●  Higher > lower income h 
Pokhrel 2014 (31) Hawaii, USA L 
307 adult current/former/never 
smokers 
 
○ 
  
Pokhrel 2013 (32) Hawaii, USA L 1,685 adult smokers  ○   
Popova 2013 (15) USA L 7,776 adult current/recent smokers  ○ ● Lower > higher income 
Regan 2013 (16) USA L 41,240 adults ○ ● ○ Mixed results 
Sochor 2014 (50) Brno city, Czech Republic L 966 adults   ○  
Sutfin 2013 (34) North Carolina, USA L 4,857 undergrad students  ○   
Vickerman 2013 (35) USA L 7,966 adult smokers  ●  Mixed results 
DISABILITY OR HEALTH STATUS 
Pearson 2012 (18) USA H 19,026 adult smokers  ●  Better > worse self-reported health status 
Richardson 2014 (22) USA M 
1,487 adult current/former 
smokers 
 
○ 
  
Tan 2014 (8) USA M 9,080 adults ○    
Hayes 2014 (28) USA L 2,376 adult smokers   ● Medical illnesses, depressed mood, alcohol use > absence of these 
SEXUAL ORIENTATION 
Emery 2014 (20) USA M 17,522 adults ○    
Agaku 2014 (11) USA L 60,192 adults   ● Lesbian, gay or bisexual > heterosexual & unspecified d,g 
AGE 
Kasza 2013 (17) USA H 6,110 adult smokers  ●  18-24yo > 40yo+ 
Pearson 2012 (18) USA H 19,026 adult smokers ● ●  Younger > Older adults 
Pepper 2013 (1) USA H 421 male adolescents ●   Older > Younger children 
Adkison 2013 (2) UK, USA, Canada, Australia M 5,939 adult smokers ● ● ○ Younger > Older adults c 
Amrock 2014 (19) USA M 24,658 high school students ● ● ● Older > Younger children d 
King 2014 (6) USA M 14,758 adults ○ ● ○ Younger > Older adults f 
Gallus 2014 (3) Italy M 3,000 adults ● ● ● Younger > Older adults 
Giovenco 2014 (4) USA M 2,136 adult current/recent smokers  ● ○ Younger > Older adults 
Goniewicz 2012 (5) Poland M 20,240 high school/uni students  ● ● High school students > Uni students 
Lee 2014 (7) Korea M 79,202 high school students  ◌ ● Older > Younger children 
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Key findings 
Lippert 2014 (21) USA M 15,264 adolescents  ○   
Richardson 2014 (22) USA M 
1,487 adult current/former 
smokers 
 
● 
 
Younger > Older adults 
Tan 2014 (8) USA M 9,080 adults ●   Younger > Older adults 
Vardavas 2014 (9) EU member states M 26,566 adults  ●  Younger > Older adults 
Agaku 2014 (11) USA L 60,192 adults   ● Younger > Older adults d,g 
ASH 2014 (54) Great Britain L 53,719 adults & children ◌ ◌ ◌  
ASH Wales 2014 (38) Wales L 740 adolescents ◌ ◌ ◌  
Baeza-Loya 2014 (55) USA L 184 adults  ◌   
Biener 2014 (39) USA L 5,150 adults   ◌  
Brown 2014 (40) UK L 4,117 adult smokers  ○   
Cho 2011 (41) Seoul & province in Korea L 4,341 middle/high school students  ○   
Choi 2013 (25) Minnesota, USA L 2,624 adults ○ ●  20-24 year olds > 25-28 year olds 
Czoli 2014 (26) Canada L 1,188 young adults  ◌ ◌  
Dautzenberg 2013 (42) Paris, France L 3,409 high school students  ◌   
Dockrell 2013 (56) UK L 12,171 adolescents ◌ ◌ ◌  
Dockrell 2013 (43) UK L 12,432 adults  ●  Younger > Older adults 
Douptcheva 2013 (12) b Switzerland L 5,081 men  ◌   
EU 2012 (36) 27 EU member states L 26,751 adults ◌    
Grana 2014 (27) USA L 1,549 adult smokers   ● Younger > Older adults 
Johns 2014 (57) USA L 504 adolescents  ●  Older > Younger children 
King 2013 (53) USA L 10,739 adults ● ○  Younger > Older adults 
Kinnunen 2013 (44) Finland L 3,535 adolescents ◌ ◌   
Kralikova 2013 (45) Czech Republic L 1,738 smokers  ● ● Younger > Older adults (ever use); Older > Younger adults (current use) 
Krishnan-Sarin 2014 (46) USA L 4,780 middle/high school students ◌ ◌ ◌  
Li 2013 (30) New Zealand L 840 adult current/recent smokers  ●  Younger > Older adults h 
Martinez-Sanchez 2014 
(48) 
Barcelona, Spain L 1,291 adults 
 
● ○ Younger > Older adults 
McMillen 2012 (13) USA L 3,240 adults  ○   
Pepper 2014 (14) USA L 17,522 adults ●   Younger > Older adults 
Pokhrel 2014 (31) Hawaii, USA L 307 undergrad students  ● ● Younger > Older adults 
Pokhrel 2013 (32) Hawaii, USA L 1,685 adult smokers  ●  Younger > Older adults 
Popova 2013 (15) USA L 7,776 adult current/recent smokers  ●  Younger > Older adults 
Regan 2013 (16) USA L 41,240 adults ● ○ ○ Younger > Older adults 
Sherratt 2014 (33) Liverpool, England L 256 adult smokers   ○  
Sochor 2014 (50) Brno city, Czech Republic L 966 adults   ● Older > Younger adults 
Stillman 2014 (51) USA L 723 flight attendants   ○  
Sutfin 2013 (34) North Carolina, USA L 4,857 undergrad students  ○   
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Key findings 
Vickerman 2013 (35) 6 states, USA L 7,966 adult smokers  ◌   
Yong 2014 (58) Australia L ~13,500 current/former smokers l ◌ ◌   
 
 
a Current use defined as self-reported use ‘regularly’ or ‘occasionally’. 
b Among smokers only. Ever use defined as any use in last 12 months. 
c Plot shows results for all 4 countries combined. 
d Statistical significance inferred by review authors from non-overlapping confidence intervals 
e Rates also higher among whites for ‘established use’ (used an e-cigarette at least once in the past 30 days and more than 50 times in their lifetime). 
f Study reports multiple years of data; for reporting purposes, plot reflects data from most recent year. 
g Current use defined as reporting smoking electronic cigarettes at least once during their lifetime and now smoking them ‘every day’ or ‘some days’. 
h Ever purchase of an e-cigarette taken as proxy for ever use. 
i Among smokers only. 
j Among both current and former smokers respectively. 
k Current use defined as ‘do you use e-cigarettes?’ (i.e. no 30-day timeframe given). 
l Estimated by review team due to sample size not being reported directly by authors. 
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 APPENDIX C – Qualitative workstream: supplementary recruitment information 
 
Participant recruitment summary 
  
Site A 
 
Site B 
 
Site C 
 
TOTALS 
 
CURRENT AND 
EX-SMOKERS  
 
SSS users 
Vapers 
1: Fri 8th Dec  
2: Mon 18th Dec  
3: Fri 25th May  
- 
1: Mon 4th Dec  
2: Mon 4th Dec  
3: Weds 6th Dec  
4: Tues 22nd May  
1: Weds 7th March  
2: Mon 12th March  
3: Weds 21st March  
- 
10 
17 
Non-vapers 
1: Fri 8th Dec  
2: Weds 17th Jan  
3: Tues 6th Feb  
1: Fri 15th Dec  
2: Tues 6th March  
- 
1: Weds 7th March  
2: Weds 21st March  
- 
7 
Non SSS users 
Vapers 
1: Fri 4th May 
2: Mon 25th June  
1: Fri 8th June  
- 
1: Weds 30th May  
2: Fri 24th Aug  
5 
12 
Non-vapers 
1: Fri 13th April  
2: Fri 4th May  
3: Fri 25th May  
1: Tues 17th April  
2: Fri 11th May  
3: Tues 15th May  
1: Fri 24th Aug  
- 
- 
7 
STOP SMOKING 
SERVICE (SSS) 
PROFESSIONALS 
Staff  
1: Tue 31st Oct  
2: Wed 1st Nov  
3: Fri 3rd Nov  
4: Fri 3rd Nov  
1: Mon 30th Oct  
2: Tues 21st Nov  
3: Tues 21st Nov  
4: Mon 27th Nov  
1: Thurs 14th Dec  
2: Thurs 14th Dec  
3: Thurs 11th Jan  
4: Thurs 11th Jan   
12 
17 
Stakeholders  
1: Tue 31st Oct  
2: Weds 1st Nov  
1: Mon 19th Feb  
2: Tues 13th March  
1: Mon 12th March  
- 
5 
 
TOTALS 
 
17 16 13 46 
 
 
Within the SSS professionals group of interviewees (n=17), ‘staff’ (n=12) included SSS managers (n=3) and practitioners (n=9), while 
‘stakeholders’ (n=5) included local council-employed public health consultants (n=3), a local Trust-employed public health consultant 
(n=1) and a local council-employed public health commissioner (n=1). 
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Site recruitment 
 
 Site A was recruited after being identified as a strong candidate for the study in light of their public statements regarding e-
cigarettes. The lead researcher then met with the SSS manager on several occasions to discuss the proposed research with them.  
 Site B was recruited following the lead researcher consulting public health registrar colleagues for SSS contacts in suitable local 
authorities, which led to a discussion with the local authority public health consultant responsible for Site B, followed by 
meetings with the SSS manager.  
 Site C was recruited through the lead researcher consulting two national and regional smoking subject matter experts about 
suitable sites, followed again by discussions with the SSS manager.  
 For each of the three sites, the lead researcher was also invited to meetings with wider SSS team members where the plans for 
the study were presented, discussed and refined. 
 
Thumbnail sketches of sites 
 
Site A was an urban SSS with a staff of 15 people (including the manager), which covered the whole city where the service was based. 
Clinics were provided out of GP surgeries, community centres, council offices and other voluntary organisations (e.g. Age UK). There 
was then a further network of “associate providers” in the form of community pharmacists and practice nurses who also delivered 
smoking cessation support on behalf of the SSS, though these had been reduced in number by about two thirds in recent years, as the 
best quit rates were observed with the core team of smoking cessation advisors. 
 
Site B was an urban SSS covering one of many local authority areas within a major city. It employed 7 people in total (including the 
manager), and the provider was the local hospital trust. Unlike the other two sites, it no longer provided services through pharmacists 
and nurses; the SSS was now mainly delivered by the core team of specialists operating half or full-day clinics out of GP surgeries 
(particularly large practices or those in the most deprived areas). A further key focus of work was the development of an online stop 
smoking programme to allow self-referral for local smokers, text message support and automated provision of prescriptions to GP 
practices. 
 
Site C was a SSS covering a large county, which was primarily rural but included several towns. It employed 8 people (including the 
manager) within the core team, but these specialists then trained a wide network of “intermediate advisors” in the form of 
pharmacists, GPs, practice nurses and healthcare assistants. The provider of the SSS was the local hospital trust. 
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 APPENDIX D – Qualitative workstream: recruitment flyer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Would you like to tell me what you think about: 
 E-CIGARETTES? 
 
I’m doing a research study into e-cigarette use and how 
the NHS responds to it. I would love to hear your views, 
whether you vape, smoke or both! 
 
 
For more information, with no obligation to take part, please get in 
touch with me, Greg Hartwell, by: 
 
Phone or text: 07854 233 655 
Email: gregory.hartwell@lshtm.ac.uk 
 
All participants will receive a £20 shopping voucher as a thank you. 
 
 
 ? 
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 APPENDIX E – Qualitative workstream: participant information 
sheets 
 
[Current and ex-smokers version] 
 
 
 
 
 
Participant Information: LSHTM study into stop smoking services & e-cigarettes 
 
This is an information sheet for a research study (IRAS 223311) about what influences smokers 
who also vape when they are deciding whether or not to access NHS stop smoking services.  
Please note though that we seeking to recruit both smokers who use e-cigarettes, and smokers 
who do not use them. This is because we are interested in differences between these two 
groups. 
 
You are being invited to take part in this study. Before you decide, please read through this 
sheet which provides further information on why the study is taking place and what it will 
involve. Please take as long as you need to decide whether you would like to take part, and feel 
free to ask us any questions you like about the study (contact details below).  
 
1. What is the purpose of this study? 
 
We want to understand more about people who use e-cigarettes to try to stop smoking, and 
whether e-cigarette use influences their decisions to attend (or not to attend) NHS stop smoking 
services. Ultimately, the aim is to provide better informed and more effective services for 
smokers who want to quit. 
 
2. Why have I been asked? 
 
As someone who either currently uses or has previously used, e-cigarettes or conventional (i.e. 
tobacco) cigarettes, your views on issues around e-cigarettes, smoking and quitting are highly 
relevant for this study. As outlined above, we are interested in recruiting both smokers who use 
e-cigarettes, and those who do not use them. 
 
3. Do I have to take part? 
 
Not at all – we would love to hear your views on these issues but participation is entirely 
voluntary. Furthermore, declining to take part in the study will have no impact whatsoever on 
the care you receive from your stop smoking service. 
 
4. What does taking part involve? 
 
If, after reviewing this information sheet, you are willing to take part, please just let our 
research team know (contact details are below if required). We will arrange a one-to-one 
interview lasting approximately 30-45 minutes at whatever time and place is most convenient 
to you. We are particularly interested in your views and experiences of NHS stop smoking 
services (even if you have never used these services before, we will still be interested to hear 
your views on them). The kinds of topics we will be keen to discuss with you will therefore 
include: your history of smoking and e-cigarette use; your experiences (if any) of your local NHS 
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 stop smoking services; your perceptions of these services and of other methods of quitting, 
including e-cigarette use; and your views on broader social factors that can influence smoking 
and e-cigarette use (such as their social acceptability). You will be free to decline to answer any 
specific questions within the interview that you wish to. 
 
5. What are the possible disadvantages and risks of taking part? 
 
The only disadvantage is giving up 30-45 minutes of your time. Even if you have decided to take 
part and signed the consent form, you can still change your mind and withdraw from the study 
at any point (i.e. before, during or after the interviews), without having to give any reason. 
Again, should you do so, this will have no impact whatsoever on the care you receive from your 
stop smoking service. 
 
6. What are the possible benefits of taking part?  
 
While there are no direct benefits to you in taking part, people often enjoy the experience of 
being able to give their views on such an interesting and topical area. In addition, you will be 
contributing to research of national importance that could ultimately help provide better 
support to smokers who wish to quit smoking. We can also share the overall results of the study 
with you directly by email, if you would like to receive these. 
 
7. Will my taking part in the study be kept confidential? 
 
You will be asked before the interview if you are happy for it to be recorded so that it can be 
transcribed afterwards in order for us to analyse it along with the other interviews. We use 
third party transcribers (i.e. external to our university) for this, but they are bound under a 
confidentiality agreement, and all the information you provide in the interview will be fully 
anonymised during this transcription process. You will therefore not be identifiable in any 
report or publication. Similarly, data about/from your interview may be shared via a public data 
repository or by sharing directly with other researchers, but you will not be identifiable from 
this information since it will all be anonymised. The only person we would want to make aware 
of your participation in the study, as a courtesy, is your stop smoking service advisor (if you 
have one). This will be entirely up to you though, so you will be able to let us know if you would 
rather we did not inform them. 
 
If you provide your contact details to us, these will be used to arrange the interview with you 
and will then be immediately deleted. The only exception would be if you wish to receive a copy 
of the research’s final findings (which again would be entirely up to you) – if so, we would need 
to keep an email address for you in order to be able to circulate this to you when it is ready, 
after which we would immediately delete it. 
 
8. What if I am unhappy with the process? 
 
If you have any concerns at any point, you can discuss these with Greg Hartwell from our 
research team, whose contact details are below. If for any reason you are still unhappy, you can 
also contact the lead supervisor Mark Petticrew at mark.petticrew@lshtm.ac.uk or on 020 7976 
2009.  
 
9. Who is organising and funding the study? 
 
We are researchers from the London School of Hygiene and Tropical Medicine, a University of 
London medical school (www.lshtm.ac.uk). Our study is funded by Health Education England 
and the National Institute for Health Research, and forms part of a PhD being undertaken by 
Greg Hartwell. 
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10. Who has reviewed the study? 
 
This study has been granted ethical approval by the London School of Hygiene and Tropical 
Medicine’s ethical committee (ref 11672), the NHS Health Research Authority (IRAS ref 
223311) and the National Research Ethics Service (REC ref 17/LO/0414). Local R&D approval 
in [name of research site added here] has also been obtained [local R&D reference added here]. 
 
11. What do I do if I am interested in taking part? 
 
If you are interested in taking part or would like to ask any questions to help you make your 
mind up, please contact:  
 
Greg Hartwell 
School of Public Health Research 
London School of Hygiene and Tropical Medicine 
Tel: 07854 233 655 
Email: gregory.hartwell@lshtm.ac.uk  
 
All participants will receive a £20 shopping voucher as a thank you. 
 
Thank you for considering this study 
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[Stop smoking service staff version] 
 
 
 
 
 
Participant Information: LSHTM study into stop smoking services & e-cigarettes 
 
This is an information sheet for a research study (IRAS 223311) about what influences smokers 
who also vape when they are deciding whether or not to access NHS stop smoking services.   
 
You are being invited to take part in this study. Before you decide, please read through this 
sheet which provides further information on why the study is taking place and what it will 
involve. Please take as long as you need to decide whether you would like to take part, and feel 
free to ask us any questions you like about the study (contact details below).  
 
1. What is the purpose of this study? 
 
We want to understand more about people who use e-cigarettes to try to stop smoking, and 
whether e-cigarette use influences their decisions to attend (or not to attend) NHS stop smoking 
services. Ultimately, the aim is to provide better informed and more effective services for 
smokers who want to quit. 
 
2. Why have I been asked? 
 
You have been asked to take part as someone who works in one of the NHS stop smoking 
services being researched as part of this study. We are particularly interested in your views and 
experiences of smokers using e-cigarettes and their attendance at NHS stop smoking services.  
 
3. Do I have to take part? 
 
Not at all – we would love to hear your views on these issues but participation is entirely 
voluntary.  
 
4. What does taking part involve? 
 
If, after reviewing this information sheet, you are willing to take part, please just let our 
research team know (contact details are below if required). We will arrange a one-to-one 
interview lasting approximately 30-45 minutes at whatever time and place is most convenient 
to you. The kinds of topics we will be keen to discuss your views on will include: factors 
influencing your service’s policy on e-cigarettes; the accessibility of your services to smokers 
using e-cigarettes; your service’s methods of recruiting clients; and advice offered to clients 
regarding e-cigarettes. You are not expected to know the answers to all of these – we are simply 
interested in exploring the areas with you. You will also be free to decline to answer any specific 
questions within the interview that you wish to.  
 
5. What are the possible disadvantages and risks of taking part? 
 
The only disadvantage is giving up 30-45 minutes of your time. Even if you have decided to take 
part and signed the consent form, you can still change your mind and withdraw from the study 
at any point (i.e. before, during or after the interviews), without having to give any reason.  
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 6. What are the possible benefits of taking part?  
 
While there are no direct benefits to you in taking part, people often enjoy the experience of 
being able to give their views on such an interesting and topical area. In addition, you will be 
contributing to research of national importance that could ultimately help provide better 
support to smokers who wish to quit smoking, both across England and within your own 
borough. We can also share the overall results of the study with you directly by email, if you 
would like to receive these. 
 
7. Will my taking part in the study be kept confidential? 
 
You will be asked before the interview if you are happy for it to be recorded so that it can be 
transcribed afterwards in order for us to analyse it along with other interviews. We use third 
party transcribers (i.e. external to our university) for this, but they are bound under a 
confidentiality agreement, and all the information you provide in the interview will be fully 
anonymised during this transcription process. You will therefore not be identifiable in any 
report or publication. Similarly, data about/from your interview may be shared via a public data 
repository or by sharing directly with other researchers, but you will not be identifiable from 
this information since it will all be anonymised. 
 
If you provide your contact details to us, these will be used to arrange the interview with you 
and will then be immediately deleted. The only exception would be if you wish to receive a copy 
of the research’s final findings (which again would be entirely up to you) – if so, we would need 
to keep an email address for you in order to be able to circulate this to you when it is ready, 
after which we would immediately delete it. 
 
8. What if I am unhappy with the process? 
 
If you have any concerns at any point, you can discuss these with Greg Hartwell from our 
research team, whose contact details are below. If for any reason you are still unhappy, you can 
also contact the lead supervisor Mark Petticrew at mark.petticrew@lshtm.ac.uk or on 020 7976 
2009.  
 
9. Who is organising and funding the study? 
 
We are researchers from the London School of Hygiene and Tropical Medicine, a University of 
London medical school (www.lshtm.ac.uk). Our study is funded by Health Education England 
and the National Institute for Health Research, and forms part of a PhD being undertaken by 
Greg Hartwell. 
 
10. Who has reviewed the study? 
 
This study has been granted ethical approval by the London School of Hygiene and Tropical 
Medicine’s ethical committee (ref 11672), the NHS Health Research Authority (IRAS ref 
223311) and the National Research Ethics Service (REC ref 17/LO/0414). Local R&D approval 
in [name of research site added here] has also been obtained [local R&D reference added here]. 
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 11. What do I do if I am interested in taking part? 
 
If you are interested in taking part or would like to ask any questions to help you make your 
mind up, please contact:  
 
Greg Hartwell 
School of Public Health Research 
London School of Hygiene and Tropical Medicine 
Tel: 07854 233 655 
Email: gregory.hartwell@lshtm.ac.uk  
 
All participants will receive a £20 shopping voucher as a thank you. 
 
Thank you for considering our study 
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[Stop smoking service stakeholders version] 
 
 
 
 
 
Participant Information: LSHTM study into stop smoking services & e-cigarettes 
 
This is an information sheet for a research study (IRAS 223311) about what influences smokers 
who also vape when they are deciding whether or not to access NHS stop smoking services.   
 
You are being invited to take part in this study. Before you decide, please read through this 
sheet which provides further information on why the study is taking place and what it will 
involve. Please take as long as you need to decide whether you would like to take part, and feel 
free to ask us any questions you like about the study (contact details below).  
 
1. What is the purpose of this study? 
 
We want to understand more about people who use e-cigarettes to try to stop smoking, and 
whether e-cigarette use influences their decisions to attend (or not to attend) NHS stop smoking 
services. Ultimately, the aim is to provide better informed and more effective services for 
smokers who want to quit. 
 
2. Why have I been asked? 
 
You have been asked to take part as someone who is an important stakeholder of one of the NHS 
stop smoking services being researched as part of this study. We are particularly interested in 
your views on smokers using e-cigarettes and their attendance at NHS stop smoking services.  
 
3. Do I have to take part? 
 
Not at all – we would love to hear your views on these issues but participation is entirely 
voluntary.  
 
4. What does taking part involve? 
 
If, after reviewing this information sheet, you are willing to take part, please just let our 
research team know (contact details are below if required). We will arrange a one-to-one 
interview lasting approximately 30-45 minutes at whatever time and place is most convenient 
to you. The kinds of topics we will be keen to discuss your views on will include: factors 
influencing your local service’s policy on e-cigarettes; the accessibility of your local services to 
smokers using e-cigarettes; your local service’s methods of recruiting clients; and advice offered 
to clients regarding e-cigarettes. You are not expected to know the answers to all of these – we 
are simply interested in exploring the areas with you. You will also be free to decline to answer 
any specific questions within the interview that you wish to.  
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 5. What are the possible disadvantages and risks of taking part? 
 
The only disadvantage is giving up 30-45 minutes of your time. Even if you have decided to take 
part and signed the consent form, you can still change your mind and withdraw from the study 
at any point (i.e. before, during or after the interviews), without having to give any reason.  
 
6. What are the possible benefits of taking part?  
 
While there are no direct benefits to you in taking part, people often enjoy the experience of 
being able to give their views on such an interesting and topical area. In addition, you will be 
contributing to research of national importance that could ultimately help provide better 
support to smokers who wish to quit smoking, both across England and within your own 
borough. We can also share the overall results of the study with you directly by email, if you 
would like to receive these. 
 
7. Will my taking part in the study be kept confidential? 
 
You will be asked before the interview if you are happy for it to be recorded so that it can be 
transcribed afterwards in order for us to analyse it along with other interviews. We use third 
party transcribers (i.e. external to our university) for this, but they are bound under a 
confidentiality agreement, and all the information you provide in the interview will be fully 
anonymised during this transcription process. You will therefore not be identifiable in any 
report or publication. Similarly, data about/from your interview may be shared via a public data 
repository or by sharing directly with other researchers, but you will not be identifiable from 
this information since it will all be anonymised. 
 
If you provide your contact details to us, these will be used to arrange the interview with you 
and will then be immediately deleted. The only exception would be if you wish to receive a copy 
of the research’s final findings (which again would be entirely up to you) – if so, we would need 
to keep an email address for you in order to be able to circulate this to you when it is ready, 
after which we would immediately delete it. 
 
8. What if I am unhappy with the process? 
 
If you have any concerns at any point, you can discuss these with Greg Hartwell from our 
research team, whose contact details are below. If for any reason you are still unhappy, you can 
also contact the lead supervisor Mark Petticrew at mark.petticrew@lshtm.ac.uk or on 020 7976 
2009.  
 
9. Who is organising and funding the study? 
 
We are researchers from the London School of Hygiene and Tropical Medicine, a University of 
London medical school (www.lshtm.ac.uk). Our study is funded by Health Education England 
and the National Institute for Health Research, and forms part of a PhD being undertaken by 
Greg Hartwell. 
 
10. Who has reviewed the study? 
 
This study has been granted ethical approval by the London School of Hygiene and Tropical 
Medicine’s ethical committee (ref 11672), the NHS Health Research Authority (IRAS ref 
223311) and the National Research Ethics Service (REC ref 17/LO/0414). Local R&D approval 
in [name of research site added here] has also been obtained [local R&D reference added here]. 
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 11. What do I do if I am interested in taking part? 
 
If you are interested in taking part or would like to ask any questions to help you make your 
mind up, please contact:  
 
Greg Hartwell 
School of Public Health Research 
London School of Hygiene and Tropical Medicine 
Tel: 07854 233 655 
Email: gregory.hartwell@lshtm.ac.uk  
 
All participants will receive a £20 shopping voucher as a thank you. 
 
 
Thank you for considering our study 
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 APPENDIX F – Qualitative workstream: consent form 
 
INFORMED CONSENT FORM: LSHTM study into stop smoking services & e-cigarettes  
(Research Study IRAS 223311) 
 
Please read the following statements, initial those you agree with in the boxes on the right,  
and sign your name at the end if you are happy to take part in the study: 
               (Initials) 
1. I confirm that I have read the participant information sheet dated …… (version ……) for this 
study and have had the opportunity to consider the information within it.  
 
2 I confirm that I have had the opportunity to ask questions about the study and to have 
these answered fully. 
 
3. I agree to take part in an interview for this study.  
4. I agree to the interview being audio recorded.  
5. I understand that my participation is voluntary and that I am free to stop the interview at 
any point without having to give any reason. 
 
6. I understand that the interview is part of a research study being conducted for the purposes 
of a PhD degree. 
 
7. I understand that all information I give during the interview will be strictly confidential 
and that the results of the study will be anonymised (i.e. no one will be able to trace anything 
I say during the interview back to me). 
 
8. I understand that data about/from me may be shared via a public data repository or by 
sharing directly with other researchers, and that I will not be identifiable from this 
information. 
 
9. I agree that anonymised, unidentifiable direct quotations may be used in the reporting of 
this study. 
 
 
 
 
_____________________ _____________________ _____________________ 
     Name of participant    Signature of participant      Date 
             (PRINTED)   
 
 
_____________________ _____________________ _____________________ 
 Principal investigator (PI)          Signature of PI        Date 
             (PRINTED)  
 
1 copy to be retained by the participant; 1 copy to be retained by the Principal Investigator 
 
If you would like more information, please contact:   
 
Greg Hartwell 
London School of Hygiene & Tropical Medicine 
15-17 Tavistock Place 
London WC1H 9SH 
Tel: 07854 233 655 
Email: gregory.hartwell@lshtm.ac.uk 
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 APPENDIX G – Qualitative workstream: topic guides 
 
[Current and ex-smokers version] 
 
NB: Interviewees included people with varying histories of quitting tobacco (i.e. current and recent ex-smokers), using e-cigarettes (i.e. current, ex 
and never vapers) and accessing stop smoking services (i.e. ever users and never users). Questions included/omitted and specific wording of 
questions asked therefore inevitably flexed depending on the individual respondent.  
 
Key area of 
investigation 
Themes Example questions 
Smoking/ 
vaping: 
initially and 
now 
1) Frequency & duration 
of tobacco and/or e-
cigarette use 
2) Reasons for tobacco 
and/or e-cigarette use 
 
 Can you tell me about when you first started smoking / can you remember your first 
cigarette? 
 And what were the kinds of reasons why you first started smoking? 
 And during the period you smoked, how much were you smoking on average? (e.g. 
cigarettes per day) And as a maximum? 
 So when did you quit? 
 When did you first start using e-cigs? 
 Could you tell me a bit about how often you usually use e-cigs at present? (e.g. 
periods of vaping per day, for how long) 
 How has that amount changed (if at all) over time since you first started? 
 And what were the kinds of reasons why you first started using e-cigs? 
 And to what extent are the reasons why you use e-cigs today still the same as that or 
have they shifted at all?  
Quit 
attempts 
1) Previous quit attempts 
and success or failure 
2) Periods of abstinence 
 
 When you quit for good, how did you go about it? (e.g. what kind of quit aids, if any, 
did you use?) 
 How often (if at all) had you tried quitting smoking before you quit for good?  
 And how did you go about quitting each time? (e.g. what kind of quit aids did you 
use?) 
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 Key area of 
investigation 
Themes Example questions 
 How helpful did you find those? 
 How long did any quit periods last? 
 What were the kinds of reasons why you started smoking again? 
E-cigs: 
Perceptions 
and 
influence on 
use  
1) General views on e-
cigs 
2) Plans to continue or 
curtail vaping 
3) E-cigarettes safety & 
efficacy as quitting 
aids  
4) Influence of 
family/friends 
5) Cultural acceptability  
6) Sense of identity & 
belonging  
 
 How do you feel about vaping generally? 
 Who else do you know, if anyone, that uses e-cigs or has used them? 
 If you/they wanted to quit vaping, how do you think you/they would go about it? 
 What are your thoughts on the safety or harms of e-cigs compared to smoking? 
 What are your thoughts on e-cigs as a tool for quitting smoking / how effective, if at 
all, do you think they are at helping people to quit smoking? 
 How do you think e-cigs are viewed by the general public nowadays?  
 How do you think this compares to how smoking is viewed? 
 How far (if at all) do you think anything you’ve read/seen in the media has 
influenced your views on e-cigs and decisions about using them? 
 How much (if at all) do you feel vaping is an important part of your identity and how 
does this compare to how you feel/felt about your smoking? 
 What kind of responses have you had from friends, family, work colleagues etc to 
your vaping?  
 Have you had any positive or negative comments/feedback on your vaping? 
 To what extent (if at all) do you think any of these responses have had any influence 
on your own views or decisions around vaping?  
SSS: past 
experiences 
and future 
intentions  
1) Previous use of 
services 
2) Awareness of services 
3)  Peer precedents 
4) Positive or negative 
experiences  
5) Potential future use of 
SSS & rationale 
 
 How often have you accessed a SSS in the past? 
 How did you hear about your SSS (each time)? 
 What kind of people (if any) do you know personally who have accessed SSSs? 
(prompt if required: e.g. family, friends, work colleagues, general acquaintances etc) 
 Could you tell me about your experiences with the SSS? 
 How helpful or unhelpful would you say the SSS was in your efforts to quit? 
 How likely or unlikely would you say you are to ever use SSSs in the future to try to 
quit smoking / quit vaping? How likely would you be to recommend them to other 
people?  
 Why is that? 
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 Key area of 
investigation 
Themes Example questions 
SSS: 
Perceptions 
and 
influences 
on use 
1) General influences on 
use  
2) Influence of family & 
friends  
3) Influence of logistical 
hurdles 
4) Perceptions of SSS 
effectiveness 
5) SSS advice on e-cigs 
6) Perceptions of SSS e-
cigarette policies 
 
 What would you say were the main reasons why you decided to use the SSS? 
 What do you think were the reasons that stopped you using it before then? 
 How far, if at all, do you feel any logistical challenges affected your decisions about 
attending SSSs? (prompt if required: e.g. distance to travel, opening hours, time 
required to attend etc) 
 To what extent, if at all, do you think your family or friends had any influence on your 
decisions about whether or not to attend SSSs? 
 How effective or not do you think SSSs are at helping people to quit smoking?  
 How about compared to e-cigarettes?  
 To what extent (if at all) do you feel budget cuts / cost constraints might have had 
any impact on your local SSS?  
 What advice did the SSS give you about e-cigs? 
 How did you feel the SSS viewed e-cigs compared to other ways to quit smoking? 
 How do you think your SSS would respond to you /other people who are trying to 
quit smoking using e-cigs? i.e. how willing or not would you expect them to be to help 
such smokers? 
 How do you think your SSS would respond to you /other people who are trying to 
quit e-cigs having already quit smoking? i.e. how willing or not would you expect 
them to be to help such people? 
CLOSING   Is there anything else you’d like the chance to speak about not covered already? 
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 [Stop smoking service professionals version] 
 
NB: Interviewees included both managers and practitioners of stop smoking services, as well as a small number of their key stakeholders. Questions 
included/omitted and specific wording of questions asked therefore inevitably flexed depending on the individual respondent. 
 
Key area of 
investigation 
Themes Example questions 
Respondent 
characteristics 
1) Career history 
2) Motivation 
3) Role & tenure in 
team 
 
 Could you tell me how you ended up in the field of smoking? 
 What was your background before this job? (i.e. kinds of other roles you have had) 
 What was it about the field of smoking in particular that attracted or inspired you? 
 Could you tell me about your role with the service here and what it encompasses? 
 How long have you been with the team? 
General 
context:  
service set-up, 
recruitment 
and dual user 
attendance 
1) General service 
structure 
2) Recruitment of 
smokers, including 
proactive work on 
dual users 
3) Systematic 
differences 
between dual users 
& other smokers 
 Could you describe the challenges the borough faces in relation to smoking, i.e. any 
that are particularly key or pressing for your area specifically as a result of its 
demographics, for instance? 
 Could you very briefly describe the current set-up of the service here, i.e. how 
support is provided within the borough? To what extent has this shifted at all in 
recent years due to any changes in commissioning arrangements, budget cuts or 
reconfigurations?  
 Could you describe the current broad approaches taken to recruiting smokers? How 
far, if at all, has any of your recruitment work focused on e-cigs?  
 What kind of data do you collect at present relating to e-cigs? 
 To what extent have there been any obvious broad differences between smokers 
using e-cigarettes to try to quit smoking and the other smokers you see? 
 How likely do you feel dual users (of e-cigs and tobacco) are to use the service 
compared to other smokers? Why do you think that is? 
Service position 
on e-cigs 
1) Nature of service’s 
policy & where 
captured  
2) Policy in practice 
 How would you describe the philosophy/approach towards e-cigs that the service 
has? 
 To what extent would you say this is written down formally anywhere? To what 
extent would you say the service here has historically had any kind of formal policy 
on e-cigs? 
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 Key area of 
investigation 
Themes Example questions 
3) Staff understanding 
& adherence  
4) Frequency of 
review 
5) Similarity to other 
areas 
 If someone presented to your service wanting to quit smoking solely through the use 
of e-cigs rather than any other aids, what advice/support would they receive? 
 Similarly, if they presented having already quit smoking but now wanting to quit e-
cigs too, what advice or support would be given to them? 
 How far do you feel staff have a shared awareness & understanding of this 
position/policy? 
 How consistent across staff would you say advice given to people about e-cigs is? 
 How regularly (if at all) do you think the position/policy is discussed and updated?  
 How do you think your service’s policy/position on e-cigs probably compares to 
those of other services around the country? 
Influences on 
services’ policy 
1) History of e-cig 
policy’s 
development  
2) Discussions across 
borough 
3) Local influences  
4) National influences  
5) Influence of other 
boroughs  
6) Overall balance 
between internal & 
external control/ 
influences 
7) Budget cuts & 
reconfigurations 
 How do you think the service’s position on e-cigs developed to what it is today? 
 So what do you feel were the most particularly important influences on your 
service’s policy/approach, i.e. from which groups or organisations? 
 How much discussion has there been specifically on e-cigs amongst stakeholders 
across the borough? Do you think local stakeholders had a particular influence on the 
position/policy? e.g. what role (if any) did your local authority public health or 
commissioning team have in determining the current position/policy? 
 And how do you think local smokers have influenced it (if at all)? 
 What other particularly important influences on your service’s position/policy have 
there been from any other groups or organisations? (prompts if required: e.g. national 
organisations/guidelines, local or national media, research and new studies) 
 To what extent would you say you’ve been influenced by services in other areas? 
 Overall, how far would you say staff across the service shaped the position/policy 
from within, compared to these external influences and pressures?  
 What kind of influences (if any) do you think any changes to commissioning 
arrangements, budget cuts or reconfigurations have had on the service’s present 
policy/position on e-cigs? 
Individual 
views on e-cigs 
1) Views on e-cigs 
2) Future for e-cigs 
 How would you say your own views on e-cigs have developed over time, if at all? 
 How do you think e-cigs will be viewed ten, twenty years from now? 
CLOSING   Is there anything else you’d like the chance to speak about not covered already? 
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 APPENDIX H – Ethical clearances 
 
 
 
The following pages contain scanned copies of: 
 
1) LSHTM REC approval (09/09/16, REC Reference 11672) 
 
2) National Research Ethics Service (NRES) approval (18/04/17, REC Reference 
17/LO/0414, IRAS ID 223311) 
 
3) Health Research Authority (HRA) approval (19/04/17, REC Reference 
17/LO/0414, IRAS ID 223311) 
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Observational / Interventions Research Ethics Committee
 
 
 
Mr Greg Hartwell 
LSHTM
9 September 2016 
Dear Greg
Study Title: Understanding the facilitators and barriers that impact on the attendance of electronic cigarette users at NHS stop smoking services: a mixed methods investigation 
LSHTM Ethics Ref: 11672 
Thank you for responding to the Observational Committee’s request for further information on the above research and submitting revised documentation.
The further information has been considered on behalf of the Committee by the Chair. 
Confirmation of ethical opinion
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above research on the basis described in the application form, protocol and supporting documentation
as revised, subject to the conditions specified below.
Conditions of the favourable opinion
Approval is dependent on local ethical approval having been received, where relevant. 
Approved documents
The final list of documents reviewed and approved by the Committee is as follows:
Document Type File Name Date Version
Information Sheet 2016.06.06 Consent form DRAFT 06/06/2016 1
Investigator CV 2016.06.20 Greg Hartwell CV - LSHTM ethics 20/06/2016 1
Information Sheet 2016.06.30 Ipsos MORI Information Sheet FINAL 30/06/2016 1
Information Sheet 2016.08.30 Participant Information Sheet (Smokers & E-cig users) DRAFT v2 30/08/2016 2
Information Sheet 2016.08.30 Participant Information Sheet (Service staff) DRAFT v2 30/08/2016 2
Advertisements 2016.08.30 Recruitment poster DRAFT v2 30/08/2016 2
Protocol / Proposal 2016.08.30 Protocol FINAL (LEO) v2 30/08/2016 2
Covering Letter 2016.08.30 Letter to Chair (with UCL letter appended) FINAL 30/08/2016 1
 
After ethical review
The Chief Investigator (CI) or delegate is responsible for informing the ethics committee of any subsequent changes to the application.  These must be submitted to the Committee for review
using an Amendment form.  Amendments must not be initiated before receipt of written favourable opinion from the committee.  
The CI or delegate is also required to notify the ethics committee of any protocol violations and/or Suspected Unexpected Serious Adverse Reactions (SUSARs) which occur during the project
by submitting a Serious Adverse Event form.  
At the end of the study, the CI or delegate must notify the committee using an End of Study form. 
All aforementioned forms are available on the ethics online applications website and can only be submitted to the committee via the website at: http://leo.lshtm.ac.uk
Additional information is available at: www.lshtm.ac.uk/ethics
Page 1 of 2
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Professor John DH Porter
Chair
ethics@lshtm.ac.uk
http://www.lshtm.ac.uk/ethics/ 
Page 2 of 2
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London - Camberwell St Giles Research Ethics Committee 
Level 3, Block B 
Whitefriars 
Lewins Mead 
Bristol 
BS1 2NT 
 
Telephone: 02071048044 
  
 
 
 
 
 
 
 
 
 
 
 
18 April 2017 
 
Mr Gregory J Hartwell 
NIHR Clinical Doctoral Research Fellow 
London School of Hygiene and Tropical Medicine (LSHTM) 
Room 145, 15-17 Tavistock Place 
London 
WC1H 9SH 
 
 
Dear Mr Hartwell 
 
Study title: Understanding influences on the attendance of ‘dual 
users’ of tobacco and e-cigarettes at NHS stop smoking 
services 
REC reference: 17/LO/0414 
Protocol number: N/A 
IRAS project ID: 223311 
 
Thank you for your response received 10th April 2017.  I can confirm the REC has received the 
documents listed below and that these comply with the approval conditions detailed in our letter 
dated 29 March 2017 
 
Documents received 
 
The documents received were as follows: 
 
Please note:  This is an 
acknowledgement letter from 
the REC only and does not 
allow you to start your study 
at NHS sites in England until 
you receive HRA Approval  
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Document   Version   Date   
IRAS Checklist XML [Checklist_10042017]    10 April 2017  
Participant consent form [Consent form (track changes)]  2  10 April 2017  
Participant consent form [Consent form (no track changes)]  2  10 April 2017  
Participant information sheet (PIS) [Service staff version (track 
changes)]  
2  10 April 2017  
Participant information sheet (PIS) [Service staff version (no track 
changes)]  
2  10 April 2017  
Participant information sheet (PIS) [Smokers/vapers version (track 
changes)]  
2  10 April 2017  
Participant information sheet (PIS) [Smokers/vapers version (no 
track changes)]  
2  10 April 2017  
Participant information sheet (PIS) [Stakeholders version (track 
changes)]  
2  10 April 2017  
Participant information sheet (PIS) [Stakeholders version (no track 
changes)]  
2  10 April 2017  
 
Approved documents 
 
The final list of approved documentation for the study is therefore as follows: 
 
Document   Version   Date   
Contract/Study Agreement [Schedule of Events]  1  15 February 2017  
Copies of advertisement materials for research participants [Poster]  1  15 February 2017  
Copies of advertisement materials for research participants 
[Flyer-type initial info sheet]  
1  15 February 2017  
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [LSHTM sponsor letter]  
1  15 February 2017  
GP/consultant information sheets or letters [Practitioner Letter]  1  15 February 2017  
Interview schedules or topic guides for participants [Dual 
users/smokers version]  
1  15 February 2017  
Interview schedules or topic guides for participants [Service staff 
version]  
1  15 February 2017  
Interview schedules or topic guides for participants [Stakeholders 
version]  
1  15 February 2017  
IRAS Application Form [IRAS_Form_15022017]    15 February 2017  
IRAS Application Form XML file [IRAS_Form_15022017]    15 February 2017  
IRAS Checklist XML [Checklist_15022017]    15 February 2017  
IRAS Checklist XML [Checklist_10042017]    10 April 2017  
Letter from funder [Funding Letter]      
Participant consent form [Consent form (track changes)]  2  10 April 2017  
Participant consent form [Consent form (no track changes)]  2  10 April 2017  
Participant information sheet (PIS) [Service staff version (track 
changes)]  
2  10 April 2017  
Participant information sheet (PIS) [Service staff version (no track 
changes)]  
2  10 April 2017  
Participant information sheet (PIS) [Smokers/vapers version (track 
changes)]  
2  10 April 2017  
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Participant information sheet (PIS) [Smokers/vapers version (no 
track changes)]  
2  10 April 2017  
Participant information sheet (PIS) [Stakeholders version (track 
changes)]  
2  10 April 2017  
Participant information sheet (PIS) [Stakeholders version (no track 
changes)]  
2  10 April 2017  
Referee's report or other scientific critique report [Upgrading report]  1  15 February 2017  
Research protocol or project proposal [Research protocol]  1  15 February 2017  
Summary CV for Chief Investigator (CI) [CI summary CV]    15 February 2017  
Summary CV for supervisor (student research) [Supervisor CV]  1  15 February 2017  
 
You should ensure that the sponsor has a copy of the final documentation for the study.  It is 
the sponsor's responsibility to ensure that the documentation is made available to R&D offices 
at all participating sites. 
 
17/LO/0414 Please quote this number on all correspondence 
 
Yours sincerely 
 
 
Tina Cavaliere 
REC Manager 
 
 
E-mail: nrescommittee.london-camberwellstgiles@nhs.net 
 
 
Copy to: Ms Patricia Henley 
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Mr Gregory J Hartwell 
NIHR Clinical Doctoral Research Fellow 
London School of Hygiene and Tropical Medicine (LSHTM) 
Room 145, 15-17 Tavistock Place 
London 
WC1H 9SH 
 
Email: hra.approval@nhs.net 
 
19 April 2017 
 
 
Dear Mr Hartwell    
 
 
Study title: Understanding influences on the attendance of ‘dual users’ 
of tobacco and e-cigarettes at NHS stop smoking services 
IRAS project ID: 223311  
Protocol number: N/A 
REC reference: 17/LO/0414   
Sponsor London School of Hygiene and Tropical Medicine 
 
I am pleased to confirm that HRA Approval has been given for the above referenced study, on the 
basis described in the application form, protocol, supporting documentation and any clarifications 
noted in this letter.  
 
Participation of NHS Organisations in England  
The sponsor should now provide a copy of this letter to all participating NHS organisations in England.  
 
Appendix B provides important information for sponsors and participating NHS organisations in 
England for arranging and confirming capacity and capability. Please read Appendix B carefully, in 
particular the following sections: 
 Participating NHS organisations in England – this clarifies the types of participating 
organisations in the study and whether or not all organisations will be undertaking the same 
activities 
 Confirmation of capacity and capability - this confirms whether or not each type of participating 
NHS organisation in England is expected to give formal confirmation of capacity and capability. 
Where formal confirmation is not expected, the section also provides details on the time limit 
given to participating organisations to opt out of the study, or request additional time, before 
their participation is assumed. 
 Allocation of responsibilities and rights are agreed and documented (4.1 of HRA assessment 
criteria) - this provides detail on the form of agreement to be used in the study to confirm 
capacity and capability, where applicable. 
Further information on funding, HR processes, and compliance with HRA criteria and standards is also 
provided. 
Letter of HRA Approval 
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Page 2 of 8 
 
 
It is critical that you involve both the research management function (e.g. R&D office) supporting each 
organisation and the local research team (where there is one) in setting up your study. Contact details 
and further information about working with the research management function for each organisation 
can be accessed from www.hra.nhs.uk/hra-approval.  
 
Appendices 
The HRA Approval letter contains the following appendices: 
 A – List of documents reviewed during HRA assessment 
 B – Summary of HRA assessment 
 
After HRA Approval 
The document “After Ethical Review – guidance for sponsors and investigators”, issued with your REC 
favourable opinion, gives detailed guidance on reporting expectations for studies, including:  
 Registration of research 
 Notifying amendments 
 Notifying the end of the study 
The HRA website also provides guidance on these topics, and is updated in the light of changes in 
reporting expectations or procedures. 
 
In addition to the guidance in the above, please note the following: 
 HRA Approval applies for the duration of your REC favourable opinion, unless otherwise 
notified in writing by the HRA. 
 Substantial amendments should be submitted directly to the Research Ethics Committee, as 
detailed in the After Ethical Review document. Non-substantial amendments should be 
submitted for review by the HRA using the form provided on the HRA website, and emailed to 
hra.amendments@nhs.net.  
 The HRA will categorise amendments (substantial and non-substantial) and issue confirmation 
of continued HRA Approval. Further details can be found on the HRA website. 
 
Scope  
HRA Approval provides an approval for research involving patients or staff in NHS organisations in 
England.  
 
If your study involves NHS organisations in other countries in the UK, please contact the relevant 
national coordinating functions for support and advice. Further information can be found at 
http://www.hra.nhs.uk/resources/applying-for-reviews/nhs-hsc-rd-review/. 
  
If there are participating non-NHS organisations, local agreement should be obtained in accordance 
with the procedures of the local participating non-NHS organisation. 
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User Feedback 
The Health Research Authority is continually striving to provide a high quality service to all applicants 
and sponsors. You are invited to give your view of the service you have received and the application 
procedure. If you wish to make your views known please use the feedback form available on the HRA 
website: http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/. 
 
HRA Training 
We are pleased to welcome researchers and research management staff at our training days – see 
details at http://www.hra.nhs.uk/hra-training/  
 
Your IRAS project ID is 223311. Please quote this on all correspondence. 
 
Yours sincerely 
 
Joanna Ho 
Assessor 
 
Email: hra.approval@nhs.net  
 
 
 
Copy to: Ms Patricia Henley, Sponsor Representative, London School of Hygiene and 
Tropical Medicine 
Professor Mark Petticrew, Academic Supervisor, London School of Hygiene and 
Tropical Medicine 
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Appendix A - List of Documents 
 
The final document set assessed and approved by HRA Approval is listed below.   
 
 Document   Version   Date   
Contract/Study Agreement [Statement of Activities]  1  15 February 2017  
Contract/Study Agreement [Schedule of Events]  1  15 February 2017  
Copies of advertisement materials for research participants [Poster]  1  15 February 2017  
Copies of advertisement materials for research participants [Flyer-
type initial info sheet]  
1  15 February 2017  
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [LSHTM sponsor letter]  
1  15 February 2017  
GP/consultant information sheets or letters [Practitioner Letter]  1  15 February 2017  
Interview schedules or topic guides for participants [Dual 
users/smokers version]  
1  15 February 2017  
Interview schedules or topic guides for participants [Service staff 
version]  
1  15 February 2017  
Interview schedules or topic guides for participants [Stakeholders 
version]  
1  15 February 2017  
IRAS Application Form [IRAS_Form_15022017]    15 February 2017  
IRAS Application Form XML file [IRAS_Form_15022017]    15 February 2017  
IRAS Checklist XML [Checklist_15022017]    15 February 2017  
IRAS Checklist XML [Checklist_10042017]    10 April 2017  
Letter from funder [Funding Letter]      
Participant consent form [Consent form]  1  15 February 2017  
Participant consent form [Consent form (track changes)]  2  10 April 2017  
Participant consent form [Consent form (no track changes)]  2  10 April 2017  
Participant information sheet (PIS) [Service staff version (no track 
changes)]  
2  10 April 2017  
Participant information sheet (PIS) [Smokers/vapers version (track 
changes)]  
2  10 April 2017  
Participant information sheet (PIS) [Smokers/vapers version (no 
track changes)]  
2  10 April 2017  
Participant information sheet (PIS) [Stakeholders version (track 
changes)]  
2  10 April 2017  
Participant information sheet (PIS) [Stakeholders version (no track 
changes)]  
2  10 April 2017  
Participant information sheet (PIS) [Service staff version (track 
changes)]  
2  10 April 2017  
Referee's report or other scientific critique report [Upgrading report]  1  15 February 2017  
Research protocol or project proposal [Research protocol]  1  15 February 2017  
Summary CV for Chief Investigator (CI) [CI summary CV]    15 February 2017  
Summary CV for supervisor (student research) [Supervisor CV]  1  15 February 2017  
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Appendix B - Summary of HRA Assessment 
 
This appendix provides assurance to you, the sponsor and the NHS in England that the study, as 
reviewed for HRA Approval, is compliant with relevant standards. It also provides information and 
clarification, where appropriate, to participating NHS organisations in England to assist in assessing 
and arranging capacity and capability. 
For information on how the sponsor should be working with participating NHS organisations in 
England, please refer to the, participating NHS organisations, capacity and capability and 
Allocation of responsibilities and rights are agreed and documented (4.1 of HRA assessment 
criteria) sections in this appendix.  
The following person is the sponsor contact for the purpose of addressing participating organisation 
questions relating to the study: 
 
Name:  Mr Greg Hartwell   
Tel:   0207 927 7915 
Email:   gregory.hartwell@lshtm.ac.uk  
 
 
HRA assessment criteria  
Section HRA Assessment Criteria Compliant with 
Standards 
Comments 
1.1 IRAS application completed 
correctly 
Yes No comments  
    
2.1 Participant information/consent 
documents and consent 
process 
Yes No comments 
    
3.1 Protocol assessment Yes No comments 
    
4.1 Allocation of responsibilities 
and rights are agreed and 
documented  
Yes Sponsor will use the Statement of 
Activities to act as agreement of an 
NHS organisation to participate.  No 
other site agreement is expected. 
4.2 Insurance/indemnity 
arrangements assessed 
Yes Sponsor indemnity is in place for the 
management, design and conduct of 
the study. 
Where applicable, independent 
contractors (e.g. General Practitioners) 
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Section HRA Assessment Criteria Compliant with 
Standards 
Comments 
should ensure that the professional 
indemnity provided by their medical 
defence organisation covers the 
activities expected of them for this 
research study 
4.3 Financial arrangements 
assessed  
Yes No funding will be provided to the 
participating NHS organisations as 
indicated in the Statement of Activities. 
    
5.1 Compliance with the Data 
Protection Act and data 
security issues assessed 
Yes No comments 
5.2 CTIMPS – Arrangements for 
compliance with the Clinical 
Trials Regulations assessed 
Not Applicable No comments 
5.3 Compliance with any 
applicable laws or regulations 
Yes No comments 
    
6.1 NHS Research Ethics 
Committee favourable opinion 
received for applicable studies 
Yes REC Favourable Opinion with 
Conditions issued 29 March 2017; REC 
acknowledgment of Conditions Met 
issued 18 April 2017  
6.2 CTIMPS – Clinical Trials 
Authorisation (CTA) letter 
received 
Not Applicable No comments 
6.3 Devices – MHRA notice of no 
objection received 
Not Applicable No comments 
6.4 Other regulatory approvals 
and authorisations received 
Not Applicable No comments 
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Participating NHS Organisations in England 
This provides detail on the types of participating NHS organisations in the study and a statement as to whether 
the activities at all organisations are the same or different.  
This is a non-commercial single centre study.  All participating NHS organisations will be acting as a 
Participant Identification Centre only undertaking the same activities to identify participants for the 
main research site, there is therefore, only one site-type for this study. 
 
If this study is subsequently extended to other NHS organisation(s) in England to become a research 
site, an amendment should be submitted to the HRA, with a Statement of Activities and Schedule of 
Events for the newly participating NHS organisation(s) in England.  
 
The Chief Investigator or sponsor should share relevant study documents with participating NHS 
organisations in England in order to put arrangements in place to deliver the study. The documents 
should be sent to both the local study team, where applicable, and the office providing the research 
management function at the participating organisation. For NIHR CRN Portfolio studies, the Local 
LCRN contact should also be copied into this correspondence.  For further guidance on working with 
participating NHS organisations please see the HRA website. 
 
If chief investigators, sponsors or principal investigators are asked to complete site level forms for 
participating NHS organisations in England which are not provided in IRAS or on the HRA website, 
the chief investigator, sponsor or principal investigator should notify the HRA immediately at 
hra.approval@nhs.net. The HRA will work with these organisations to achieve a consistent approach 
to information provision.  
 
Confirmation of Capacity and Capability  
This describes whether formal confirmation of capacity and capability is expected from participating NHS 
organisations in England. 
Participating NHS organisations in England will be expected to formally confirm their capacity 
and capability to host this research.  
 Following issue of this letter, participating NHS organisations in England may now confirm to 
the sponsor their capacity and capability to host this research, when ready to do so. How 
capacity and capacity will be confirmed is detailed in the Allocation of responsibilities and 
rights are agreed and documented (4.1 of HRA assessment criteria) section of this appendix.  
 The Assessing, Arranging, and Confirming document on the HRA website provides further 
information for the sponsor and NHS organisations on assessing, arranging and confirming 
capacity and capability. 
 
 
Principal Investigator Suitability 
This confirms whether the sponsor position on whether a PI, LC or neither should be in place is correct for each 
type of participating NHS organisation in England and the minimum expectations for education, training and 
experience that PIs should meet (where applicable). 
A Local Collaborator is expected at participating NHS organisations acting as a Participant 
Identification Centre only.  These have already been identified as listed in Part C of the IRAS form. 
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GCP training is not a generic training expectation, in line with the HRA statement on training 
expectations. 
 
HR Good Practice Resource Pack Expectations 
This confirms the HR Good Practice Resource Pack expectations for the study and the pre-engagement checks 
that should and should not be undertaken 
As a non-commercial study undertaken by local staff substantively employed by the participating 
NHS organisation, it is unlikely that letters of access or honorary research contracts will be 
applicable, except where local network staff employed by another Trust (or University) are involved 
(and then it is likely that arrangements are already in place).   
Where arrangements are not already in place, network staff (or similar) undertaking any of the 
research activities listed in A18 or A19 of the IRAS form (except for administration of questionnaires 
or surveys), would be expected to obtain an honorary research contract from one NHS organisation 
(if university employed), followed by Letters of Access for subsequent organisations.  This would be 
on the basis of a Research Passport (if university employed) or an NHS to NHS confirmation of pre-
engagement checks letter (if NHS employed).  These should confirm enhanced DBS checks, 
including appropriate barred list checks, and occupational health clearance.  For research team 
members only administering questionnaires or surveys, a Letter of Access based on standard DBS 
checks and occupational health clearance would be appropriate. 
 
Other Information to Aid Study Set-up  
This details any other information that may be helpful to sponsors and participating NHS organisations in 
England to aid study set-up. 
The applicant has indicated that they intend to apply for inclusion on the NIHR CRN Portfolio. 
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